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Abstract 
The oesophagus as an organ can be affected by a number of medical conditions 
which may necessitate the need for extensive treatment to correct. One potential 
approach is to tissue engineer a suitable biomaterial-based replacement for 
oesophageal tissue. Small intestine submucosa (SIS) is one of a number of 
naturally-derived extracellular matrix (ECM) biomaterials currently in clinical use; 
however one of their key limitations is poor mechanical properties. 
In this work it was found that SIS can be consistently and reliably processed into 
tubular scaffolds which impart certain potential advantages. The decellularisation of 
tubular SIS was carried out using four different protocols. One protocol emerged as 
the most suitable by the criteria mentioned, a perfusion-based method using sodium 
deoxycholate. 
Electrospinning was used produce to polymers PLGA nanofibres which 
mechanically reinforced the tubular SIS. It was hypothesised that this would improve 
the ECM material’s mechanical properties. Attachment remained an issue between 
the two layers but this was overcome by altering the shape of the SIS. The SIS-
PLGA scaffold was produced with varying fibre alignment, a factor shown to have 
some influence in vitro and in vivo. The drug delivery potential of the fibres was also 
considered and the scaffolds had VEGF added to them. Evaluation was by physical 
testing, in vitro analysis and in vivo implantation.  
The PLGA scaffold were found to perform well both mechanically and in terms of 
biocompatibility. They also performed well in vivo with a limited foreign body 
reaction. The highly aligned fibres (5000 rpm) group was chosen as the best in 
terms of its all-round properties including good cellular infiltration. The electrospun 
fibres remained intact at 4 weeks which indicates a potential lasting support role, 
4 
 
which was intended.  The result of the VEGF incorporation was that there was an 
increase in the blood vessel density of the tissue surrounding the scaffolds 
highlighting the benefits of adding growth factors to the scaffold. Overall, it was 
concluded that the hybrid scaffold have potential for use in oesophageal tissue 
engineering. 
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1.1 - Introduction 
Oesophageal tissue engineering has a spectrum of considerations and 
complications, which make no current approach currently adopted as being deemed 
to be entirely successful. Decellularised extracellular matrix (ECM) represent a 
potential option for a scaffold material however they are inherently limited in their 
physical properties. It was hypothesised that the limitations of an ECM material 
could be overcome by the additional of an electrospun polymer layer and would 
make a hybrid scaffold better suited to the role as an oesophageal scaffold. The 
criteria for a successful scaffold would be determined by creating the scaffold with 
an application in mind. In addition to this, the question was raised and assessed 
whether the ECM material (small intestine submucosa) could be made in a 
seamless tubular form. 
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1.2 - The Oesophagus 
1.2.1  Structure & Function 
The primary role of the oesophagus is the transportation of food and liquids from the 
oral cavity and oropharynx down to the stomach and the on to the rest of the 
gastrointestinal tract. The food or liquids are transported in distinct quantities known 
as boli (singular: bolus), which correspond to material which is swallowed. The 
oesophagus performs this action by a series of peristaltic contractions which occur 
along the length of the organ. A lesser function is the drainage of mucus and saliva 
from the nasal and oral cavities respectively. Finally the oesophagus also facilitates 
the evacuation of stomach contents to the oral cavity when vomiting occurs.  
The oesophagus is a tubular organ that descends within the thorax, alongside the 
trachea, and then through the diaphragm itself into the abdomen where it joins the 
stomach as seen in Figure 1.1(a). The oesophagus possesses two sphincters; an 
upper oesophageal sphincter (the pharyngoesophageal sphincter) and a lower 
oesophageal sphincter (the gastroesophageal sphincter) where it joins the stomach. 
While the outwards appearance of the oesophagus is smooth and featureless the 
internal structure of the oesophagus is quite a complex one. Work carried out on the 
mechanical properties of the passive oesophagus describe the revised structure of 
the oesophagus consisting of three (two in earlier work) separate mechanically 
functional layers (Yang, Fung et al. 2007; Sokolis 2010; Stavropoulou, Dafalias et 
al. 2012). These layers being an inner mucosal-submucosa layer surrounded by a 
muscularis externa layer which is further divided into two distinct layers i.e. the inner 
circumferential muscular layer and the outer longitudinal muscle layer. While 
mechanically they may be intimately associated, the mucosal and submucosal 
layers are well known to be two distinct functional layers.  
16 
 
Structurally speaking, however, there are a far larger number of layers. Starting 
from the lumen there is the mucosa which itself is layered in structure, with the first 
being the epithelial layer which consists of stratified squamous non-keratinized 
epithelium and is commonly found on surfaces which encounter friction. Moving 
outwards there is the lamina propria, which is a connective tissue layer. The final 
mucosal layer is the muscularis mucosae which is a layer of smooth muscle 
consisting mainly of longitudinal muscle fibres. After the mucosa is the submucosa 
containing mucous secreting glands (oesophageal glands) and connective 
structures termed papillae. There are then the two muscular fibre layers (inner 
circumferential and outer longitudinal) both separated by a connective tissue layer. 
The oesophagus also has an outer ―sheath‖ layer, the serosal (adventitia). 
Consequently it can be said that there are at least 7 layers, as seen in Figure 2.1(b) 
& (c). 
 
 
 
 
 
                                                                                                               
Figure 1.1 Physical features of the oesophagus. (a) Location and surrounding tissues. (b) Illustrative cross-section 
highlighting the layered anatomy (from www.hopkins-gi.org- John Hopkins Medicine) (c) Cross-section of the 
human oesophagus: Mucosa (M) consisting of epithelium (E) and the muscularis mucosa (MM), the submucosa 
(SM) and muscularis externa showing the inner circular (IC) and outer longitudinal (OL) muscle layer. (Tan, Chua et 
al. 2012) 
 
(a) 
  (b) 
(c) 
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Another structural feature of the oesophagus is that the muscularis externa varies 
throughout the length of the oesophagus. The upper third of the oesophagus 
consists of skeletal muscle and has the capacity for voluntary contraction. The 
middle third is a mixture of both skeletal and smooth, while the lower third is made 
up entirely of smooth muscle. 
The mechanical structure of the oesophagus is a complex one. An investigation the 
mechanical properties of the oesophagus by Yang et al. (Yang, Fung et al. 2007) 
describes how, in the rat oesophagi studied, the mucosa/submucosa layer was 
much stiffer than the muscle layer in both the longitudinal and the circumferential 
directions, as well as in shear.  Thus, the oesophagus was found to be anisotropic 
and non-homogeneous. 
1.2.2 Clinical Significance 
There are a number of widespread medical conditions which necessitate surgical 
treatment for damaged or missing lengths of the oesophagus usually due to surgical 
removal or developmental malformation. While less common oesophageal trauma 
might also necessitate such treatment. Some of the most common conditions which 
might involve treatment of this nature are listed below. 
1.2.2.1 Oesophageal Atresia 
This is a congenital medical condition which presents in new-born children in which 
the oesophagus ends in a blind-ended pouch as opposed to connecting normally 
with the stomach. In 85-88% of cases it also presents with associated 
tracheoesophageal fistula, involving one or both unconnected ends of the 
oesophagus forming abnormal communications with the trachea. Oesophagus 
atresia appears in most populations with a frequency of between 1 and 2,500 to 
4,500 live births.  (Holland and Fitzgerald 2010).  
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In the majority of cases treatment of this condition is usually in the form of primary 
repair where the two ―free‖ ends of the oesophagus are surgically connected 
following any required fistula sectioning. In cases referred to as ―long gap‖ this is not 
possible and alternative methods are required. The number of methods that can be 
employed is extensive and will usually be determined by the condition of the host 
oesophagus and the location and type of any fistula present. Methods include either 
delayed primary anastomosis following dilation, or a variety of surgical oesophageal 
lengthening techniques including the creation of flaps, spiral myotomy and gastric 
division (Spitz, Kiely et al. 1996). 
The indications for actual oesophageal replacement are quite rare, though causes 
include intractable corrosive strictures, extended long gap situations or in cases 
where there have been repeated failed attempts at retaining the host oesophagus 
and the infants life is at risk (Spitz 2007; Arul and Parikh 2008).  In current clinical 
practice there are currently three predominant methods used on children requiring 
oesophageal replacement; gastric transportation, colonic interposition and jejunal 
interposition (Spitz 2007). All three methods are quite pronounced in their levels of 
surgical invasiveness and an alternative to these methods would provide a 
significant improvement as no further organs would have to be compromised. 
This condition represents the most likely application for oesophageal tissue 
engineering as here an implanted scaffold would form the basis of a treatment. The 
following two conditions, while undoubtedly could benefit from tissue engineered 
approaches, are neoplastic in origin and therefore the scaffolds use would only be 
reconstructive in nature following more conventional treatment forms. 
1.2.2.2 Barratt’s Oesophagus 
This is a pathologic change in the cells lining the lower oesophagus from normal 
squamous epithelial cells to metaplastic specialised columnar cells, a type found in 
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the intestine. The condition is highly associated with chronic gastro-oesophageal 
reflux disease (GORD or GERD) which has a  damaging effect on the lower 
oesophageal cells and it is presumed that the high degree of cellular renewal and 
replacement creates the opportunity for columnar metaplasia (the name for this 
process of metaplastic replacement) (Spechler 2000). These metaplastic cells in 
Barrett’s oesophagus are prone to develop genetic changes which then can then 
lead to malignancy. Indeed, both GORD and Barrett’s Oesophagus are considered 
clinical risk factors for oesophagus adenocarcinoma. Barrett’s oesophagus is 
diagnosed in approximately 10-15% of patients who present with reflux and have 
undergone an endoscopy (Vaira, Gatta et al. 2011).  
1.2.2.3 Oesophageal Cancer  
Oesophageal cancer is a highly prevalent condition and has been observed to be 
increasing in incidence worldwide (Hartel and Wente 2004). In 2007 oesophageal 
cancer accounted for an estimated 400,000 deaths annually (Smith et al., 2008) and 
was the sixth leading cause of cancer-related deaths worldwide (Lin and 
Papadopoulos, 2007) and this is currently likely to be higher.  It has a higher 
incidence rate in the regions of India, China, Iran and Africa where it can be 
between 10-100 times more common than worldwide averages (Ritchie, Chian et al. 
2006). In the United States alone, in 2011 there were 16,980 new cases and 14,710 
deaths (Kuppan, Sethuraman et al. 2012). There are two predominant types which 
occur which are adenocarcinoma and squamous carcinoma. Diagnosis of this 
condition has not progressed to the stage where it can detected early and the 5-
year survival rate amongst suffers of the oesophageal cancer is less than 5%. 
Oesophageal cancer is difficult to treat and this has been attributed to the poor 
regenerative properties of oesophageal tissue (Kuppan, Sethuraman et al. 2012). 
Squamous cell carcinoma and adenocarcinoma are both aggressive malignancies 
largely require surgical removal of the portion of affected oesophagus (Tan, Chua et 
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al. 2012). While current surgical techniques are often employed to bridge any gaps 
these are large relatively destructive in nature necessitating surgical relocation of 
intestinal segments or in extreme cases sectioning and repositioning of the stomach 
itself. A tissue engineered construct which was able to be used as an alternative 
would represent a significant step forward.  
1.2.3 Tissue Engineering as an Approach to Treatment 
An alternative approach to conventional surgical techniques is the repair of 
damaged or malformed oesophageal tissue with tissue engineered constructs. 
Tissue engineering approaches have been used for a variety of different 
applications including the regeneration of bone, skin,  cardiovascular tissues , and  
nervous tissue  to name only a few (Kuppan, Sethuraman et al. 2012).   
1.2.3.1 Properties of an Ideal Replacement 
The foundation of any tissue engineered construct is usually the scaffold. The 
scaffold forms the primary support for the cells grow and multiply upon and can be 
permanent or temporary. Principally the scaffold should have suitable levels of 
porosity, surface chemistry and mechanical properties to aid cell attachment. 
Important other in vivo events such as tissue organisation, matrix deposition and 
angiogenesis have also been shown to be influenced by scaffold characteristic such 
as the surface morphology, size distribution of  porosity, geometry and thickness 
and so these factors need to be taken into consideration (Ritchie, Chian et al. 2006; 
Kuppan, Sethuraman et al. 2012). 
In the case of the oesophagus, a cylindrical structure with a complex layered 
morphology, an ideal scaffold should also have a cylindrical shape and aim to 
replicate some of the complex functional layers which may necessitate the use of a 
composite material. A scaffold should be biocompatible and not cause inflammation 
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to any significant degree and should have a level of micromorphology present which 
will also facilitate cell regeneration.  The composite materials should be 
biodegradable and the degradation rate should reflect the tissue regeneration time, 
and in doing so also function as an oesophagus replacement until regeneration has 
occurred. It should also be resistant to hot and cold temperatures associated with 
food and drink in addition to the reflux of gastric juices from the stomach. The 
scaffold should have sufficient mechanical strength to withstand abrasive forces and 
pressure generated by the bolus in addition to resisting the forces associated with 
suturing. It should have a large enough burst strength to allow for normal function 
without the risk of rupturing. To maintain its mechanical properties the oesophageal 
scaffold will have to be able to minimise a fibrosis reaction. The porosity of the 
scaffold will also be highly significant; outer pore sizes in the range of 50 to 200 μm 
are able to facilitate cell seeding, and transport of waste and nutrients, and smaller 
pores in the range of 35 to 70 μm are considered important in the promotion of 
angiogenesis (Ritchie, Chian et al. 2006; Poghosyan, Gaujoux et al. 2011; Kuppan, 
Sethuraman et al. 2012; Tan, Chua et al. 2012).  
1.2.3.2 Past and Current Approaches  
A number of different tissue engineering approaches have been investigated for 
oesophageal defect repair and short-segment replacement. Earlier approaches 
were dominated by non-resorbable materials. Some of the materials which were 
used for defect repair were tubular silicone, polyethylene terephthalate (Dacron) and 
expanded polytetraflouroethylene. These materials were not particularly 
biocompatible and their use resulted in chronic infection, material extrusion, 
anastomotic leakage, stricture and poor tissue growth (Poghosyan, Gaujoux et al. 
2011; Kuppan, Sethuraman et al. 2012; Tan, Chua et al. 2012). These results have 
prompted to the move to biodegradable materials (both synthetic and natural) and 
ECM (extracellular matrix) materials.  
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Polymer scaffolds have been one of the most studied approaches for oesophageal 
tissue engineering. The number of approaches is growing and is covers a large 
range of materials. Natural materials have been used and some have shown some 
promising results. The use of glutaraldehyde cross-linked bovine collagen sheets 
was investigated in conjunction with ovine oesophagus epithelial cells  and patches 
of oesophageal epithelium organization were observed on the luminal side and 
vascular ingrowths on the outer surface (Saxena, Baumgart et al. 2010). Collagen in 
graft form has also been investigated (OptiMaix®) (Kuppan, Sethuraman et al. 
2012) and showed some smooth muscle and tissue organisation.  Collagen sheets 
have also been cultured with multiple cell types also showed good tissue growth 
and promising oesophageal organisation (Hayashi et al. 2004). Ultimately, the 
limitation of natural polymers was rapid  degredation, poor mechanical strength and 
inflammatory responses (Kuppan, Sethuraman et al. 2012).  
Synthetic polymers represent an alternative to the natural polymers. They also have 
the advantage of being highly modifiable with respect to degradation rates, pore 
sizes and mechanical properties. Poly (L-lactic acid) (PLLA), poly (lactide-co-
glycolide) (PGLA), poly (caprolactone) (PCL), poly(glycolic acid) PGA, poly(L-
lactide-co-caprolactone) (PLLC) are all polymers that have been used in various 
approaches in oesophageal tissue engineering.   
Electrospun PLLC fibres were used to construct a tubular scaffold with the use of a 
rotating mandrel modified with fibronectin, and cultured with porcine oesophageal 
epithelial cells (Zhu, Leong et al. 2007). Immunochemistry showed good 
oesophagus-resembling epithelial morphology particularly on the modified scaffold 
over the unmodified. A scaffold made from non-woven polyglycolic acid along with 
oesophagus organoid units of rat origin (mesenchyme surrounded by epithelial 
cells) were tested in vivo, using a rat model and histology revealed a seemingly 
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complete oesophagus wall. Immunostaining also confirmed smooth muscle was 
present by staining for α-actin. (Grikscheit, Ochoa et al. 2003) 
Polymer scaffolds which are made without the addition of cells for oesophageal 
tissue engineering are not common and have not met with much success. One of 
the advantages of this approach, however,  is that is promotes growth from the 
surrounding epithelium (Kuppan, Sethuraman et al. 2012). One of the major 
disadvantages is that this approach is quite slow, with epithelial regeneration taking 
3 to 4 weeks (Saxena, Ainoedhofer et al. 2009). In studies where a section of 
oesophagus was replaced common complications included stricture, dilation and the 
lack of significant muscle growth (Doede, Bondartschuk et al. 2009).  
An alternative to polymer scaffolds is the use of ECM (extracellular matrix) 
materials. ECM material will be discussed in more depth in Section 1.3. A number of 
different ECM materials have been applied to oesophageal tissue engineering 
including small intestine submucosa (SIS), urinary bladder matrix (UBM), dermal 
grafts, and also acellular tissues such as the oesophagus and aorta (Lopes, Cabrita 
et al. 2006; Doede, Bondartschuk et al. 2009; Gu and Zhang 2011; Basu, Mihalko et 
al. 2012). Patches in a rat model have shown that there was promising growth when 
used to repair defects using UBM  (Basu, Mihalko et al. 2012) and SIS (Lopes, 
Cabrita et al. 2006). However, when SIS was used in a tubular form in a porcine 
model the results were largely unsuccessful with severe stenosis reported in several 
animals (Doede, Bondartschuk et al. 2009). The mechanical properties of the 
material were likely a contributing cause for this failure and the authors also indicate 
that a biodegradable stent which was able to function during the initial ―problematic‖ 
three month period may be a possible solution to the observed failures.  
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1.2.3.3 Properties of an Oesophageal Scaffold 
As mentioned previously, the ideal medical condition for which oesophageal tissue 
engineering could be applied is in oesophageal atresia.  Consequently the scaffolds 
for this purpose would be required to have some specific properties beyond that 
those discussed above particularly with respect to how the scaffold will be applied in 
vivo.  This will be discussed further in Section 1.5 Aims and Objectives. 
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1.3 - ECM materials 
1.3.1 Background and Composition 
The extracellular matrix is made up of a highly complex cross-linked network of 
various proteins and other macromolecules of which collagen is the principle 
structural component. The structural and functional molecules present in the ECM 
includes; proteins, proteoglycans, glycosaminoglycans, glycoproteins and other 
small molecules. The matrix aids in organising the cells in space and additionally 
provides attachment, environmental signals and separation between tissues. The 
use of extracellular matrices (ECMs) as surgical materials has become a successful 
and established practice for a number of years. These materials consist of the 
processed, and yet largely intact, ECM sourced from a variety of allogeneic or 
xenogeneic tissues. The increasing variety of different tissue types all individually 
vary in their composition and properties, consequently they are suitable for different 
applications. ECM materials in clinical use, have been created  with the goal being 
to preserve as much of the composition and structure of the ECM as possible 
without any adverse effects to the recipient (Badylak 2004; Badylak 2005; Hodde 
2006; Huber and Badylak 2011).  
The function of the extracellular matrix is not only limited to functioning as a 
constituent of mature tissues. Additionally, the ECM plays a crucial role in 
embryonic development by acting to mediate biophysical stimuli, biochemical and 
molecular signalling and spatial organisation (Song and Ott 2011). The ECM 
continues to play important roles throughout development, up to and including 
organogenesis. A process of dynamic reciprocity occurs where the constant 
interchange between cells and the ECM occurs, and aiding in determining cell fate 
and influencing the shift from proliferation to structural formation  (Bissell, Hall et al. 
1982). The ECM continues to play a role and is also influential though to organ 
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maturation and even plays an active role in organ maintenance and repair (Song 
and Ott 2011). 
ECM, as all biomaterials, have to be assessed carefully prior to application in a 
clinical capacity.  A large number of factors can affect can affect their clinical 
behaviour including the tissue type and source, structure, composition, the type of 
processing performed, and the relative in vivo performance of the material at the 
site of application.  
In clinical use extracellular matrix materials are derived entirely from mammalian 
sources and to date these have been human, porcine, bovine or equine in origin 
(Badylak, Freytes et al. 2009). The tissues from which ECM can be isolated from 
including small intestine (Badylak 1989), urinary bladder (Merguerian, Reddy et al. 
2000), skin (Wainwright 1995), liver (Sellaro, Ravindra et al. 2007) , skeletal muscle 
(Borschel, Dennis et al. 2004), heart valves (Bader, Schilling et al. 1998) blood 
vessels (Conklin, Richter et al. 2002),  nerves (Dufrane, Mourad et al. 2008; Huber 
and Badylak 2011), fascia lata (Barber and Aziz-Jacobo 2009),  tendons (Omae, 
Zhao et al. 2009) and ligaments (Woods and Gratzer 2005). Given the variety of the 
source material it is understandable that significant differences in the structure, 
function and molecular characteristics of each ECM material exist. An example of 
this is in the comparison of the two most frequently used materials, small intestine 
submucosa (SIS) and urinary bladder matrix (UBM) in terms of the relative 
quantities of different collagen forms. ECM materials made from SIS typically 
contain approximately 90% collagen, which is predominately collagen type I,  with 
smaller quantities of collagen types III, IV, V and VI (Badylak, Tullius et al. 1995). 
ECM materials made from UBM, however, have been shown to have larger 
amounts of collagen types III and IV, type IV being notable as it is an important 
epithelial basement membrane component and therefore is characteristic of the 
source tissue being highly epithelial (Brown, Lindberg et al. 2006).  
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An extensive amount of research has been carried out on SIS in recent years with 
respect to its components. In addition to the most abundant component collagen, 
there is also glycosaminoglycans (GAGs), including heparin, hyaluronic acid, 
heparin sulfate, chondroitin sulfates (Hodde, Badylak et al. 1996); proteoglycans 
such as dorcin (Badylak, Freytes et al. 2009); glycoproteins such as biglycan and 
enactin (Badylak, Freytes et al. 2009); in addition to a number of  adhesion 
molecules such as fibronectin and laminin (Hodde, Record et al. 2002; Brown, 
Lindberg et al. 2006). A large variety of  growth factors (Roberts, Gallagher et al. 
1988) are also found including, transforming growth factor (TGF-b) (VoytikHarbin, 
Brightman et al. 1997; McDevitt, Wildey et al. 2003); basic fibroblast growth factor 
(b-FGF) (VoytikHarbin, Brightman et al. 1997), and vascular endothelial growth 
factor (VEGF) (Hodde, Record et al. 2001). This list is by no means exhaustive and 
a study carried out on decellularised UBM using high-performance liquid 
chromatography with an ion trap mass spectrometer identified 129 distinct proteins 
with a large spectrum of functional roles and with 14% native to the ECM with  39% 
of those being cytoplasmic in origin (Marcal, Ahmed et al. 2012). While the 
composition of ECM materials differs they all broadly share the same component 
macromolecules with each other and with the tissues into which they are implanted 
and this is likely one of their reasons for success. 
The composition of ECM materials is undoubtedly important but structure also plays 
a significant role in the materials interaction with the surrounding cells and tissue 
(Brown, Barnes et al. 2010). Using time of flight mass spectroscopy and SEM the 
ultrastructure and the molecular composition of three porcine lab-prepared 
decellularised ECM materials were analysed; SIS, UBM and liver matrix were 
shown to have significant differences not only in their composition both also in their 
ultrastructure (Brown, Barnes et al. 2010). In a different study carried out using the 
same three matrices with in vitro culture using hepatic sinusoidal endothelial cells it 
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was found that that the liver based scaffold was better able to culture cells and for a 
longer duration than the two other matrices (SIS and UBM) (Sellaro, Ravindra et al. 
2007).  Therefore the origin of the tissue will likely have an effect on the cellular 
phenotype with which it interacts.  Additionally it was shown (Brown, Barnes et al. 
2010) that there were also ultrastructural differences in the individual UBM and SIS 
matrices between  the two planar faces i.e. between the luminal face and the 
abluminal face, though obviously the liver tissue was shown not have this 
characteristic though the actual significance of this is currently unknown. In 
summary the microstructure of the ECM will likely influence cellular interaction and 
the behaviour of the material and is different for each ECM. 
The composition and the ultrastructure of a material are not the only factors which 
influence cell-scaffold integration with other scaffold properties such as ligand 
presence and presentation (Hodde, Record et al. 2002; Quirk, Kellam et al. 2003; 
Beckstead, Santosa et al. 2006) the hydophilicity/hydrophobicity (Jansen, Sladek et 
al. 2005), mechanical properties (Rehfeldt, Engler et al. 2007) and surface 
topography (Flemming, Murphy et al. 1999; Henry, Burugapalli et al. 2009) also 
shown to play a role, amongst a large number of other factors .  
 
1.3.2 Advantages over synthetic materials 
The effective use of ECM materials depends largely on their post implantation in 
vivo properties at the localised site of treatment. The immune response of a host to 
any implantable device will always be a very important consideration. In the study of 
organ transplantation, it is a well-established fact that immune recognition of 
―foreign‖ antigens, whether xenogeneic or allogeneic, is followed by the production 
of pro-inflammatory mediators, cytotoxicity and in extreme cases, subsequent organ 
rejection (Brown, Valentin et al. 2009). This extreme rejection response has not 
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been observed with the use ECM materials. Work has been carried out which has 
shown that the macromolecules present in the ECM are quite well conserved 
between mammalian species and are quite well received even if xenogeneic in 
origin. The ECM materials are found to provoke a reaction in accordance with 
integration into the host tissue or degraded by non-immunogenic means (Badylak, 
Taylor et al. 2011). 
Studies have shown that decellularised xenogeneic ECM grafts are found to elicit an 
immune response which is restricted to Th2 lymphocytes (Allman, McPherson et al. 
2001).  This response is believed to be conducive to graft acceptance, and which 
differs from Th1 lymphocyte-mediated immune response which is more commonly 
associated with xenogeneic graft rejection (Bach, Ferran et al. 1997). The immune 
response associated with ECM materials has also been identified as having an 
increased presence of alternatively activated M2 macrophages and also associated 
low levels of pro-inflammatory cytokines (Brown, Valentin et al. 2009; Keane, 
Londono et al. 2012). 
It is believed that following the in vivo degradation of ECM materials there is a 
release of growth factors and biologically active cryptic peptides whose action can 
directly influence the processes of angiogenesis, mononuclear infiltration, cell 
proliferation, cell migration and cell differentiation (VoytikHarbin, Brightman et al. 
1997; Valentin, Badylak et al. 2006). Cumulatively all these processes are important 
for new tissue formation which is undoubtedly one of the fundamental functional 
clinical benefits which ECM materials provide. The rapid degradation of the ECM 
materials in conjunction with the resultant release of the growth factors both 
contribute towards successful constructive tissue remodelling.  
Generally speaking degradation does result in an initial loss with respect to 
mechanical strength during the early phase of in vivo modelling. However 
30 
 
subsequent newly infiltrated cells experience mechanical stress which initiates the 
formation of new ECM. With the development of this new site-specific tissue 
strength eventually increases though this process does take time (Badylak, Kokini et 
al. 2001).  
To improve their properties, ECM’s have been modified by cross-linking.  However 
the effects of the in vivo implantation to ECM are altered when the ECM materials 
have been chemically cross-linked using glutaraldehyde, carbodiimide or 
hexamethylene-diisocyanate, or even through the use of non-chemical means. The 
benefits of cross-linking are quite well known in that the mechanical strength of the 
material is improved and the rate of scaffold degradation is reduced (Huber and 
Badylak 2011). However as a consequence these modification can result in the 
development of a chronic, pro-inflammatory, foreign-body type tissue response 
upon implantation and consequently a lower level of constructive remodelling. This 
adverse host response is observed in the higher proportion of M1 macrophages, a 
higher level of pro-inflammatory cytokines and the initiation of a Th-1 response 
which corresponds with a cell-mediated immune response (Mosser 2003) which is 
not dissimilar to that observed with synthetic polymers scaffolds. The negative 
impact on the healing and regenerative responses elicited by the material as a 
result of cross-linking is well researched (Brennan, Reing et al. 2006; Beattie, 
Gilbert et al. 2009). In addition to this, while SIS has also demonstrated the ability to 
delay clotting, crosslinking of the material resulted in an increase in clotting time.  
(Glynn, Polsin et al. 2014) 
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1.3.3 Small Intestine Submucosa (SIS) 
1.3.3.1 Background 
Small intestine submucosa is a material what has been the subject of research for a 
significant period of time. Work done as early 1966 by Matsumoto et al., used 
various sections taken from the jejunum of the small intestine and used it as a 
vascular graft in a canine model. Different variations of the jejunum were grafted 
between ends of the vena cavae of the animals and one variation contained only the 
submucosa which was prepared by ―vigorous abrasion of the serosal and mucosal 
surface with gauze‖.  The method for isolating this layer seems to have been 
established here. The study was carried out with a large number of animals and all 
those with the mucosal lining facing the blood flow failed. It is important to note that 
the SIS used in this work was grafted in an inverted orientation.  So while it was 
deemed to be successful its orientation was not a reason for its success 
(Matsumoto, Holmes et al. 1966; Matsumoto, Holmes et al. 1966). 
Inverted SIS in the canine model was again investigated as a vascular graft by 
Lawler et al. The finding from this work indicated that inverted SIS was again 
successful as an autograft for the thoracic vena cava (though the same success 
was not achieved with the abdominal vena cava, and this was consistent with other 
work). The use of preserved homografts from donor dogs was also observed to be 
quite successful. The issues of rejection were not very well analysed in this work. 
(Lawler, Foster et al. 1971) 
Preserved SIS homografts were observed to initially function well when applied to 
the thoracic aorta up to six months, prior to aneurysms developing. When these 
grafts were analysed with elastin stains they were observed to show “absence of 
strong supporting fibers‖. The fresh samples did not perform as well as the 
preserved ones when used as aortic grafts. In order to even prevent immediate 
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aneurysmal dilatation of the fresh tissue the segment were actually carefully 
prepared to be “tailored to size and muscularis of the bowel wall left attached to the 
submucosa”. What could be inferred here is that the turnica muscularis layer gave 
the SIS grafts some addition mechanical support and prevented failure. With 
additional thickness made of a smooth muscle it appears quite logical that these 
grafts would have better mechanical properties than SIS alone (Lawler, Foster et al. 
1971).  
1.2.3.2 Heterogeneity in SIS 
While the commercial SIS is produced in the form of a uniform sheet there is some 
evidence for a degree of heterogeneity present in the tissue of origin. The 
organisation of the divisions of the small intestine is as follows (in bold): stomach  
pyloric valve  duodenum  jejunum  ileum  ileocecal valve. The duodenum 
of the small intestine is usually discarded, so Raghavan et al. took SIS samples 
labelled proximal (from the proximal end of the jejunum) and distal (from the distal 
end of the ileum) and analysed these as separate samples.  The distal samples 
were shown to be more elastic in tensile tests and also less permeable to urea. The 
surface structure was observed to be different (i.e. proximal being more porous) 
using SEM imaging however this was not quantified and there was no evidence to 
suggest that this difference was present throughout the thickness of the SIS 
(Raghavan, Kropp et al. 2005). This reinforces the notion that the material is 
intrinsically heterogeneous. In a previous canine bladder augmentation study it was 
demonstrated that distal SIS remarkably enhances bladder regeneration relative to 
proximal SIS, reduces the risk of both heavy scarring and calcification, and resulted 
in greater smooth muscle bundle formation (Kropp, Cheng et al. 2004). A more 
recent study has shown that in a rat model for bladder regeneration proximal and 
distal SIS samples were shown to have different immune cell profiles over a 56 day 
time period (Ashley, Roth et al. 2010).  
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While these are important considerations it should be mentioned that in all the 
above cases the proximal and distal samples were taken from quite extreme ends of 
the small intestine and any inherent differences are likely to be exaggerated as the 
structural changes also occur in a gradual fashion. In all these cases the application 
was only limited to bladder regeneration therefore these apparent differences might 
not manifest in other applications.  
1.2.3.3 Applications of SIS  
SIS is one of the most frequently used ECM materials along with urinary bladder 
and dermal materials. There are a significantly large number of applications for 
which commercially available SIS products, in their various forms and brands, are 
being applied with some listed in Table 1.1. SIS as a material is used in the repair of 
multiple types of hernia (Franklin, Gonzalez et al. 2004) and are also in use for the 
repair of the rotator cuff tendon of the shoulder joint (Derwin, Baker et al. 2006; 
Ricchetti, Aurora et al. 2012). It has been used extensively in urological and 
gynaecological surgery, including bladder repair, pelvic organ prolapse repair, 
stress urinary incontinence treatment and Peyronie’s disease treatment amongst 
others. It has also been applied gastrointestinal surgery; for the use of anal fistula 
closure and small intestine reparative surgery. Other applications in which SIS has 
been used include in abdominal wall repair, general wound healing when 
augmentation of primary closure is required, burns treatment, ulcer treatment, 
localised head and neck tissue repair, post-mastectomy breast reconstruction, 
cardiovascular repair and as a dural replacement/graft (Misseri, Cain et al. 2005; 
Derwin, Baker et al. 2006; Bejjani, Zabramski et al. 2007; Trabuco, Klingele et al. 
2007; Hoshiba, Lu et al. 2010; Huber and Badylak 2011; Stokes 2011; Caione, 
Boldrini et al. 2012). This list is by no means exhaustive and new more varied 
applications will undoubtedly arise.  
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Table 1.1 A selection of commercially available SIS products.  
Product   Company   Material   Processing   Form 
CuffPatch
TM
   Arthrotek  
 Porcine small 
intestinal submucosa 
(SIS)  
  Crosslinked   Hydrated sheet 
Durasis
 TM
  SIS Cook  
 Porcine small 
intestinal submucosa 
(SIS)  
 Natural   Dry sheet 
Oasis
 TM
  Healthpoint  
 Porcine small 
intestinal submucosa 
(SIS)  
 Natural   Dry sheet 
Restore
 TM
  DePuy  
 Porcine small 
intestinal submucosa 
(SIS)  
 Natural   Dry sheet 
Stratasis
 TM
   Cook  
 Porcine small 
intestinal submucosa 
(SIS)  
 Natural   Dry sheet 
Surgisis
 TM
  Cook  
 Porcine small 
intestinal submucosa 
(SIS)  
 Natural   Dry sheet 
 
1.3.3.4 SIS in Research  
Clinical applications aside, extracellular matrix materials are currently being 
researched in a variety of different application in both in vitro and in vivo animal 
studies. SIS has been researched in numerous different potential applications, 
including tracheal reconstruction (Du, Kwon et al. 2012), oesophageal repair 
(Badylak, Meurling et al. 2000), small intestine interposition (Qin and Dunn 2011), 
vascular repair (Sandusky, Badylak et al. 1992; Fallon, Goodchild et al. 2012; 
Wang, He et al. 2012). SIS has also been applied for corneal reconstruction in an 
animal study (cats and dogs) involving 106 individual cases where materials was 
found to be an excellent alternative to conventional conjunctival grafts with nearly 
69.8% of cases had healing with no or discrete healing scars, and the remaining 
cases had only mild or marked scarring. Additionally, vision was preserved in all 
eyes at three months post-surgery (Goulle 2012).  
SIS was also compared with decellularised skeletal muscle in muscle tissue 
engineering, though no clear advantage of muscle ECM over the control SIS was 
found (Borschel, Dennis et al. 2004; Wolf, Daly et al. 2012). Additionally myocardial 
repair has been carried out using by SIS patch (Badylak, Obermiller et al. 2003; 
Kochupura, Azeloglu et al. 2005; Kelly, Rosen et al. 2009).  
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Further development will most likely be the development of new modified or hybrid 
materials, some early examples of which are UBM/Polyglycolic acid (Eberli, Filho et 
al. 2009) and SIS/Hyaluronic Acid (Roth, Mondalek et al. 2011). These 
developments will, of course, also compete with efforts to make entirely artificial 
extracellular matrices (Kim, Park et al. 2011). 
1.3.3.5 Limitations of SIS 
It is well known that the main limitation of SIS, and indeed, all ECM materials is that 
they do not provide any significant level of mechanical stability (Badylak, Freytes et 
al. 2009). In addition to this they are known to lose mechanical properties relatively 
rapidly as they are remodelled in vivo. Consequently there have been attempts 
made to improve these properties through cross-linking however, as mentioned 
previously, this approach negatively impacts their in vivo performance. Another 
approach has been to make the SIS in multilaminate form, which is the method 
used for most commercial products available.  
 
1.3.4  Decellularisation 
1.3.4.1 Background 
The use of a decellularised matrix has been well described in the literature. Work 
done as early as 1972 isolated renal tubular basement membranes from rabbits 
kidneys by decellularising proximal convoluted, proximal straight, and cortical 
collecting tubules by a perfusion method using  sodium deoxycholate (Welling and 
Grantham 1972). They also investigated using the same method but alternatively 
using Triton X-100. The result was a tubular sheath described as ―transparent‖ 
which is a common observation of decellularised matrices. While the purpose of 
their work was carried out to study the physical properties of the matrix, and not 
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concerned with for example cell culture work, the method they utilised is readily 
identifiable in today’s tissue engineering practices. They also found that sodium 
deoxycholate consistently yielded tubular basement membrane fragments entirely 
free of adherent cellular debris. 
Work done by Meezan et al. (Meezan, Hjelle et al. 1975) isolated basement 
membranes from a variety of tissues including bovine retinal and brain blood 
vessels, rabbit renal tubules and rat renal glomeruli. Their method did not aim to 
preserve the structure of the tissue, however they did utilise 4% sodium 
deoxycholate, 0.1% sodium azide (which was used to “lyse the cells and release the 
intracellular contents”), and DNase (Deoxyribonuclease 1), and all of these reagents 
are readily identifiable in modern decellularisation protocols. The use of 
centrifugation stages indicates that their aim was to merely isolate, and not 
preserve, the basement membranes. They described their method, i.e. 
deoxycholate treatment, as not altering the chemical composition of the basement 
membrane.  
This method has also been used in a more modern context. A modified version of 
this method was used in the decellularisation of the trachea by Conconi et al. 
(Conconi, De Coppi et al. 2005) . The method was used here in the form of 
repeated cycles which had the effect of producing a decellularised scaffold which 
was subsequently used in patient treatment (Macchiarini, Jungebluth et al. 2008). 
The use of this method was also then used by Totonelli et al. (Totonelli, 
Maghsoudlou et al. 2012) and applied to the decellularisation of the rat small 
intestine using a perfusion method. In summary the method described has shown a 
degree of effectiveness in decellularisation that has been successfully applied to a 
number of different tissues  
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The use of the detergents is quite common generally in the area of tissue 
engineering.  Triton X-100 is a detergent which has been in use for some time. Its 
early use has been well described by Cortijo et al. (Cortijo, Dixon et al. 1987). This 
work also describes a number of tissues which have been decellularised with this 
agent. SDS is another detergent which has been shown to be an extremely useful 
for decellularisation, and described in early work as breaking down cell membranes 
by  ―generally disrupting all tertiary and quaternary structure in the formation of rod 
shaped protein-dodecyl sulfate complexes‖[sic](Clarke 1981) 
For any ECM to function in vivo it must be suitably decellularised as the presence of 
specific cell membrane epitopes and DNA, xenogeneic or allogeneic, could result in 
an adverse immune response upon implantation (Gilbert, Freund et al. 2009). In 
reviewing tissue decellularisation Crapo et al. proposed a potential framework of 
three criteria to determine satisfactory decellularisation. These criteria are; <50ng 
dsDNA (double stranded DNA) per mg of ECM (dry weight), a lack of visible nuclear 
material in tissue sections stained with 4’,6-diamidino-2-phenylindole (DAPI) or 
Hematoxylin and Eosin (H&E), and <200bp DNA fragment length (Crapo and Gilbert 
2011). It should be stated that these criteria are theoretical as no substantial work 
has been carried out which establishes the threshold level of cellular remnants in 
ECM materials that elicits a negative remodelling response. 
1.3.4.2 ECM Material Production 
The production of ECM materials is a biochemical, physical and mechanical 
multistage process which aims to remove the cellular content of the ECM. It aims to 
do this while preserving the mechanical integrity, the composition and the biological 
activity of the remaining ECM matrix. The stages involved include physical 
manipulation to extricate and isolate the tissues; one or more means of actual 
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decellularisation usually in a particular sequence, disinfection, lyophilisation and/or 
hydrolysation, followed by final sterilisation.  
Most commercial ECM products available today are processed into sheets prior to 
decellularisation which also necessitates at least one further step. In the case of 
porcine SIS the cylindrical intestine segments are cut to produce sheets which will 
then undergo gentle mechanical abrasion to remove the layers of the intestinal wall 
either side of the submucosa (Lantz, Badylak et al. 1990). Porcine urinary bladder 
matrix is also largely produced in a similar manner (Hodde, Record et al. 2002). 
Once isolated, the sheet-like ECM material undergoes the actual process of 
decellularisation and DNA removal. It is understood that any decellularisation 
requires a degree of disruption of the ECM to allow for adequate exposure to 
reagents and to provide a pathway for the removal of cellular debris (Gilbert, Sellaro 
et al. 2006). The actual process of decellularisation is achieved in a number of 
ways. Detergents, hypotonic or hypertonic solutions, acids, bases, solvents, 
alcohols and enzymes or other biological agents have all been applied for this 
purpose. A number of physical means have also been employed including freeze-
thawing, agitation, temperature, sonication, force and pressure and also non-
thermal irreversible electroporation (NTIRE) (Gilbert, Sellaro et al. 2006; Crapo and 
Gilbert 2011).  
The process of decellularisation is not uniquely applied in the preparation of ECM-
derived materials, the process has also been applied to a large number of intact 
tissues for the purposes of tissue engineering (which are not covered here and are 
reviewed elsewhere) (Badylak, Taylor et al. 2011; Song and Ott 2011). 
In decellularisation the primary purpose of the process is to remove xenogeneic and 
allogeneic cellular antigens whose presence may result in an adverse inflammatory 
response or even immune-related rejection (Badylak and Gilbert 2008). However, it 
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has been shown that residual amounts of DNA and certain species specific 
immunogenic antigens will still be present in the ECM matrices, including the 
galactosyl-a-1,3-galactose (Gal epitope), though these fail to trigger immune 
mechanisms such as complement activation or the IgM antibody-mediated 
response. This is likely to be due to the relatively small quantities of antigens in 
addition to their dispersed distribution within the matrices (Raeder, Badylak et al. 
2002; Daly, Stewart-Akers et al. 2009; Gilbert, Freund et al. 2009). 
ECM materials are further processed prior to terminal sterilisation and packaging. 
The materials can be lyophilised (freeze-dried), vacuum pressed or subjected to 
both to extend the products longevity. These processes are also said to avoid the 
leaching of soluble factors, such as VEGF and b-FGF, which might otherwise occur. 
SIS has been shown to be capable of being processed into a variety of shapes 
including multilaminate sheets (Freytes, Badylak et al. 2004), cones (Nieponice, 
Gilbert et al. 2006) or tubes (Badylak, Vorp et al. 2005). That being said, the vast 
majority of the commercially available SIS products are in the form of sheets, in 
single or multilaminate forms, which aid in the handling characteristics of the 
materials. Variations in the number of layers and structural features (such as holes) 
can influence the properties of the material and so can aid in matching the 
properties to the most suitable applications (Freytes, Badylak et al. 2004).  
SIS can also be lyophilised and crushed to produce powders (Gilbert, Stolz et al. 
2005), liquids, or hydrogels (Choi, Yang et al. 2009). In these forms it can be 
potentially used in minimally invasive treatments or combined with sheet forms to 
produce hybrid materials (Huber and Badylak 2011). 
The processing changes do inevitably lead to changes in the structure and 
composition of the ECM materials. Peracetic acid is a commonly used 
decellularisation agent which is used in the production of UBM and SIS (Hodde, 
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Record et al. 2002). Peracetic acid is a well-known oxidative agent (Freytes, 
Badylak et al. 2004) and when SIS that was decellularised with it was subjected to 
analysis it was found that the levels of VEGF had fallen by 99%, the levels of TGF-
β1 had fallen to 18% of the original quantity present, while the level of FGF-2 had 
only fallen by 50%. Alternatively the fibronectin, sulphated GAG, and hyaluronic acid 
quantities were only slightly affected (Hodde, Janis et al. 2007).  
Peracetic acid has been used as a sterilisation for a large number of tissues 
including dermal tissues (Huang, Dawson et al. 2004). With respect to SIS peracetic 
acid is ostensibly used in a disinfectant capacity and forms an important part of 
much of the initial work on ECM materials (where SIS was principally tested 
mechanically and its constituent components analysed) (Kropp, Eppley et al. 1995; 
Badylak, Kokini et al. 2001). In the initial protocols it represents the only form of 
chemical treatment of the materials aside from washes with PBS. Consequently as 
the DNA content was tested it was also found that the washing with peracetic acid 
also removed DNA. This was reinforced by Keane] et al. where it was shown that 
lowering the 2 h wash with peracetic acid to 1 h resulted in a higher DNA content in 
the SIS (Keane, Londono et al. 2012). It is important to note that these samples 
were all then terminally sterilised with ethylene oxide at the end of the process. 
Peracetic acid is organic peroxide that acts as an oxidising agent giving it highly 
biocidal properties. Oxidising agents have been known to denature proteins, disrupt 
cell wall permeability, and oxidize sulfhydral and sulfur bonds in proteins, enzymes, 
and other metabolites. Consequently it stands to reason that the cellular component 
of the SIS would be affected, including the DNA present, though this effect is not 
likely limited to the cellular component and this will be discussed later. The direct 
action of peracetic acid in decellularisation has not been researched in any detail.  
This loss of component is not limited to a single decellularisation agent, another 
study carried out with porcine dermis, decellularised with two protocols using the 
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commonly used detergents sodium dodecylsulfate (SDS) and Triton X-100 (SDS 
was excluded in one protocol) along with the enzyme Trypsin (Crapo and Gilbert 
2011), showed similar levels of component loss with the decellularised tissues 
shown to contain no detectable VEGF or TGF-β1, FGF levels at 99% or 
60.1%(without SDS) lower, though an unaffected GAG content (Reing, Brown et al. 
2010). 
The effects of the loss of these components are difficult to assess. When 
decellularised SIS and UBM were compared with control tissue the adherence of 
human microvascular endothelial cells was unaffected (Freytes, Badylak et al. 2004) 
possibly indicating the preservation of adhesion molecules. In addition to this murine 
fibroblasts cultured on decellularised SIS have been shown to produce endogenous 
VEGF and thus possibly negating the need  to retain certain growth factors at all 
(Hodde, Janis et al. 2007b) and also highlight that the effectiveness of ECM 
materials may not be limited to the growth factors retained.  
Some growth factors may be lost however research had shown that there are a 
large number of functionally active proteins are still retained (Freytes, Badylak et al. 
2004; Freytes, Rundell et al. 2005; Freytes, Tullius et al. 2008; Gilbert, Wognum et 
al. 2008).  
1.3.4.3 Sterilisation 
The final stage of production is sterilisation which is necessary if the material is to 
be used in any form in vivo application.  SIS as a material has been sterilised a 
number of different ways and these methods have been well documented. The most 
commonly used methods include using E-beam irradiation, γ- irradiation and the 
ethylene oxide infiltration (Grimes, Pembroke et al. 2005). Each of these methods 
has certain advantages and disadvantages. Both forms of irradiation are forms of 
ionising radiation and work through the action of disrupting the DNA present in the 
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microorganisms (Grimes, Pembroke et al. 2005).  However these can greatly affect 
the properties of the material particularly due to the physical damage which can 
occur especially in the form of collagen chain scission which results in the reduced 
mechanical properties. They also cause the materials to have an increased 
degradation rate.(Delgado, Pandit et al. 2014).  Ethylene oxide involves the 
gaseous infiltration into the material and while it does also result in some increased 
degradation this occurs to a far lower degree than that observed with irradiation 
methods and have lower collagen chain scission (Grimes, Pembroke et al. 2005). 
Ethylene oxide has also been shown to and also a good retention of growth factors 
(Hodde, Janis et al. 2007; Hodde, Janis et al. 2007b). The method has been shown 
to suffer from residual gas remaining in a material which may result in cytotoxicity 
towards the surrounding cells and tissue after implantation however this can be 
mitigated by allowing for adequate time for the gas to diffuse out (Olde Damink, 
Dijkstra et al. 1995).  
Sterilisation need not be limited to these methods and alternative approaches have 
been employed on other collagen-based materials. These methods include gas 
plasma, ethanol and peracetic acid. While peracetic acid has been applied to SIS 
extensively it is commonly applied in the initial phase of preparation. Ostensibly this 
is under the description of being a ―disinfectant‖, which given the contents of the 
small intestine, is understandable. The use of peracetic acid as a complete means 
of sterilisation is generally not carried out but has been applied to was shown to 
have a negative effect on the mechanical properties (Delgado, Pandit et al. 2014).  
In the case of gas plasma it has been applied to collagen sponges which caused a 
degree of structural degradation though this was found to be less than γ- irradiation. 
Ethanol has not been extensively used, though when used with pericardium though 
was found to affect the mechanical properties (Delgado, Pandit et al. 2014). 
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A further form of sterilisation which is largely restricted to skin is the use of glycerol 
immersion. While considered to be slow-acting it has effective bactericidal and 
antiviral properties (Mackie 1997; Ectors, Lismont et al. 2008). Cadaveric dermal 
grafts for some time have been successfully used clinically after being sterilised and 
stored in glycerol (Khoo, Halim et al. 2010; Pirayesh, Hoeksema et al. 2015). By 
immersing the grafts the antimicrobial properties of the glycerol has been shown to 
take effect and furthermore the graft can be then stored in the glycerol at 4°C. This 
method has not been used with small intestine submucosa given that the materials 
differ greatly in their structure and properties the effect of the method could possibly 
be different particularly with respect to altering the properties of the SIS.  
In summary, collagen-based material can be sterilised a large number of ways but 
there does not appear to be a definitive method. It should also be noted that high 
temperature or steam related methods have not been addressed here due to the 
damage they would cause to these materials. What is more likely the case is that 
each material will have an optimum method according to the properties of the 
material and the application for which the material is being used.  
In this work the sterilisation methods will likely be selected from the established 
methods which have been applied to SIS. Of these methods, ethylene oxide does 
appear to be the most suitable particularly due to the fact that it does the least 
damage to the material in question and this remains an important consideration if 
the material is too be used in form requiring strength. In addition to this modern 
ethylene oxide sterilisation units can cycle at far lower temperatures (i.e. 37°C) than 
that used for equipment sterilisation such as 55°C and so limit the temperature 
damage that might occur otherwise. 
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1.4 - Electrospun Scaffolds 
1.4.1 Electrospinning 
1.4.1.1 Background 
Electrohydrodynamic processing is the term given to describe a number of related 
processes used to create polymer particles or fibres by applying an electrical field to 
polymer solutions or melts. More specifically, the term electrospinning has been 
used to describe the creation of micro and nano scale polymer fibres by the 
formation and the charge induced elongation of an electrified fluid jet (Reneker and 
Yarin 2008).  
Over the last few decades the use of electrospinning has increased and emerged as 
a significant method for the production of micrometre and nanometre scale fibres for 
a variety of electrical, chemical and biomedical applications (Reneker and Yarin 
2008; Bellan and Craighead 2011). Within biomedical research significant promising 
work has been carried out in the synthesis of nanofibre-based three-dimensional 
scaffolds for use in tissue engineering, and in the creation of nanofibre devices for 
controlled delivery of pharmaceuticals (Andrady 2008). Additional potential 
biomedical applications include the fabrication and development of microfluidic 
devices, printed 3D structures and patterns, and ―lab on a chip‖ devices. As 
electrospinning has become more established it has become an effective method 
for the large scale synthesis of nanofibres which themselves can be  used for textile, 
filter, mechanical reinforcement, sensors, optoelectronics, catalysis applications 
amongst others (Dersch, Graeser et al. 2007). A key advantage of electrospinning is 
the ability it gives operators to manipulate the micro-morphology of the fibres which 
are produced.  
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1.4.1.2 Theory of Electrospinning 
Electrospinning is now a well-established process for the production of polymer 
fibres and on which an extensive amount of research has been carried out (Reneker 
and Chun 1996; Yarin, Koombhongse et al. 2001; Thompson, Chase et al. 2007; 
Yu, Branford-White et al. 2010). The process involves the use of an applied 
electrical field which interacts with the charge of the polymer solution or melt thus 
overcoming  the  surface tension of the liquid and causing an electrified jet to be 
produced (Reneker and Chun 1996). The process shares many similarities with 
electrospraying (or electrohydrodynamic (EDH) atomisation) from which atomised 
particles are produced as opposed to fibres.  
Pioneering work was done in both these areas by Lord Rayleigh who observed that 
above a critical charge level, the electrical forces (electrostatic) overcome the 
surface tension forces of the liquid and render it unstable. He also observed that 
there is in fact a balance of opposing forces which affect the behaviour of a drop 
suspended from a capillary (Rayleigh 1882).  
In further work done in this area Zeleny observed the characteristic ―cone-jet‖ which 
is formed at the mouth of the nozzle of the needle when electrohydrodynamic 
activity is present (Zeleny 1917) and identified the ―cone-jet‖ mode which is the 
basis of electrospraying and spinning. Sir Geoffrey Taylor then provided an 
explanation for the formation of the liquid cone based on the balance of electrostatic 
and capillary pressure (Taylor 1964). When EHD processes occur and the pendant 
drop deforms into a stable cone shape this is now referred to as a ―Taylor cone‖ 
(Yarin, Koombhongse et al. 2001). Following Taylor, a large amount of work 
advancing electrohydrodynamic knowledge was performed with these works 
providing the basis for electrohydrodynamic theory upon which the later 
developments were built.  
46 
 
Electrospinning, as separate from electrospraying, in that if the viscosity of the 
polymer solution is sufficiently high then the flow that is produced does not disperse 
and a charged liquid stream is formed. The literature on this subject often refers to 
this stream as a ―jet‖. 
The applied voltage, the polymer viscosity, and the surface tension are not the only 
forces involved in the process, Hartman et al. describes the varying forces which 
are at work within the cone shape and demonstrated its dependence on these 
forces (Hartman, Borra et al. 1999). The forces described are liquid pressure, liquid 
surface tension, gravity and electrical stresses present on the liquid surface as seen 
in Figure 1.2.  
 
There are a number of spraying modes which have been described by various 
researchers (Hayati, Bailey et al. 1987a; Hayati, Bailey et al. 1987b; Enayati, Chang 
et al. 2011).  These descriptions are more concerned with the process of 
electrohydrodynamic spraying and not on electrospinning. The different modes that 
have been mentioned are summarised in Figure 1.3. 
Figure 1.2: Representation of the cone–
jet mode indicating the controlling forces 
(Hartman, Borra et al. 1999). 
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Figure 1.3: Electrospraying Modes (Wilhelm 2004). 
 
The modes of electrohydrodynamic processing will be dependent on various factors 
though these are all not essential for electrospinning and are not covered here and 
reviewed elsewhere (Paine, Alexander et al. 2007). The electrospinning process 
may be broken down into several operational components. The actual process of 
electrospinning involves the several different stages to occur successfully.  These 
basic stages can be summarised as follows: 
• The formation of the cone-jet 
• The movement of the jet through the electrical field and the effects of the 
instabilities. (Thinning also occurs.) 
• The solidification of the fibres 
The basic structure of the jet begins with a short straight segment where the 
trajectory of the polymer solution jet is parallel to the axis of the jet. Within this 
straight segment the diameter of the jet decreases with distance from the tip 
(Reneker and Yarin 2008; Hardick, Stevens et al. 2011).  Extensive work has shown 
that the charged jet then begins to move in a radial manner in addition to moving 
along the axis of the needle.  This radial movement occurs due the development of 
an electrical bending instability (Reneker and Yarin 2008). The jet continues to 
move in a radial manner and begins a coiling action. The electrical forces due to the 
charge carried within the jet then cause the jet to further elongate as it progresses in 
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its coiling action and in the process it becomes narrower in diameter. This is 
illustrated in the Figure 1.4.   
 
 
 
 
 
As the fibres flow through the electrical field with some tangential electrical stresses 
stabilising the accelerating jet, it will ultimately become unstable and a number of 
instabilities develop. These instabilities distort the jet as it traverses through the 
applied electrical field. The significance of these instabilities is considered high and 
they are believed to be the primary basis for electrospraying and electrospinning in 
addition to being the prevailing forces in determining the fibre morphology. 
These modes of instability are Raleigh instability, axisymmetric instability, and 
bending mode (or whipping) instability (Shin, Hohman et al. 2001a; Shin, Hohman et 
al. 2001b). The mode of instability which occurs during the electrospinning process 
will largely depend on the strength of the electrical field, the polymer solution 
surface charge density and the surface tension (Andrady 2008). 
The whipping instabilities are the significant driving forces in electrospinning 
(Reneker, Yarin et al. 2000). The movement of the jet at this point is usually referred 
as a ―whipping action‖. There have been several mathematical models which have 
been created to describe and explain this process and these are outlined by 
Hartman et al. (Hartman, Borra et al. 1999). A large amount of work been carried 
Figure 1.4: Fibre formation by 
electrospinning (Hardick, Stevens et al. 
2011). 
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out modelling the whipping jet and has described it as essentially occurring due to 
competition between several modes of instability (Reneker, Yarin et al. 2000).  
For a steady jet to be produced there are two primary conditions which are 
important. There must be sufficient forces present which hold the jet together (i.e. 
viscoelastic forces) against any capillary instabilities which occur and additionally 
there must also be suitable relaxation time for the solution to behave in a 
viscoelastic manner. Reneker and Yarin (Reneker, Yarin et al. 2000) describe three 
stages in the whipping process, a straight section, the development of an array of 
bends and finally the bends developing into a series of spiralling loops. As the 
diameter of the loops increases the diameter of the fibres decreases as seen in 
Figure 1.4.  
The radial ―whipping‖ motion causes the process of elongation by electrostatic 
repulsion which occurs at small bends in the jet.  The result of this elongation is an 
increasingly narrow jet eventually reaching the grounded collection plate at the 
nanometre-scale. The whipping action dramatically increases the surface area of 
the jet but it also rapidly lowers the surface charge density. During this process the 
solvent evaporates and the result is solidified polymer fibres (Hardick, Stevens et al. 
2011). Evaporation of the solvent also contributes to the decreasing diameter in 
addition to elongation. Multiple polymer fibres can also be formed when the radial 
forces exerted by the electrical charges overcome the cohesive forces in the jet and 
due to mutual repulsion they separate in a phenomenon known as splaying 
(Reneker and Chun 1996; Natarajan and Mahavadi 2011). 
1.4.1.3 Factors Affecting Electrospinning 
While the influence of the instabilities in electrified fluid jet can be described in 
simple terms involving only a few important variables such as applied voltage and 
some basic properties of the polymer solution there are in fact a large number of 
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variables which can influence the electrospinning process and, in turn, the fibre 
morphology.  
These factors include  gravitational forces, the electrostatic force (which actually 
attracts and extends the jet towards the charged collection plate), Coulombic 
repulsion forces on the surface of the jet (which are responsible of the instabilities 
and therefore the whipping motion), viscoelastic forces (which working against the 
elongation process are also vital to the creation of continuous fibres and are 
dependent on the polymer molecular weight, the solvent properties and the type of 
polymer which is used), surface tension forces (which also could be said to work 
against the forces which act to elongate the electrospinning jet), and frictional forces 
(which act between the surface of the jet and atmospheric gas molecules through 
which they traverse (Fong, Chun et al. 1999; Reneker, Yarin et al. 2000). A list of 
some of these factors is presented in Table 1.2.  
Table 1.2: Table of parameters affecting fibre morphology 
Solution Properties   Operating Conditions 
Ambient  
Conditions 
Dielectric Constant  Potential Difference Temperature 
Electrical Conductivity  Needle Diameter Humidity 
Entanglement Concentration  Solution Flow Rate Pressure 
Extensional Viscosity  Collection Distance   
Polymer Concentration Collection Method   
Polymer Molecular Weight      
Polymer Molecule Chain Length      
Shear Viscosity      
Solvent Vapour Pressure     
Surface Tension      
Temperature      
 
In addition to the aforementioned factors there are a number of more subtle factors 
that can also be considered.  These include the diameter of the flowing jet near its 
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origin, the relaxation time, the elongation velocity and the partial pressure of the 
solvent vapour which is surrounding the jet (Reneker, Yarin et al. 2007; Reneker 
and Yarin 2008). While all these factors have important influences the key ones 
which have been described as have dominating the onset of the transformation from 
electrospraying to electrospinning and therefore the synthesis of fibres, and the also 
having a key influence on the morphology on the aforementioned fibres are the feed 
rate of the polymer solution, the applied voltage and the properties of the solution, 
such as concentration, viscosity and surface tension  (Deitzel, Kleinmeyer et al. 
2001; Luo, Nangrejo et al. 2010).  Consequently the feed rate of the polymer 
solution and the applied voltage were decided on to be the variables which would be 
investigated in this work, as it was already decided to keep the polymer solution 
properties constant.  
One further consideration that can be made for the influence of the variables is the 
geometrical dimension of the needle used (Frenot 2003). In general terms work has 
been done which indicates that smaller diameter needles yield fibres which are 
smaller in diameter. Having said that, there is a limited practicality to pumping a 
viscous liquid through very small diameter tubes. It should also be noted that the 
diameter of the jet will have a similar effect and this is influenced by the applied 
electrical field and the surface tensional forces and so can therefore also be seen as 
a secondary nozzle. Furthermore, as a result of this phenomenon, fibre sizes  
produced using this method of processing can be four orders of magnitude smaller 
than the needle outlet (Ahmad, Nangrejo et al. 2009). Consequently choosing a 
suitably sized needle bore was taken to be an important consideration as choosing 
too small a bore size could result in the fibres being too small to be suitable for the 
investigative aim of this work.  
With respect to fibre diameter specifically, the process is  governed by the balance 
between the normal stresses due to surface tension and surface charge repulsion 
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(Fridrikh, Yu et al. 2003)  in addition to the vapour pressure, evaporation rate 
(Shenoy, Bates et al. 2005) of the solvent and concentration of the solution. As a 
result fibre diameter is a product of a significant number of variables 
 
1.4.2 Scaffold Properties 
The successful functioning of a scaffold will be dependent on its properties. These 
properties are vital to the performance and need to be evaluated according to the 
application required. 
1.4.2.1 Surface Properties 
Surface properties are an important consideration for the design of a scaffold. The 
surface chemistry influences the point of interaction between scaffolds the micro 
environment found in vivo. Cellular adhesion represents an important stage for the 
successful application any tissue engineering implant. Synthetic scaffolds do 
sometimes present a challenge for cell adhesion and a variety of approaches have 
been adopted to improve this.   Modifications to the scaffold can either be in the 
form of certain bulk additions to the material or by surface modifications (Hu, Eaton 
et al. 2001). These modifications either facilitate cellular attachment directly or 
influence protein adsorption onto the scaffold surface which, in turn, influences 
cellular adhesion. The modification can include altering the surface charge on the 
scaffold, which influences protein adsorption, or also in incorporation of well 
understood attachment proteins including fibronectin or the peptide Arg-Gly-Asp 
(RGD) (Hersel, Dahmen et al. 2003). A further approach might be to influence the 
water uptake into the scaffold, by the use of surface washes, which can also aid 
cellular infiltration and adhesion.  
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In addition to the surface chemistry, the physical surface topography of the scaffold 
is also an important factor. Features such as pores, nodes, steps, ridges or grooves 
have been shown to have an influence on cell morphology, the processes 
performed by the cell, and the production of autocrine or paracrine regulatory 
factors when compared to smooth, featureless surfaces (Flemming, Murphy et al. 
1999). It has been shown that in the case of PLGA scaffolds surface roughening 
through the use of a simple treatment with sodium hydroxide was shown to increase 
chondrocyte adhesion, proliferation and increased ECM production (though some of 
these effects were accounted for by an increase in the porosity along with the 
surface roughness). It should be added that scaffolds made with synthetic 
nanofibres have been shown to provide a complex topography which then supports 
cell and tissue growth (Woo, Chen et al. 2003). 
While the surface properties are particularly relevant for synthetic fibres this is not 
the case with naturally derived scaffold. These materials contain a large number of 
innate biological materials, in addition to the main constituent collagen, which aid in 
cell attachment and proliferation (Yamada and Yamada 1983).  
1.4.2.2 Scaffold porosity 
The physical characteristics of any scaffold play an important role in how it is to 
function in vivo.  The structure and the geometry of the scaffold have a number of 
significant effects, with porosity being one of the key parameters. The porosity of a 
scaffold facilitates the cellular growth into the scaffold and allows for mass transport 
of nutrients into, and waste products away from, the interior of the scaffold. This is 
vital for cell growth as cells have to be within 200 µm of a blood supply otherwise 
risk being placed under oxygen tension the result of which can be cell death (Colton 
1995).  
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The nature of the porosity is also vital. Pore size is one of the well-studied factors 
which have been shown to affect how a scaffold performs. While there is no 
definitive consensus as to the ideal pore size for a scaffold for any given application 
(the requirements of which are likely to be different) there are some broad 
observations which have been made. In the case of bone tissue engineering there 
seems a requirement for the pores to be ~100 µm (in diameter)(Hulbert, Young et 
al. 1970; Karageorgiou and Kaplan 2005). In the case of soft tissue engineering, 
such as the small intestine, pore sizes which have been shown to be successful are 
at a size of ~250 µm (Kaihara, Kim et al. 1999; Kim, Kaihara et al. 1999). 
Additionally pores in the size range of >50 µm are known to better facilitate nutrient 
transport and cell infiltration and smaller pores in the range of <20 µm have a larger 
surface area allowing for greater protein adsorption, ionic solubility, and cell 
attachment (Woodard, Hilldore et al. 2007). Additionally the pore size of 10 µm has 
been suggested to be optimum for cellular infiltration (Zhang, Ouyang et al. 2005). 
Consequently, for the purposes of soft tissue engineering the range of 10-250 µm 
seems to be suitable range. It should also be added that the combination of micro- 
and macro-pores have, in the case of bone tissue engineering at least, been shown 
to improve drug delivery and strength and stiffness (when compared to exclusively 
micro- or macroporous).  
Pore interconnectivity (or tortuosity) is another important characteristic. Good 
interconnectivity is vital for mass transport (including nutrients growth factors and 
cytokines), cellular infiltration and for the formation of neovasculature. All these 
factors need to be taken into consideration where good porosity characteristics 
providing a higher surface area (and consequently a high surface area to volume 
ratio) and good mass transport, thus allowing for high cellular infiltration, attachment 
and growth (Yang, Leong et al. 2001). These factors all need to be balanced by the 
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mechanical requirements of the scaffold as excessive porosity can compromise the 
mechanical integrity of the scaffold (Yoon and Fisher 2006). 
1.4.2.3 Biodegradability 
For the purposes of tissue engineering a scaffold should ideally provide a temporary 
structure and support for the growth of new tissue and then once this growth has 
been established it should naturally degrade. This degradation should ideally also 
occur at an equal rate to tissue formation (or wound healing), however, this is 
difficult to achieve. In addition the differences which may occur in scaffold 
degradation on an individual basis, there are also a large number of factors which 
can affect the scaffolds degradation profile in vivo including the levels of cellular 
activity, cell-induced pH changes, the presence or absence of enzymes or proteins. 
The physical properties of the scaffold can also have a large effect including the 
scaffold porosity, fibrous structure, polymer molecular weight, glass transition 
temperature, crystallinity, and polydispersity (Engineer, Parikh et al. 2001).  
The actual process of degradation occurs by two mechanisms namely; surface or 
bulk erosion. Surface degradation is primarily localised at the surface of the material 
and is characterised by the material retaining its mechanical properties but gradually 
decreasing in size. Bulk degradation is where the material degrades throughout the 
volume of the scaffold and is characterised with the material losing mechanical 
strength but maintaining a relatively intact surface. The retention of surface integrity 
in bulk degradation does allow for better cell attachment when compared to surface 
degrading scaffolds (Yoon and Fisher 2006). Polyester scaffolds, like PCL and 
PLGA, tend to undergo bulk degradation, however one potential negative effect of 
this is the accumulation of degradation products. In the case of PLGA, which is 
made of lactic and glycolic acid, it is the acidic nature of the products may have a 
negative effect on the tissue. 
56 
 
1.4.2.4 Mechanical Properties 
All scaffolds which are placed in vivo are usually subject to some form of 
mechanical stress usually equivalent to the stress experienced by the surrounding 
tissue. Consequently, the mechanical properties of the scaffold should resemble 
those of the surrounding tissue and should be able to sustain any expected forces 
which are applied to it. Moreover, these properties should also be sustained for the 
duration required for new tissue formation (Hayashi 1994). A large number of 
physical factors may influence the mechanical properties of a scaffold, including 
fibre characteristics, porosity and surface properties to name a few. In addition to 
these the mechanical properties of scaffolds will also be governed by the bulk 
properties of the constituent materials. 
1.4.2.5 Polymers 
The use of polymer biomaterials is very established and there are a number of 
important properties which make them highly useful. Polymer biomaterials have a 
very high level of processability and can be produced into a large number of forms 
(films, sheets, fibres, particles etc.) and they can also have their properties 
chemically altered in a large number of ways which can affect their mechanical, 
chemical, physical and biological properties. These materials can also be 
biodegradable, which is particularly useful for tissue engineering applications, have 
reasonable cost and availability, and have a reasonable degree of biocompatibility 
(a number of them having gained FDA approval for clinical use). Many of the 
commonly use polymers are polyesters, such as PCL and PLGA, and degrade 
through non-specific hydrolysis of their ester bonds and consequently degradation 
results in a loss of polymer molecular weight (Vert, Li et al. 1992). 
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1.4.2.6 Poly(ε-caprolactone) (PCL) 
PCL is a semi-crystalline polymer that is that is produced through the ring-opening 
polymerization of lactone monomer ε-caprolactone. The polymer properties include 
toughness and flexibility with a meting point of 58-65°C and a glass transition 
temperature of around -60°C. The degradation rate is described as quite slow, when 
compared to polymers such as PLLA, and consequently it is considered a polymer 
suitable for long term drug release (Yoon and Fisher 2006). The degradation rate 
may be enhanced through the copolymerisation with other monomers such as 
lactide and glycolide. 
            
Figure 1.5 Synthesis and structure of Poly(ε-caprolactone) 
 
1.4.2.7 Poly(lactide-co-glycolide) (PLGA) 
PLGA is a polymer which is produced through a random ring opening 
polymerisation of lactide and glycolide. Glycolide is a dimer of glycolic acid and is in 
the form of a cyclic diester.  This can be polymerised to poly glycolic acid (PGA) 
(Pachence, Bohrer et al. 2007). 
 
Figure 1.6 Chemical structure of glycolide and polyglycolic acid/poly(glycolide) (PGA). 
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Lactide is cyclic diester form of lactic acid and can be polymerised to form polylactic 
acid (PLA). However, the lactic acid molecule has an addition methyl group on the 
α-carbon compared to the glycolic acid molecule making it a chiral molecule, 
therefor when polymerising with lactide there can be L-, D- and mixed (D, L-) forms 
of PLA. This additional methyl group also means that PLA is more hydrophobic than 
PGA and this results in a slower hydrolysis rate. The L-PLA form is more frequently 
employed than D-PLA, since the hydrolysis of L-PLA yields L-lactic acid, which is 
the naturally occurring stereoisomer of lactic acid (Pachence, Bohrer et al. 2007). 
 
Figure 1.7 Chemical structure of lactide and polylactic acid/poly(lactide) (PLA). 
 
Figure 1.8 Chemical structure of polylactic acid isomers: (a) L- PLA and (b) D-PLA 
 
PLGA is the result of the co-polymerisation of the two monomers mentioned above. 
The monomers are linked together to form a linear aliphatic polymer. The polymer 
PGA is crystalline in form, however when it is co-polymerised with PLA there is a 
reduction in the degree of crystallinity. This reduction results in the polymer 
becoming more susceptible to hydration and hydrolysis. Consequently the ratio of 
the two monomers can result in changes in the degradation behaviour of the 
polymer. It is understood that that the higher the glycolide content (the more 
hydrophilic of the two), the faster the rate of degradation of the PLGA polymer with 
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the exception of the 50:50 ratio (see Fig 1.9b.)(Middleton and Tipton 2000). An 
example of this is that over a 4 week time period, PLGA 85:15 was found to lose 
10% of its mass as opposed to 50% for PLGA 75:25 and 70% for PLGA 50:50 
(Intra, Glasgow et al. 2008). These rates are related to the in vitro properties of 
these materials, however a similar pattern can be observed in vivo. Work involving 
implanted PLGA scaffolds showed that post implantation that the PLGA 50:50 
scaffold lost structural integrity by two weeks, with the  PLGA 75:25 scaffold lost 
approximately half of its mass by 3 months and the PLGA  85:15 scaffold  was 
found to lose half of its mass after 4 months (Blackwood, McKean et al. 2008). 
 
 
Figure 1.9 (a ) Synthesis of PLGA (b) Half-life of PLA and PGA homopolymers and copolymers 
(Middleton and Tipton 2000). 
 
PLGA as a polymer degrades by direct or enzyme-catalysed hydrolysis in four 
steps: 1) the amorphous region is penetrated by water and there is a disruption of 
secondary forces 2) hydrolysis of the covalent bonds of the polymer backbone occur 
3) mass loss begins due to increased cleavage of the polymer backbone then 4) 
erosion occurs with large scale weight loss (Catiker, Gumusderelioglu et al. 2000). 
(a) 
(b) 
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In addition to the ratio of monomers the rate of degradation is also affected by the 
polymer crystallinity (which is dependant, in part, on the monomer ratio), the 
temperature and the pH (Lu, Peter et al. 2000).  Once degraded the components 
take the form of lactic and glycolic acids, which while acidic are biocompatible. 
 
Figure 1.10 Structure of polylactic-co-glycolic acid and its decomposition in lactic and glycolic acid (Hacker and 
Mikos 2011) 
 
One of the limitations of PLGA as a biomaterial used in tissue engineering is that 
the material possesses a relatively high degree of hydrophobicity. As a result the 
material exhibits sub-optimal cellular adhesion and growth at the surface. It also 
results in there being relatively low hydraulic permeability, which can be useful for 
controlling mass transport (Shearer, Ellis et al. 2006).  That being said, this is quite 
a critical assessment of the material’s properties and in a broader context the 
material has been shown to perform well with suitable levels of cellular adhesion 
when implanted in vivo (Blackwood, McKean et al. 2008; Pan and Ding 2012).     
1.4.2.8 Fibre Alignment 
As mentioned previously, there are a large number of factors which can affect the 
properties of electrospun polymer fibres.  In addition to those mentioned with 
electrospun fibres there is also the potential to produce fibres which are aligned. 
Alignment can be achieved by a number of different approaches and have been 
applied to various different polymers. 
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A large number of alternative approaches have been taken which have successfully 
produced aligned fibres using a variety of methods, including against flat rotating 
discs, onto arrays of aligned needles, between ring-shaped electrodes and the 
―reeling‖ of  already electrospun fibres collected on liquid (Teo and Ramakrishna 
2006). However, the most common approach is through the use of a rotating drum 
with the rotational speed of the drum having been shown to have a direct influence 
on this.   
One method used was with a rotating plastic drum at a very slow speed of 1 rpm, a 
hollow drum being embedded with copper wire and while aligned fibres were 
observed the placement of the wires had additional effects on the localised 
alignment as the wires were causing a higher degree of attraction and therefore the 
results were not ideal (Katta, Alessandro et al. 2004).  
Stitzel et al. did not achieve any alignment of fibres when making a tube of PLGA for 
vascular use at 500 rpm when carried out with a cylindrical mandrel.  Here it was 
noted that at a relative low speed (500 rpm) and a small diameter mandrel (4.75 
mm) the fibres were highly randomised (Stitzel, Liu et al. 2006).  
Alignment has been demonstrated with a rotating mandrel at 1000 rpm, and 
compared to a randomly aligned sample at 100 rpm (Boland, Wnek et al. 2001). 
Also Sundaray et al used a pin and a rotating thin plastic sheet folded into a cylinder 
rotating at 2000 rpm with some alignment in addition to a criss-cross pattern being  
observed (Sundaray, Subramanian et al. 2004). 
It was demonstrated that fibre alignment resulted in the alignment of smooth muscle 
cells which were cultured on them. It was also shown that while affecting the 
orientation of the cells, there did not change in phenotypic expression of the cells 
(Jia, Prabhakaran et al. 2014). Using aligned nano-fibrous P(LLA-CL) scaffolds it 
was also shown that there was improved vascular SMC adhesion, parallel 
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organisation and a higher degree of contractile phenotype when compared to 
unaligned samples (Nivison Smith and Weiss 2012).  
With the ability to produce alignment in electrospun fibres it has since been shown 
to alter the mechanical properties of fibre scaffolds produced using this method. 
Elastic modulus and strain to failure were tested and significant differences 
observed between the aligned and unaligned scaffolds, with the higher being 
observed in the aligned fibre constructs (Boland, Wnek et al. 2001).  
Interestingly, while the rotation speed of the mandrel has been shown to have an 
effect on the alignment of the fibres produced it has also been shown by Choi et al. 
that this does not impact the diameter of the fibres produced (Choi, Lee et al. 2008). 
1.4.2.9 Adherence 
While the concept of electrospinning fibres onto the surface of an ECM material 
does appear straightforward, in practice this does not appear to be the case. In work 
spinning PLGA fibres onto mandrel mounted UBM (Urinary bladder matrix) Horst et 
al. found that it was necessary to alter the conditions of the UBM so as to improve 
attachment. Testing the fibres onto dry, wet, and continuously rehydrated UBM, with 
the highest degree of attachment found with the continuously hydrated sample 
(Horst, Madduri et al. 2013). In the case of this material, the UBM was never freeze-
dried and was maintained in a hydrated state or dried prior to use. UBM has also 
been successfully used with electrospun fibres made from silk fibroin. The matrix 
here was flat and the adhesion characteristics of fibroin is likely to vary compared to 
PLGA (Li, Song et al. 2015). 
63 
 
1.4.3 Drug Delivery 
1.4.3.1 Background 
Electrospinning offers significant flexibility for use in drug delivery applications. 
Recent studies have demonstrated that a wide spectrum of drug such as antibiotics, 
anticancer treatments, growth factors and nucleic acids (both DNA and RNA), can 
all be incorporated into electrospun fibres. A number of different methods have been 
employed including coatings on the fibres, direct embedding and encapsulation of 
drug within the fibres via coaxial or emulsion electrospinning (Prabaharan, 
Jayakumar et al. 2012). 
1.4.3.2 Vascular Endothelial Growth Factor 
Sufficient blood supply is one of the key factors for obtaining a successful tissue-
engineered construct. The rapid ingrowth of newly formed blood vessels is an 
important process, and angiogenesis is the process by which new branches are 
created from existing blood vessels (Komura, Kim et al. 2011). The process begins 
with the production of angiogenic growth factors, such as vascular endothelial 
growth factor (VEGF) or basic fibroblast growth factor (bFGF). These factors may 
be introduced as part of an implant, originate from the host tissue cells due to tissue 
injury during an implantation procedure, or as a consequence of an inflammatory 
response to an implant (Laschke and Menger 2012). Endothelial cells present in the 
local microvasculature are stimulated to produce matrix metalloproteinases which 
degrade their basement membrane (Carmeliet 2000). The endothelial cells 
subsequently migrate into the surrounding interstitial tissue, resulting in the 
formation of vascular buds and sprouts. The walls of these new vessels are finally 
stabilized by the production of extracellular matrix compounds and the recruitment 
of smooth muscle cells or pericytes (Anderson, Ponce et al. 2004). 
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VEGF is an angiogenic growth factor specific for vascular endothelial cells that is 
able to induce angiogenesis in vivo (Leung, Cachianes et al. 1989). It is a potent, 
multifunctional cytokine that while known for facilitating angiogenesis and has been 
known to stimulate a variety of, possibly independent, endothelial cell processes 
including inducing transient accumulation of cytoplasmic calcium, shape change, 
cell division and migration and gene expression changes (Dvorak, Brown et al. 
1995; Lindhorst, Tavassol et al. 2010). Most of the research carried out has been 
one form but it should also be stated that there are a five  different VEGF isoforms 
that are produced by alternative splicing of the VEGF gene to form active disulfide-
linked homodimers which vary in function with most abundant being the 165 amino 
acid form (Neufeld, Cohen et al. 1999; Silvestre, Tamarat et al. 2003). VEGF exerts 
its effect through two endothelial receptors, tyrosine kinase VEGFR-1 (Flt-1) and 
VEGFR-2 (KDR/Flk-1) though there are a number of accessory receptors 
(Yancopoulos, Davis et al. 2000). 
While VEGF has been incorporated into electrospun fibres, the process is not a 
simple one with a variety of different approaches having been used. Methods used 
are often quite complicated due to the water-soluble nature of VEGF, a property 
which prevents direct incorporation into many of the most popular polymers in use. 
A method around this problem is the incorporation of VEGF into a water soluble 
polymer which can then be coaxially spun, and example of this was carried out 
along with PLGA fibres (Jia, Zhao et al. 2011). This type of process makes VEGF 
incorporation into electrospun fibres a time-consuming, technically complex and not 
readily viable. The complexities of the properties of coaxial fibres are quite difficult 
to ascertain and therefore if fibres are required to be consistent in size and in 
properties (so as to control degradation rate and the mechanical properties) then 
coaxial spinning might not be an ideal option.  
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A simpler method is the direct application of VEGF onto the scaffold and for it to be 
adsorbed on the surface. Using this method VEGF has been successfully applied 
onto polymers prior to in vivo implantation (Lode, Wolf-Brandstetter et al. 2007; 
Moioli, Clark et al. 2008; Freeman and Cohen 2009; Wernike, Montjovent et al. 
2010; Singh, Wu et al. 2012). VEGF has also been successfully applied to collagen 
coated PLGA scaffolds with the results confirmed in vivo (Lindhorst, Tavassol et al. 
2010). 
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1.5 - Aims and Objectives 
1.5.1 Primary Objective 
As mentioned previously, while there are a number of conditions that could be 
treated using a tissue engineered construct however the most likely condition which 
benefit from this approach is oesophageal atresia. 
With this in mind, the scaffold was designed to be able to address the issues which 
arise from this condition.  Principally, that the scaffold should be able to function as 
a short segment replacement for malformed or stricture-affected oesophagi in 
infants with atresia. It is envisioned that the scaffold could be implanted directly, 
without the use of cells, and be sterilise packaged and cut to the required length 
much as SIS is today. 
The scaffold is expected to under regenerative cellular ingrowth from epithelial and 
smooth muscle cells from the adjoining oesophageal tissue to which it is sutured. 
The use of a growth factor which could aid in the survival of these infiltrated cells 
through the promotion of angiogenesis is appealing and therefore was also 
investigated. The scaffold is expected to be able to resist the mechanical forces to 
which it is likely to be exposed and also to remain mechanically patent particularly 
during the initial 3-4 weeks period where decellularised materials are known to be 
rapidly remodelled and loose structural strength. The scaffold is expected to then be 
degraded overtime and replaced with the patient’s own tissues. 
1.5.2 Hypothesis 
It is hypothesized that by combining unmodified SIS with an electrospun 
reinforcement layer that this would allow the scaffold to have the benefits of an ECM 
material while overcoming the poor mechanical qualities of these materials and 
without necessitating modification to the SIS.  
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1.5.3 Experimental Objectives 
To achieve overall objectives of this work of this work the following objectives will 
have to be addressed: 
 Produce a base SIS scaffold which is structurally and biologically suitable for 
electrospin coating with polymer fibres. This can be achieved by the scaffold: 
1) having an optimal tubular shape and 2) being suitably decellularised to 
prevent rejection.  
 To create a protocol for the production of an electrospun fibre layer that 
reinforces and adheres to the SIS.  
 Investigate the potential for the hybrid scaffold to facilitate drug delivery to 
improve in vivo performance.  
 
It is also important to state that the scaffold in question should have the properties 
expected of any biological scaffold, such as biocompatibility, non-toxicity and 
adequate porosity. For the purposes of this this work the scaffold would also be 
expected to have specific physical/mechanical criteria; specifically be able to extend 
by 50% in the longitudinal direction and to have a diameter of at least 10 mm. For 
the scaffold to function well, it is also important that the two layers have a suitable 
level of adhesion so that they are able to function and be handled as a single hybrid 
scaffold. 
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2. Decellularisation and Synthesis 
of Tubular SIS
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2.1 - Introduction 
As mentioned in the Section 1.1, the goal of this work is to investigate the creation 
of a hybrid scaffold for use in oesophageal tissue engineering. The decision was 
taken that the first stage of this would be the creation of a suitable ECM layer to 
function as a base layer for such a construct. The question was raised whether a 
suitable SIS scaffold could be made into a seamless tubular form as this would 
provide a suitable surface onto which electrospun fibres could be spun. Additionally, 
it was also hypothesized that the lack of a seam could improve mechanical 
performance and other potential benefits such as the prevention of leakages.  
SIS has been commonly made in sheet form and decellularised using peracetic acid 
under simple agitation (Badylak, Tullius et al. 1995; Hodde, Record et al. 2002). 
However if SIS was to be created in a tubular form an alternative decellularisation 
protocol was considered necessary to adequately decellularised the tissue. With this 
in mind a variation of perfusion decellularisation was chosen, a techniques applied 
to a variety of tissues and for which a large number of protocols and agents exist 
(Gilbert, Sellaro et al. 2006; Crapo and Gilbert 2011). In this chapter two perfusion 
protocols were selected which have been used to decellularise a variety of tissues. 
The detergent-based protocols were compared with each other, a perfusion protocol 
using peracetic acid, peracetic acid under agitation, and with an undecellularised 
control.  The aim here was to obtain an optimal decellularisation protocol for tubular 
SIS. 
The first method researched was a perfusion method successfully applied by Ott et 
al. to decellularise intact rat hearts (Ott, Matthiesen et al. 2008). This used two 
detergents: SDS (sodium dodecyl sulfate), an anionic detergent, and Triton X-100 
(t-octylphenoxypolyethoxyethanol), a non-ionic detergent considered to be non-
denaturing (Gilbert, Sellaro et al. 2006). Both detergents have been commonly 
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applied in cell lysis in other research areas. SDS has been used for a number of 
years and on a variety of tissue types (see Section 1.3.4.1) , including less 
commonly decellularised tissues such as the kidney and temporomandibular joint 
(Crapo and Gilbert 2011). The use of Triton X-100 is also prominent in tissue 
engineering and was used for decellularisation by Cortijo et al. as early as 1987, 
when  it was applied to a number of different tissues including the ileum, arteries 
and muscles tissue (Cortijo, Dixon et al. 1987). The method used by Ott et al. was 
replicated by Akhyari et al. and shown to be the best for whole heart 
decellularisation in a comparison of four different protocols (Akhyari, Aubin et al. 
2011).  
The second protocol consists of a combination of sodium deoxycholate (SD) and 
Deoxyribonuclease I (DNase). This protocol is discussed in Section 1.3.4.1. In 
summary, has shown a degree of effectiveness on a number of tissues when used 
in a perfusion-based arrangement. 
For any ECM to function in vivo it must be suitably decellularised as the presence of 
specific cell membrane epitopes and DNA, xenogeneic or allogeneic, could result in 
an adverse immune response upon implantation (Gilbert, Freund et al. 2009). In 
reviewing tissue decellularisation Crapo et al. proposed potential framework of three 
criteria to determine satisfactory decellularisation. These criteria are; <50ng dsDNA 
(double stranded DNA) per mg of ECM (dry weight), a lack of visible nuclear 
material in tissue sections stained with 4’,6-diamidino-2-phenylindole (DAPI) or 
Hematoxylin and Eosin (H&E), and <200 bp DNA fragment length (Crapo and 
Gilbert 2011). No substantial work has been carried out which establishes the 
threshold level of cellular remnants in ECM materials that elicits a negative 
remodelling response. However, while these criteria are theoretical they are useful 
as a guideline for decellularisation. For the purposes of this work only the first two 
criteria will be considered. 
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2.2 - Materials and Methods 
2.2.1 SIS Preparation 
Frozen samples of porcine small intestine were obtained at a local abattoir from 
animals 6 months in age. Initial work carried out showed no difference mechanically 
between proximal and distally obtained SIS (Appendix A-1). The jejunum/ileum 
samples were cut into lengths of approximately 20 cm and the excess mesentery 
tissue carefully removed (Figure 2.1). The samples were thoroughly rinsed with 
deionised water repeatedly to remove debris. The small intestine submucosa (SIS) 
was isolated using slight modifications to the well-established method for 
preparation (Badylak 1989; Lantz, Badylak et al. 1990). The sections of small 
intestine were inverted and then gently abraded using both moist and dry surgical 
gauze to remove the inner mucosal layer. The tissue was thoroughly washed with 
deionised water and then re-inverted and the serosal layer was then taken off 
through the use of a scalpel to create an incision, followed by manual removal of the 
layer. Finally the outer surface was carefully abraded using damp gauze to remove 
any remnants of the smooth muscle layers.  
The SIS was then carefully washed twice in deionised water for 5 minutes. This 
involved immersing the SIS in deionised water with regular stirring. The deionised 
water was changed regularly and then the SIS rinsed. This was the standard 
washing method throughout this work. The SIS was then stored in PBS (phosphate 
buffered saline : 0.01 M phosphate buffer 0.0027 M potassium chloride and 0.137 M 
sodium chloride, pH 7.4, at 25°C). Representative tissue samples were collected at 
the end of the process and used as controls. 
The diameter of the SIS for animals of this age was found to be roughly 2.5 cm and 
this was deemed suitable as it was larger than the 1 cm required according to the 
initial objectives. 
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              (a)                                           (b)                                  (c)                                     (d)                                               
                                  
 
 
 
 
2.2.2 Decellularisation Method 1 (Perfusion/Immersion) 
Prepared SIS samples were placed in individual sealable plastic containers, 
secured to adaptors, and connected to a multi-channelled peristaltic pump (Watson-
Marlow, Cornwall, UK). The complete arrangement is shown in Figure 2.2a. The 
input channels were also secured into the same containers. The solutions described 
below were then placed in the containers creating an isolated chamber and the 
pump was run to begin perfusion. This was an improvement over an earlier 
arrangement (Figure A2, Appendix A-3). 
                                                     (a)                                                                           (b) 
       
Figure 2.2 Decellularisation container arrangement. (a) Actual arrangement. (b) Illustration of the principle: (A) 
Output from the peristaltic pump which is connected to the SIS (B) Return to the peristaltic pump which is not 
connected to SIS and the SIS and draws the medium from the container (C) The SIS to be decellularised (D) 
Figure 2.1 Stages of SIS preparation (a) Porcine small intestine section prior to debridement (b) SIS following decellularisation (c) & 
(d) Final processed form of SIS 
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Container into which the decellularisation medium would collect and immerse the external surface of the SIS. The 
red arrow indicates the direction of flow of perfusion decellularisation medium. 
 
 
This approach allowed the solution to perfuse through the tissue and collect in the 
vessel, where further immersion occurred then was recycled back to the pump. The 
benefit of this arrangement is that there is also an element of immersion 
decellularisation which occurs on the outer surface of the SIS samples as illustrated 
in Figure 2.2b. Four samples were produced simultaneously using this arrangement. 
2.2.2.1 Sodium Dodecyl Sulfate & Triton X-100 (SDS/TX) 
The original protocol on which this was based was altered for this particular 
application in terms of reducing the number the cycles to a single cycle.  Each 
container was filled with 350 ml of 1% solution of SDS (Sigma-Aldrich Company 
Ltd., Dorset, UK), then the pump was run at 500 ml h-1 for 12 hours at room 
temperature (RT).  The SIS was removed and thoroughly rinsed with deionised 
water, followed by a perfusion wash for 15 minutes with deionised water. The 
samples were then perfused with 350 ml of 1% Triton X-100 (v/v) for 30 minutes, 
rinsed, and then perfused with deionised water for a further 15 minutes. The 
decellularised SIS was then rinsed with deionised water and washed twice in 
deionised water prior to being given a final rinse. All decellularised SIS was stored 
at 4°C in PBS. Changes from the protocol as outlined by Akhari et al. include 
removing steps which were more suited to heart decellularisation including the use 
of a final stage of additional perfusion for 124 h in PBS (phosphate buffered saline) 
containing  penicillin-G, streptomycin and amphotericin B (Akhyari, Aubin et al. 
2011).  
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2.2.2.2 Sodium Deoxycholate & DNase (SD/DN) 
In this protocol each container was filled with 350 ml of 4% SD (Sigma-Aldrich 
Company Ltd., Dorset, UK) then the pump run at 500 ml h-1 for 12 h at RT. 
Following this the samples were removed and thoroughly rinsed with deionised 
water followed by a perfusion wash for 15 minutes, also with deionised water.  
The SIS was then perfused with DNase I (Sigma-Aldrich Company Ltd., Dorset, UK) 
at a quantity of 2000 kU in 300 ml of 1M NaCl solution at RT for 3 h. At the end of 3 
h an additional 1000 kU in 50 ml of 1M NaCl was further added and the perfusion 
was allowed to run for a further 1 h followed by rinsing, a final wash and rinse as 
described previously. The samples were stored at 4°C in PBS. The original protocol 
was run in a number of cycles of 4 - 6 h per cycle, here this was increased to 12 h to 
simulate approximately 2 cycles. The DNase I amount was increased to 3000 kU 
(from 2000 kU in the original protocol), and the time was extended to 4 h (from 3 h) 
(Jungebluth, Go et al. 2009). The additional quantity of enzyme (1000 kU) was only 
added in the final hour. Though not doubling, this did extend the DNase portion of a 
single cycle.   
2.2.2.3 Peracetic acid (PAA-12h) 
Peracetic acid was used for the final perfusion protocol. This protocol was run as 
described previously but using 350 ml of 0.1% solution of peracetic acid (v/v) acid 
(Sigma-Aldrich Company Ltd., Dorset, UK) per length of SIS and run for 12 h at RT. 
 
2.2.3 Decellularisation Method 2 (Immersion/Agitation) 
SIS samples used were placed in clean screw-top specimen containers (150ml 
capacity) and then an orbital–shaker (Stuart Model SSM1) to provide constant 
mechanical agitation as shown in Figure 2.3. The containers were filled to capacity 
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with 0.1% solution (v/v) of peracetic acid with care taken to immerse the samples 
completely and remove any trapped air bubbles. Decellularisation in peracetic acid 
was carried out for 2 h under mechanical agitation at 100 rpm. The SIS samples 
were removed and thoroughly washed in deionised water as described previously, 
and stored at 4°C in PBS. A summary of these methods are shown in Table 2.1. 
 
Figure 2.3 Orbital shaker arragment for agitation decellularisation. 
 
Table 2.1 Experimental conditions for SIS production. 
Decellularisation 
Method Reagents Method 
Samples 
Tested 
Processed 
and 
Tested 
Total number 
of sample 
sets 
uSIS  untreated - Untreated yes 2 
PAA-2hA Peracetic acid  
Immersion 
/Agitation  
 2h yes 2 
PAA-12h Peracetic acid  Perfusion 12h yes 2 
SD/DN 
Sodium 
Deoxycholate & 
DNase  
Perfusion 
4h, 8h, 12h 
and Final 
stage (16h) 
yes 5 
SDS/TX 
Sodium Dodecyl 
Sulfate & Triton 
X-100  
Perfusion 
4h, 8h, 12h 
and Final 
stage (12.5h) 
yes 5 
 
2.2.4 Post-decellularisation Processing  
The SIS sections were stretched over 1.9 cm diameter (3/4 inch) porous 
polyethylene tubing (60 µm pores) (Porex Corporation, Fairburn, United States) 
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(Figure 2.4a). These samples were then vacuum-dried in sealable sterile specimen 
bags and placed under low vacuum conditions (approximately 10 mbar) for 12 hours 
to compress and dry the samples as shown in Figure 2.4b. The dried SIS samples 
were subsequently lyophilised by rapid immersing in liquid nitrogen for 1 minute and 
then placed into a vacuum freeze-drier (Heto Dry Winner) for 12 h. Preliminary 
testing involved using SIS which was frozen at -80°C, however when this was tested 
mechanically it was found to fail with strain levels which were below the 50% 
required in the objectives. This was attributed to the slow-forming ice crystals 
compromising the material. The final appearance of the processed SIS is shown in 
Figures 2.1 (c) and (d). The further processing allowed creation of SIS with a rigid 
cylindrical shape. The lyophilisation additionally aided in extending the storage 
capacity of the SIS. These were stored in sterile 50 ml Falcon tubes. 
                                         (a)                                                                (b)                                                                          
      
Figure 2.4 SIS processing equipment (a) porous tube (b) vaccuum drying arrangment 
 
2.2.5 Analysis 
For the two detergent based protocols (denoted SDS/TX and SD/DN), sections 
were taken from the SIS at time points 4 h, 8 h, 12 h and upon completion of the 
protocol, by cutting 2.5 cm segments during decellularisation process. The presence 
of two stages in these protocols, i.e. a 12h stage followed by shorter stage, brought 
about the decision to test the tissue at regular intervals to assess the impact of the 
final stages, though this was extended to some time-points. 
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Sections were also taken from SIS produced from the groups decellularised by 
peracetic acid over 12 h (PAA-12h), by peracetic acid for 2 h under agitation (PAA-
2hA) at completion, as well as from the untreated control SIS (uSIS). Test sections 
were also taken from all SIS samples following processing. The sample segments 
were then sectioned further and stored according to the method of analysis. 
 
2.2.6 Histology 
SIS samples to be processed for histology were fixed in 10% formalin. The samples 
were embedded in paraffin wax, sectioned to 3 µm thickness and stained by 
haematoxylin and eosin (H&E) and Elastic Van Gieson's (EVG). At least two 
sections were taken from each sample. Images of the sections were acquired using 
a light microscope (Olympus BX50) and analysed using Image-Pro Plus (Media 
Cybernetics, USA) and the images were processed using ImageJ.  
 
2.2.7 Scanning electron microscopy (SEM) 
Samples for SEM were prepared alternatively depending on whether they had been 
processed or not. The non-lyophilised intact tissue samples were fixed in 3% (w/v) 
glutaraldehyde 0.1M CAB (sodium cacodylate) buffer for 3 h. Following rinsing with 
PBS the samples were dehydrated by separate 15 minute immersions in graded 
ethyl alcohol concentrations (50%, 70%, 90% then 100% v/v in deionised water) 
and then then briefly immersed in hexamethyldisilazane for critical point drying. 
Sections of dehydrated SIS were cut into sections of 1 mm thickness and mounted 
on aluminium stubs. Lyophilised samples were cut into 5 × 5mm sections and 
directly mounted on aluminium stubs using adhesive tabs. The stubs were then 
placed in a desiccator cabinet for at least 12 hours to ensure any acquired moisture 
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was sufficiently removed. All sections were then sputter coated with gold/palladium 
(Polaron E5000, Quorum Technology, UK). The samples were then analysed using 
scanning electron microscopes (JEOL 5410LV SEM, JEOL UK, UK and Philips XL 
30 SFEG, Netherland). 
 
2.2.8 DNA Quantification 
To dry the non-lyophilised intact tissue samples these were first frozen and stored at 
-20°C. These were then placed in a freeze dryer for 6 h to obtain a dry-weight only 
sample. DNA extraction was carried out using DNeasy Blood & Tissue Kit 50 
(Qiagen, Germany).  The DNA was quantified using the Quant-iT™ DNA Assay Kit 
or Qubit® dsDNA HS Assay Kit (Invitrogen, USA), followed by a fluorescence plate 
reader (Fluoroskan Ascent, Thermo Scientific, USA) or the Qubit® Fluorometer 
(Invitrogen, USA), respectively.  
 
2.2.9 Mechanical Testing 
Test samples were cut into rectangular shapes of dimensions 8 - 14 mm in length 
and 5 - 8 mm in width, and tested in longitudinal and circumferential directions 
(relative to the axis of the small intestine). The ends of the samples were enclosed 
in wire gauze ―clamps‖, only slightly wider than the samples, to provide grip and 
stability. The uniaxial tensile testing was carried out using a dynamic mechanical 
analyser (DMA 7e, Perkin-Elmer Instruments, USA) into which the samples were 
clamped. The dimensions of the samples were entered into the software (Pyris) and 
the distance between the two clamps was taken as the length. The tensile test was 
run with an increasing force value of 500 mN m-1. From the stress-strain graph 
produced the elastic modulus was then calculated as the gradient of the elastic 
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region of the curve (E = stress/strain). The processed SIS was rehydrated with 
deionised water for 30 minutes, prior to testing. Samples which slipped or failed 
near to the clamps were ignored. 
 
2.2.10 Statistical Analysis 
Assessment of the data showed that it did not fit normal distribution models and 
therefore non-parametric statistical analysis methods were used.  The median was 
found to be a better measure of central tendency than the mean for this type of data 
and is used in all the mechanical analysis. The group sample data was compared 
for significant differences using Kruskal-Wallis non-parametric analysis which 
indicates the presence of significant statistical differences between individual 
groups. Further analysis was also carried out by post hoc pairwise analysis 
(Dunnett’s Test). Normal distribution statistical testing was carried out using a 2-
tailed student’s t-test to a 95% confidence interval. All statistical significance tests 
were done using SPSS version 21 (IBM Corporation).  
 
2.2.11 Cell culture 
Primary human oesophageal smooth muscle cells (HESMC) (ScienCell Research 
Laboratories, Carlsbad, CA, USA) were used for the cellular assays. These cells 
were cultured in Dulbecco’s modified Eagle medium (Gibco, Life Technologies, 
Paisley, UK) supplemented with 10% foetal bovine serum (Gibco) and 1% penicillin-
streptomycin (Gibco) all further references to medium are this composition. The 
conditions for culture were at 37°C in air with 5% CO2 and 95% relative humidity. 
Only cells from passages 3-6 were used for the assays.  
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2.2.12 Biocompatibility assay 
A CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay (Promega, 
Southampton, UK) was used to measure  the metabolic activity of HESMC’s as an 
indication of biocompatibility, in accordance with ISO 10993 parts 5 and 12 
(Appendix A-4) and the manufacturer’s protocol. The  HESMC’s were seeded at a 
density of 100,000 cells/cm2 on sections of PAA-12h, PAA-2hA, SDS/TX, SD/DN, 
uSIS, a commercial scaffold, and with tissue culture plastic (TCP) as a control. The 
commercial scaffold used in this case was Biodesign® (Cook Medical, UK) and was 
used to provide a potential alternative to TCP as a control. The sections of SIS were 
stabilised within the cell culture wells using well inserts (CellCrown, Scaffdex Ltd., 
Tampere, Finland). The inserts pulled the samples taut and suspend them within the 
24-well plates.  The cells were then seeded on the abluminal surface with the 
exception of the commercial scaffold which did not have a specified orientation. The 
scaffolds were all hydrated with 200 µl of medium approximately 30 minutes prior to 
seeding cell. 
After 24 and 96 h incubation, medium was aspirated from the cells and replaced 
with six parts of medium and one part MTS solution, which consists of (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) 
(MTS) and an electron coupling agent phenazine methosulfate. MTS is metabolised 
forming formazan in the mitochondria of living cells, the result of which is a colour 
change from yellow to brown that is broadly speaking indicative of cell number. After 
sufficient colour change was observed (usually after incubation for 1 - 1.5 h), 
absorbance was measured at 490 nm, with a reference wavelength of 630 nm using 
an absorbance plate reader (M200, Teccan, Männedorf / Switzerland). The 
metabolic activity of cells residing on each scaffold was normalised to the TCP 
control, specific to each time point. Between time-points, MTS-containing medium 
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was aspirated, the cells rinsed with PBS, and replaced with fresh cell culture 
medium. 
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2.3 - Results 
2.3.1. Histology  
Histological staining with H&E revealed the presence of visible and distinct nuclei in 
all samples (Figure 2.5), with the relative number of nuclei in the final samples being 
SDS/TX < PAA-12h < SD/DN < PAA-2hA < uSIS (Figure 2.10a). The numbers of 
visible nuclei per µm2 were found to be far higher in the uSIS control and the PAA-
2hA groups than those observed in the final stages of SDS/TX, SD/DN and PAA-
12h. The SDS/TX group was observed to have the lowest number of histologically 
visible nuclei per µm2 of visible tissue by quite a substantial margin. Staining with 
EVG (Elastic Van Gieson's stain) showed quite an even dispersal of black-stained 
elastin fibres throughout the intestinal tissue. The decellularisation process did not 
appear to result in any visible loss of elastin fibres by any of the protocols (Figure 
2.6). 
             (a)                                     (b)                               (c)                               (d)  
      
                    (e) 
 
    Figure 2.5 Histological images (stained with H&E). (a) uSIS (b) PAA-2hA (c) PAA-12h (d) SD/DN (e) SDS/TX  
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                            (a)                                                          (b)                                                           (c)  
        
                         (d)                                                           (e) 
      
Figure 2.6 Histological images of decellularising SIS and the controls (stained with EVG) (a)  uSIS  (b) PAA-2hA  
(c)  PAA-12h  (d)  SD/DN  (e) SDS/TX 
 
2.3.2 SEM  
The use of SEM imaging did not reveal any visible differences between samples of 
the 5 groups (Figure 2.7). Additionally there were also no visible differences 
between samples taken from different time points during the longer multi-stage 
protocols (SDS/TX & SD/DN). The fibrous structure of the pre-processed SIS 
samples was clearly visible on some images (Figure 2.7d). The processed form of 
the SIS produced a characteristic sheet-like regular appearance (Figure 2.7h) in 
most samples with the exception of the processed PAA-12h, which showed a 
characteristic appearance with a more irregular and cracked surface with defects 
(Figure 2.7f and Figure 2.7g).  
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                      (a)                                               (b)                                     (c)                                    (d)                                                
    
                    (e)                                         (f)                                           (g)                                       (h)                                     
                 
Figure 2.7 SEM images of SIS from the protocol groups. All are taken from cross-sectional view unless specified 
(a) uSIS  (b) PAA-2hA (c) )  PAA-12h (d) SD/DNase  (e) SDS/TX (f) Luminal view of processed PAA-12h (g) 
Processed PAA-12 h (h) Processed SD/DNase 
 
 
2.3.3 Biocompatibility Assay 
The results of the biocompatibility assay were expressed in terms of metabolic 
activity and are represented as a percentage of the TCP control for that time point 
(Figure 2.8). At day 1 (24 h) the SIS specimens from the groups PAA-2hA and  
PAA-12h were found to have metabolic activity levels which were similar to the 
control (TCP), while the SD/DN and the commercial SIS group were found to be 
elevated to roughly 1.5 and 2 times, respectively, that of the control. The untreated 
SIS (uSIS) was found to have highly elevated metabolic activity with the average 
value approximately 4 times that of the control group (TCP) indicating a very rapid 
increase in the metabolic activity of the cells. The SDS/TX group conversely was 
found to have significantly lower values than the control and all other samples, 
indicating lower biocompatibility. 
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At day 4 (96 h) all specimens showed an increase in metabolic activity from the 
levels at day 1, including the control group. The SDS/TX specimens still induced 
very low cellular activity levels and at day 4 the number remained lower than all 
other groups at day 1, potentially indicating on-going cytotoxicity. Both PAA groups 
performed similarly to the control indicating a reasonable degree of biocompatibility. 
At day 4 the SD/DN, commercial SIS and the uSIS all showed numbers at least 
twice that of the relative control value. While the uSIS finished with the highest 
activity level there was also a decrease relative to the control, indicating a levelling 
off after the sudden rapid increase in the first 24 h. 
Further work was also carried out as shown in Figure 2.12 which will be discusses 
in Section 2.4 (Discussion).  
 
Figure 2.8 Metabolic activity of the cells (HESMC) cultured on the scaffold groups carried out with an MTS assay. 
The metabolic activity was normalised in relation to the control (tissue culture plastic-TCP with the same surface 
area) and is expressed here as a percentage of the control, specific to each time point. The dashed line indicates 
the metabolic activity of the TCP control at each time point. Important values differing significantly from each other 
are denoted by *; p < 0.05. 
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Figure 2.9 Metabolic activity of cells (HESMC) cultured on the SDS/TX scaffolds showing the difference between 
the original SDS/TX protocol and an adapted protocol with an extended washing regime (increased to 6h and with a 
continue flow of fresh deionised water). The metabolic activity was normalised in relation to the control (tissue 
culture plastic-TCP with the same surface area) and is expressed here as a percentage of the control, specific to 
each time point. The commercial scaffold was added as a reference point for biocompatibility. The dashed line 
indicates the metabolic activity of the TCP control at each time point. Important values differing significantly from 
each other are denoted by *; p < 0.05. 
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2.3.4 DNA Quantification 
DNA quantification revealed that the SDS/TX group produced the lowest levels of 
DNA following the completed decellularisation process (Figure 2.10b). SD/DN also 
proved to be effective at decellularisation producing DNA levels well below that 
found with the control uSIS. The levels of DNA present in the PAA-2hA samples 
were not significantly different to that of the control. The level of DNA present in the 
PAA-12h were also not significantly different from the control but were lower than 
those observed with the PAA-2hA group.  
What was also observed that SD/DN protocol produced no appreciable difference in 
the DNA quantity detected between time-points 12 h and the final stage (16 h), 
indicating that the introduction of the enzyme DNase did not appear to affect the 
quantity of the DNA remaining in the SIS.  
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(a) 
 
 
(b) 
 
Figure 2.10 (a) The average number of distinct nuclei counted per µm
2
 of SIS for all groups. Analysis was carried 
out on images taken of H&E stained histological sections, with random sites chosen and the nuclei counted using 
software tools (Image J) (n = 10-20). All counts were then averaged together for each stage. Error bars are 
standard error. (b) DNA quantification values (ng/mg of dry weight) for the all three protocols and the control with 
each column representing the concentration of DNA at various time-points in the decellularising protocols including 
the processed SIS (n = 4). Error bars are the standard error. Important values differing significantly from each other 
are denoted by *; p < 0.05. 
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2.3.5 Mechanical Analysis 
In longitudinal testing the elastic modulus values were not found to vary significantly 
between the specimens with the exception of the PAA-12h where values in both 
directions were found to be high (the longitudinal value being exceptionally high 
when compared to the other groups) (Figure 2.11a). What was also visually 
observed is that following decellularisation that the SIS produced from the PAA-12h 
protocol was physically different to all other SIS samples when handled. The SIS in 
this group took on a more ridged and less pliable texture not observed in any of the 
other groups.  
 Lyophilisation of the all the samples did not affect the elastic modulus values with 
the exceptions being the PAA-12h group, which fell dramatically and the SDS/TX 
which when compared longitudinally with the pre-lyophilised form showed a 
significant increase.  
The yield stress was considered an important parameter as it indicates the stress at 
which the elastic behaviour of the tissue is compromised. The yield stress values 
showed no significant change between the specimens with the exception of the 
PAA-12h sample, which again, was found to be significantly larger particularly in the 
longitudinal direction but also circumferentially when compared to other pre-
lyophilised SIS samples (Figure 2.11b). The lyophilisation here was found to cause 
slight increases in all samples, with the increase in SDS/TX being quite substantial, 
and the exception being the PAA-12h which fell in longitudinal testing. 
Circumferentially the only significant increase was found in the PAA-12h specimens 
which showed, as mentioned previously, substantial increase in the yield strain 
value. Again here it should be noted PAA-12h SIS produced greatly different 
behaviour when compared to the other samples. 
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The failure strain was calculated as being the strain at the point of failure of the test 
samples during tensile testing. In the longitudinal testing the values for the 
specimens from SDS/TX, SD/DN and PAA-12h were all found to be similar to the 
control uSIS or the PAA-2hA (Figure 2.11c) It was also noted that the value for 
PAA-12h was found to be very low (39.29%) with very low error indicating that while 
the PAA-12h was very stiff and gave high yield strength values, it had a greatly 
reduced elasticity when compared to the control uSIS or the other samples tested. 
In circumferential testing only the PAA-12h protocol failure strain value was found to 
be significantly lower than that of the control uSIS. Following lyophilisation, the PAA-
12h SIS was observed to change in failure strain behaviour with the value 
increasing following the processing. 
The results from the 12 h detergent decellularisation stages (time points 4h, 8h, and 
12h) in both the SD/TX and SD/DN (Figure 2.10) do not appear to indicate any 
quantifiable time-dependant changes in the mechanical properties that occurred 
during the process.  
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Figure 2.11 Mechanical testing data from the tensile testing of the SIS (a) Elastic modulus values (MPa) for the all 
final stage SIS along with the lyophilised forms (n = 12) (b) Yield stress values (MPa) for the all final stage SIS along 
with the lyophilised forms (n = 12) (c) Failure strain values (%)for the all final stage SIS along with the lyophilised form 
(n = 12). Error bars shown are the standard error. Statistical analysis was done non-parametrically and discussed in 
the results sections. 
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(b) 
 
(c) 
 
Figure 2.12 Mechanical data from tensile testing SIS from the two detergent-based protocols (SDS/TX and SD/DN) 
taken from different time points during the decellularisation process. The three analysis criteria being (a) elastic 
modulus (MPa) (b) yield stress (MPa) and (c) failure strain. The error bars are the standard error. Statistical 
analysis was done non-parametrically and discussed in the results sections. 
 
 
0
1
2
3
4
5
4h 8h 12h Final
M
P
a Elastic Modulus 
SDS/TX
(Longitudinal)
SDS/TX
(Circumferential)
SD/DN
(Longitudinal)
SD/DN
(Circumferential)
0
0.5
1
1.5
2
2.5
4h 8h 12h Final
St
re
ss
 (
M
P
a)
 
Yield Stress 
SDS/TX
(Longitudinal)
SDS/TX
(Circumferential)
SD/DN
(Longitudinal)
SD/DN
(Circumferential)
0
50
100
150
200
250
300
4h 8h 12h Final
St
ra
in
 (
%
) Failure Strain 
SDS/TX
(Longitudinal)
SDS/TX
(Circumferential)
SD/DN
(Longitudinal)
SD/DN
(Circumferential)
93 
 
2.4 - Discussion 
2.4.1 General Discussion 
The general aim of this study was to evaluate commonly used decellularisation 
protocols to create tubular SIS which has both a sufficient level of decellularisation 
to function as a tissue engineering scaffold and possessing mechanical properties 
either minimally affected or ideally unaffected by the decellularisation process. The 
perfusion method has not yet been applied to SIS previously and was hypothesised 
to be suitable on account of the shape of the tubular SIS produced in this work.  
The data from histological and quantitative DNA analysis show that the most 
effective protocol was the SDS/TX. The SIS produced by this method largely 
achieved both the criteria highlight by Crapo et al. of being below the 50 ng dsDNA 
per mg of ECM (dry weight) and with no histologically visible nuclei. While it is 
understood that no work has been carried out that sufficiently evaluates these 
criteria as indicators of sufficient decellularisation, it does stand to reason that 
minimising the amount of foreign DNA present in any type of graft tissue would likely 
increase the chance of successful implantation due to a reduced immune response. 
It was also found that both detergent-based perfusion methods produced SIS with 
DNA below the 50 ng dsDNA per mg of ECM (dry weight) threshold. Finally, both 
methods using peracetic acid did not adequately decellularise SIS though it was 
observed that there was a significant difference between the two.  The question 
arises as to whether this is due to the effectiveness of the reagents over the time 
duration of the protocols, or as a result of the physical process of the protocols 
themselves. 
When the effectiveness of the reagents is considered there is evidence to suggest 
that, by a number of varying criteria, they can all be considered effective at 
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decellularisation. When applied to sheet SIS peracetic acid is known to be an 
effective reagent for decellularisation. SDS and Triton X-100 have also been shown 
to have the capacity to decellularise SIS individually as demonstrated by Oliveira et 
al. where SIS was decellularised to levels below 50 ng dsDNA per mg using 
concentrations as low as 0.1% over a 24 h period under agitation (Oliveira, Garzon 
et al. 2013). SD while not having been used on SIS has been shown to decellularise 
the small intestine in a rat model (Totonelli, Maghsoudlou et al. 2012). Consequently 
all three agents are likely to be effective at decellularising SIS, therefore the failure 
of the SIS to decellularise in this study particularly using PAA is likely not to be 
entirely due to the effectiveness of the reagent and more likely to be due to the 
decellularisation methods or the shape and structure of the tissue. 
The length of time the protocols are run is another important factor. The level of 
DNA present in the detergent based protocols (Figure 2.10b) can be seen to 
steadily decrease over time which undoubtedly shows that time is a vital component 
of the decellularisation process. Time has also been shown to effect the process of  
peracetic acid decellularisation and halving the decellularisation time 2h to 1 h has 
been shown to cause elevated levels of DNA in sheet SIS (Keane, Londono et al. 
2012). In addition to this the increased effectiveness of the PAA-12h perfusion 
protocol (in comparison to the PAA-2hA group) does indicate that time likely 
improved the effectiveness of peracetic acid decellularisation ; however while the 
amount of DNA was slightly reduced the number of visible nuclei still suggested a 
less then optimum level of decellularisation (Figure 2.5c).  
The final difference with between the protocols was the decellularisation 
arrangements themselves. As mentioned previously there are no examples of SIS 
being decellularised using a perfusion arrangement and no work where intact 
tubular SIS has been consistently studied. Perfusion decellularisation has been 
previously used on rat small intestine using 4% SD/DNase and this was found to be 
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an effective means of decellularisation however analysis was limited to histological 
means (Maghsoudlou, Totonelli et al. 2013). Multi-organ decellularisation of rat 
tissues using SDS perfusion have also been shown to be effective at 
decellularisation (Park and Woo 2012). In the case of this work, however, it is 
unclear whether the SIS was actually undergoing true perfusion i.e. though the SIS 
itself, or creating a flow through the lumen. SIS is a largely impermeable tissue and 
given the low flow rates used it is highly unlikely that the decellularisation agents 
perfused through thickness of the tissue. The combination of a constant flow of 
decellularising agents over the luminal surface of the SIS in addition to the 
circulating agents on the outer surface  have likely produced an environment where 
suitable decellularisation can occur simultaneously on both surfaces and 
consequently provide a working method for decellularising tubular SIS.  
One of the major observations in the mechanical testing was the extreme variations 
in the data produced by the PAA-12h protocol. The large increases in the elastic 
modulus and the yield stress values were also accompanied by a drastic drop in the 
failure strain to the lowest of all SIS samples at just below 40% (Figure 2.11). This is 
indicative of SIS tissue which has lost a high degree of elasticity when compared to 
the control and as a result this SIS can be reasonably excluded from consideration. 
Furthermore, the human oesophagus also extended by up to 50% under normal 
conditions and any material which has a failure strain below this level  risks failing 
and compromising the integrity of the construct (Yang, Fung et al. 2006; Tan, Chua 
et al. 2012). The SIS produced by peracetic under agitation (PAA-2hA) did appear 
to match the control, and the SIS from the detergent based protocols, in its 
mechanical behaviour; however, as described earlier it was poorly decellularised 
and therefore not suitable as a scaffold. The short exposure of the SIS to the 
peracetic is what is likely the difference between the two PAA protocols. Currently 
there does not appear to be any definitive consensus on the effects of individual 
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decellularisation agents on the mechanical properties of many of the commonly 
used decellularised tissues (Crapo and Gilbert 2011). It has been shown that some 
acids when used on ECM can alter the mechanical properties.  An example of this is 
acetic acid which has been shown to alter the stress-strain behaviour of bovine 
pericardium (Maghsoudlou, Totonelli et al. 2013). Peracetic acid has not been 
reported to alter the mechanical properties of SIS though as in the case here the 
time of exposures is commonly limited to 2 h as opposed to the 12 h used in this 
instance (Gilbert, Sellaro et al. 2006; Park and Woo 2012). 
The two detergent-based protocols also produced decellularised SIS which was not 
adversely mechanically affected by the decellularisation process according to the 
three criteria they were evaluated by. Of the two protocols SDS/TX did produce SIS 
with high values for all three criteria, particularly in terms of the lyophilised form. It 
should be mentioned that detergents have also been known to disrupt the ECM 
matrix however this was not observed in this study (Crapo and Gilbert 2011). A 
possible reason for this is that both these protocol were both adapted in this study to 
reflect the nature of the SIS, which only consists of a thin layer of ECM and 
contrasts with intact organs, and were therefore drastically shortened. In the case of 
other tissues, these profusion protocols are run for a large number of repeated 
cycles and usually over a number of days. A variation of the SD/DNase protocol has 
been used to decellularise a human donor trachea, a process taking multiple cycles, 
though it was found that between cycles 18 and 22 the mechanical properties were 
so negatively impacted as to render the trachea ineffective (Jungebluth, Go et al. 
2009). Consequently the limited exposure of the detergents to the tissue in this work 
could be a possible reason for the preservation of the mechanical properties.  
In the mechanical testing some inconsistencies were observed between the 
longitudinal and circumferential tensile data. This was attributed to the native 
anisotropy found in SIS, and which contains a high degree of complexity (Orberg, 
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Baer et al. 1983). If both axes are simultaneously secured for example a force 
applied along one axis would directly result in changes in the stress strain behaviour 
along the other axis. This behaviour was also found to be asymmetric, with the 
application of a set forced along the longitudinal, resulting in changes to the 
circumferential stress–strain behaviour which were more pronounced than if the 
axes were reversed (Sacks and Gloeckner 1999). This anisotropy has been 
explained by the angular distribution of the fibres within the ECM of the submucosal 
layer (Lanir 1979). These fibres have been described as existing in two distinct 
populations of fibres orientated at approximately ±30° (Orberg, Baer et al. 1983; 
Sacks and Gloeckner 1999). Sacks et al. found the ±30° orientated layers as being 
part of local subdivisions within the tissue which will can vary along its length (Sacks 
and Gloeckner 1999). This is also reinforced by the description of the fibres on a 
macro scale being aligned in a spiral which can be considered conducive to 
peristalsis (He and Callanan 2012).  
The vacuum-compression and lyophilisation of the SIS were also found to alter 
mechanical properties of the material. The exact mechanism for these changes was 
not entirely clear though differences between the longitudinal and circumferential 
directions can be explained partially terms of the properties of the native tissue as 
mentioned previously. What can be observed from the data in Figure 2.11 is that in 
the longitudinal direction there were particular changes in terms of the failure strain 
for all samples.  A possible mechanism for this is that the vacuum compression of 
the SIS results in an increase level of interaction between the ECM components 
particularly the collagen fibres present and thereby altering the mechanical 
properties. It should be noted that following rehydration the processed samples did 
not expand to the same thickness as pre-processed SIS samples. In addition to 
changes in the mechanical properties, it has been shown that processing 
decellularised SIS can cause a change to the in vivo properties. Vacuum pressed 
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SIS has been compared to lyophilised SIS and the vacuum pressed SIS was found 
to be more resistant to enzymatic degradation and with a slower rate at which 
angiogenesis occurred. These affects were attributed to poor cellular infiltration. The 
compressed SIS test was found to have a far lower degree of porosity  and still 
retained a compressed appearance after rehydration (Janis, Johnson et al. 2011).  
The biocompatibility of any scaffold is an important consideration for their potential 
use. The data here showed clear differences between decellularisation protocols. 
While both peracetic acid protocols demonstrated a good degree of biocompatibility, 
cells cultured on the SDS/TX had lower levels of metabolic activity than all other 
samples. While mechanically, and in terms of the decellularisation, the SIS 
produced from this method was found to be most ideal, this level of biocompatibility 
makes it highly unsuitable. Furthermore, follow up work (Figure 2.9) where SDS/TX 
was created and then washed for 6 h using an improved washing method (Appendix 
A-2) failed to significantly improve the biocompatibility. This protocol does involve 
the use of two separate detergents which have each been shown to be cytotoxic i.e. 
SDS and Triton X-100 and with this increased exposure there is also an increased 
likelihood of some detergent being retained within the SIS itself. As both the 
reagents have been used successfully in decellularisation it is probable that a far 
longer washing protocol would eventually achieve adequate removal though it would 
require additional work to ascertain the balance between the time taken to remove 
the reagents and point at which the mechanical properties of the material would 
begin to deteriorate. 
SD is also a cytotoxic detergent and it should be noted that in the SD/DN protocol, 
had the best biocompatibility of all the decellularised SIS produced. The SIS here 
was also exposed to a 4 h rinse with a salt solution (containing the DNase) following 
detergent exposure and this could potentially have aided in removing the detergent 
sufficiently from the SIS to produce the observed results. While the SIS produced 
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with the SD/DN protocol had very high biocompatibility (higher than the commercial 
SIS) the presence of the DNase enzyme, while likely to have minimal effects on cell 
growth in vitro, and may have more negative impact if applied in vivo and this 
remained a concerned.  
The uSIS demonstrated a high degree of biocompatibility which may be attributed to 
the fact the internal structure was likely preserved and the tissue components all 
entirely retained. An intact ECM, in addition to any remaining growth factors, could 
potentially stimulate cellular activity. While in vitro testing of this scaffold indicated 
acceptable biocompatibility it will, of course, be unsuitable for in vivo applications 
due to the potential for a severe immune response.  
 
2.4.2 Conclusion 
In conclusion, the conventional peracetic acid/agitation method for SIS 
decellularisation is not suitable for SIS when made in intact tubular form. The 
primary reason for this is the insufficient level of decellularisation. Peracetic acid 
when used over 12 h with the perfusion method was also found to be an unsuitable 
owing to a drastic drop in the elasticity of the tissue following decellularisation, in 
addition to an inadequate level of decellularisation. The two detergent/perfusion 
protocols were found not only to provide adequate decellularisation of the SIS, but 
in several instances were found to possess less adversely affected mechanical 
properties over the SIS produced from peracetic acid (or the control following 
processing). There are, however, limitations associated with both methods. It was 
concluded that SDS/TX was the most suitable protocol for producing scaffolds on 
account of the highest level of decellularisation and therefore the least risk of 
immune response and/or graft rejection, the best mechanical properties following 
the processing stage, and having the added benefit of the protocol lacking enzymes 
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as used in SD/DNase which may potentially increase the risk of rejection, however it 
was found to have poor biocompatibility. Also as shown in Figure 2.12, the 
biocompatibility of the scaffold could not be improved even with increasing the 
washing time to 6 h with an improved washing protocol. Consequently whilst there 
may be some merit in researching improved wash cycles, it was deemed that 
researching longer time periods would not be practical given that there was no 
improvement observed with a single increase. It was observed that whilst SD/DN 
may show acceptable in vitro biocompatibility and suitable mechanical properties it 
does have the limitation of using the DNase enzyme which may be unsuitable for 
clinical application however this shown to not affect the level of decellularisation of 
the SIS during the protocol. In conclusion SIS produced using SD with the 
elimination DNase enzyme stage was chosen as the ideal basis for all further work. 
101 
 
 
 
 
 
 
 
3. Electrospinning 
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3.1 - Introduction 
As discussed in Chapter 1, electrospinning is a useful method for the preparation of 
scaffolds and therefore tissue engineering and related processes. In this chapter it 
has been attempted to overcome some of the inherent disadvantages of 
electrospun scaffolds, along with some of the disadvantages of extracellular 
materials, by combining the two materials together in a single hybrid scaffold.  
If these two materials are to be successfully combined one of the key hurdles which 
needs to be overcome is the issue of attachment between the two materials. With 
high surface area and an inherent flexibility, electrospun fibres have been observed 
to have a degree of adhesiveness (Bye, Wang et al. 2012) . A similar objective was 
attempted by Horst et al. where urinary bladder matrix (UBM) was combined with 
electrospun PLGA fibres.  In that work the UBM was in the form of a flat sheet and 
an issue of attachment was identified. Attempts were made to improve this with the 
outcome being that the UBM was maintained in a wet state during spinning (Horst, 
Madduri et al. 2013). This issue would need to be considered here and any 
problems overcome if a suitable hybrid scaffold was to be created for potential use 
in oesophageal tissue engineering.  
The aims of this chapter are for the establishment of protocol 1) a viable layer of 
electrospun polymer and 2) to produce suitable attachment between the tubular SIS 
decellularised scaffold produced in Chapter 2 and the layer of electrospun polymer.  
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3.2 - Materials and Methods 
3.2.1 SIS preparation 
3.2.1.1 SIS Isolation 
The SIS was prepared as described in Chapter 2. Briefly, the jejunum/ileum 
samples were cut into lengths of 20 cm, and cut and prepared as described 
previously. Following preparation the SIS was then carefully washed twice in 
deionised water for 5 minutes. The SIS was then stored in PBS (phosphate buffered 
saline : 0.01 M phosphate buffer 0.0027 M potassium chloride and 0.137 M sodium 
chloride, pH 7.4, at 25 °C).  
3.2.1.2 Decellularisation 
The initial SIS used in this work was decellularised by the perfusion method 
described in Section 2.2.2, and using the protocol SDS/TX (Sodium Dodecyl Sulfate 
& Triton X-100) described in Section 2.2.2.1. In this protocol each container was 
filled with 350 ml of 1% solution of SDS (Sigma-Aldrich Company Ltd., Dorset, UK), 
then the pump was run at 500 ml h-1 for 12 h at room temperature. The SIS was 
removed and thoroughly rinsed with deionised water, followed by a perfusion wash 
for 15 minutes with deionised water. The samples were then perfused with 350 ml of 
1% Triton X-100 (v/v) for 30 minutes, rinsed, and then perfused with deionised 
water for 15 minutes. The SIS was then washed twice in deionised water as 
described previously and stored at 4 °C in PBS.  
3.2.1.3 Post Decellularisation Processing – Initial Method 
The SIS sections were stretched over 1.9 cm diameter (designated by the 
manufacturer as 3/4 inch) porous polyethylene tubing (60 µm pores) (Porex 
Corporation, Fairburn, United States). These samples were vacuum-dried in sealed 
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sterile specimen bags and placed under low vacuum conditions (approximately 10 
mbar) for 12 h to compress and dry the samples. The dried SIS samples were 
subsequently lyophilised by immersing in liquid nitrogen for 1 minute and then 
placed into a vacuum freeze-drier (Heto Dry Winner) for 12h.  
3.2.1.4 - Post Decellularisation Processing – Altered Method 
As a results of changes made to the method as a results of the data described in 
Section 3.3.2.5 changes were made to the SIS producing method and the porous 
tubes were changed to 2.54 cm diameter (described as 1 inch) porous polyethylene 
tubing (60 µm pores) (Porex Corporation, Fairburn, United States). The differences 
between the two sizes are shown in Figures 3.1a & b. 
                                                      (a)                                                                  (b) 
   
Figure 3.1 Images showing porous polyethylene solid tubes used for SIS preparation with (a) highlighting the size 
difference and (b) the cross-section. In both images ―A‖ represents the new 2.54 cm diameter tube and ―B‖ the old 
1.9 cm diameter tube. 
 
 
 
A
A
B
B
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3.2.2 Electrospinning 
3.2.2.1 Arrangement 1 (Series 1) 
 
     
Figure 3.2 Electrospinning arrangement used in Series 1. A) Mandrel B) Needle and power connector C) Step 
motor D) Syringe Pump E) Motor controller and switch F) Power Source 
 
The basic arrangement was set up as shown in the Figure 3.2. The needle used 
was an 18 Gauge (0.838 mm) diameter. The tip of the needle was ground level 
using hand-held power tools and then smoothed using sand paper. The needle was 
suspended in a fan-ventilated acrylic box of dimensions 45 × 25 × 25 cm, as seen in 
Figure 3.1. Tubing made of polytetrafluoroethylene (PTFE) tubing was used to 
connect the needle to a 10 ml syringe, which was then placed in a Graseby 3150 
syringe pump (Graseby Dynamcs, Smiths Detection Group Plc, Watford, UK). The 
needle was connected to a high voltage power supply (Glassman Europe Limited, 
Bramley, UK) which is able to generate positive DC voltages up to 30 kV. Initial 
work used a grounded stainless steel collection platform was then placed below the 
needle with an adjustable height to allow for a variable collection distance. The 
fibres created were collected on glass slides placed over the collection plate or onto 
aluminium foil used to cover the collection plate. Later work the collection of the 
fibres took place on a rotating mandrel which was connected to a step motor. The 
speed of the mandrel was controlled through the use of a controller and a custom 
made switch. As there was very little torque required the step motor was allowed to 
A 
B 
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function as a uniphase motor with the controller providing a wave form signal for 
drive. The frequency of the wave form was used to equate the rotational speed of 
the mandrel. The mandrel was covered in aluminium foil and was earthed through 
the use of a ring-shaped rolling contact.  
3.2.2.2 Protocol 1 (Series 1) 
The polymer which was selected for Series was poly-Ɛ-caprolactone (PCL) (Sigma, 
UK). As mentioned in Section 1.4.2.6, the polymer was selected because properties 
include toughness and flexibility in addition to having a slow degradation rate which 
was particularly relevant given the properties required of the scaffold in line with the 
objectives of this work. In addition to this the electrospinning work using this 
polymer is extensive.  The solution was prepared by dissolving the PCL granules in 
the liquid dichloromethane (DCM) (Sigma, UK). The solution was then mechanically 
stirred for at least 3 hours. The complete dissolution of the granules into the solvent 
was carefully confirmed by visual inspection prior to usage. The polymer solution 
was then stored at 8◦C. The polymer solution was returned to room temperature 
prior to use. The polymer (PCL) was made into a variety of concentrations; 10%, 
15%, 20% with the concentrations being weight by volume (w/v). 
For the actual spinning process involved cutting tubular SIS into lengths of 3.5 cm in 
length. These lengths were then secured to the mandrel using a small quantity of 
adhesive tape, the tape was limited to the final 0.5 cm which would then be cut 
away and discarded at the end of the process, leaving a 3 cm length free of 
adhesive and the focus of the spin-coating. The PCL solution was prepared to the 
concentrations mentioned earlier. Electrospinning was carried out with a polymer 
solution flow rate of 15 ml h-1, with voltage at 20 kV and a height of 15 cm. The 
spinning was conducted for 15 minutes for each sample (5 m for each cm of SIS) 
and the control speed was 540 rpm. The mandrel was advanced at an increment of 
1 cm every 5 m. Samples were creating at various mandrel rotational speeds. 
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Vacuum drying was used to remove any excess solvent using a vacuum freeze-
drier (Heto Dry Winner) and they were then stored in sterile 50 ml falcon tubes at 
room temperature.  
For the purposes of attachment analysis the starting condition of the SIS was varied 
and the SIS was wetted using a spray bottle of deionised waster either initially or 
repeatedly while stopping the electrospinning to keep the SIS constantly wet, 
depending on the variable tested. The SIS was also tested by dripping acetone over 
the surface in a further variable. 
The speed of the mandrel was also varied to analyse whether the speed of rotation 
affected the alignment of the fibres. The speeds used were 540, 1260, 1440, 1620, 
1800 rpm. A list of the key variables is in Table B1 (Appendix B-3). 
3.2.2.3 Arrangement 2 (Series 2) 
(a) 
 
                                    (b)                                                      (c)                                                      (d) 
     
Figure 3.3 (a) Electrospinning arrangement used in Series 2: A) Power Source, B) Syringe Pump, C) Needle and 
power connector, D) Mandrel,  E) Servo motor, F)Motor controller. (b) Brush ground contact (c) Custom collector (d) 
Needle and power arrangement.  
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The basic arrangement for electrospinning were kept the same, however a number 
of changes were made to improve the process by solving particular challenges in 
addition to other changes which were general improvements (Figure 3.3). In this 
arrangement the polymer solution was placed in rubberless 10 ml syringes 
(Appendix B-1) (Terumo medical corporation, Somerset, NJ, USA) which were then 
placed in a syringe pump (Model Pump 11 Elite, Harvard Apparatus, USA). A 
combined servo and controller arrangement (System Model Lexium 23, Schneider 
Electric, Rueil-Malmaison, France) were attached to a mandrel of non-conductive 
Dacron, (2 cm diameter and 60 cm length) for the fibre collection and was run 
though a cut out in the box. The fibres were collected onto a stainless steel collector 
which was custom built to be secured onto the mandrel (Figure 3.3c). The earth for 
arrangement was connected to the collector via a brush contact (Figure 3.2b). The 
needle for electrospinning was carried out with an 18 Gauge (0.838mm) needle 
prepared as described previously. The needle was connected to the power source 
using the same arrangement described earlier (shown in Figure 3.3d). The 
electrospinning was moved to a larger acrylic box (dimensions 75 × 60 × 60 cm), 
increasing the space to provide space for an additional mandrel support including a 
bearing to provide stability at higher rpm. The ventilation was also improved to allow 
for better fibre production.  
3.2.2.4 Protocol 2 (Series 2) 
The polymer adopted for Series 2 was poly(lactic-co-glycolic acid) (PLGA) (Purac® 
PURASORB, PLG 8523,  85/15 L-lactide/glycolide copolymer) (Corbion, 
Amsterdam, The Netherlands). PLGA was selected because it better suited the 
properties required of the objective. This included better biocompatibility and above 
all a suitable degradation rate (weeks to months) that was more in line with the 
goals and would not remain present for longer as might be the case with PCL. 
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Furthermore the properties of the material could also be varied heavily if required by 
varying the proportions of the copolymers.  
The polymer granules were dissolved weight by volume into the solvent 
Dichloromethane (DCM) using a magnetic stirrer for at least 3 hours. The polymer 
solution was then stored at 8 ◦C. The polymer solution was returned to room 
temperature prior to use. The polymer (PLGA) concentrations which were used 
were 10%, 15% and 20%.  
For the actual spinning process involved cutting tubular SIS into lengths of 3.5 cm in 
length. These lengths were then secured to the mandrel using a small quantity of 
adhesive tape, the tape was limited to the final 0.5 cm which would then be cut 
away and discarded at the end of the process, leaving a 3 cm length free of 
adhesive and the focus of the electrospun fibre coating. The PLGA solution was 
prepared to the concentrations mentioned earlier. Electrospinning was carried out 
with a polymer solution flow rate of 1 ml h-1, with voltage at 14 - 16 kV and a height 
of 15 cm. The spinning was conducted for 45 minutes for each sample (15 m for 
each cm of SIS). The mandrel was advanced at an increment of 1 cm every 15 m. 
Samples were creating at mandrel rotational speeds of 10, 500, 1000, 2000 and 
3000 rpm. Vacuum drying was used to remove any excess solvent using a vacuum 
freeze-drier (Heto Dry Winner) and they were then stored in sterile 50 ml falcon 
tubes at room temperature.  
For the purposes of attachment analysis further samples were produced which had 
an additional 2 minute coating of the polymer solution at a flow rate of 7 ml h-1 with 
the voltage set to 25 - 30 kV and a slow rotation rate of 10 rpm. The high flow rate 
and high voltage resulted in a highly unstable spinning jet and only partially coated 
the sample with a set of large and incomplete fibres. A list of the key variations in 
the electrospinning process is in Table B1 (Appendix B-3). 
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3.2.3 SEM Analysis 
The spun fibres on the SIS were cut into 1 cm sided squares and directly mounted 
on aluminium stubs using adhesive tabs. The stubs were then placed in a 
desiccator cabinet for at least 12 h to ensure any acquired moisture was sufficiently 
removed. All sections were then sputter coated with gold/palladium (Polaron E5000, 
Quorum Technology, UK). The samples were then analysed using a scanning 
electron microscope (Philips XL 30 SFEG, Netherland). The images were analysed 
using software (ImageJ).  
 
3.2.4 Alignment   
SEM images of the electrospun fibres were analysed using the Directionality v2.01 
plugin for ImageJ which measures alignment angles for fibres present. All samples 
were cut into regular shapes and aligned prior to SEM imaging. A minimum of 10 
images were analysed. In images with lower magnification the images were cut into 
multiple images to improve the analysis using Image J.  
 
3.2.5 Mechanical Testing  
Uniaxial tensile testing was carried out using a dynamic mechanical analyser (DMA 
7e, Perkin-Elmer Instruments, USA). Test sections were cut into rectangular shapes 
of dimensions 8 - 14 mm in length and 5 - 8 mm in width, and in both the 
longitudinal and circumferential directions (relative to the axis of the small intestine). 
The ends of the samples were enclosed in wire gauze to provide grip and stability 
and the samples were then clamped into the machine. The dimensions of the 
samples were entered into the software (Pyris) and the distance between the two 
clamps was taken as the length. The tensile test was run with an increasing force 
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value of 500 mN min-1. From the stress-strain graph produced the elastic modulus 
was calculated as the gradient of the elastic region of the curve (E = stress/strain). 
The samples were rehydrated with deionised water for 30 minutes, prior to testing. 
Samples which slipped or failed near to the clamps were ignored. 
 
3.2.6 Attachment  
Samples of the material were prepared identically as those for mechanical testing 
i.e. cutting rectangular shapes of dimensions 8 - 14 mm in length and 5 - 8 mm in 
width. These were placing in individual wells of 24 well cell culture plates and then 
submerged in deionised water for 2 h at room temperature and placed on an orbital 
shaker set at 60 rpm. Sample which separated were noted and the rest removed 
using forceps and place on absorbent paper towels and dried with the said towels 
using reasonable manual force (but with care taken to apply no torsional forces) and 
allowed to dry for a further 2 h. Any further separations of the layers were then 
noted.  
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3.3 - Results 
As mentioned previously the complete spinning variations are listed Table B1 
(Appendix B-3). This list includes variations which are also used in Chapter 4.  
3.3.1 Series 1 (PCL) 
3.3.1.1 SEM Imaging (Concentration) 
                           (a)                                                    (b)                                                     (c) 
    
                           (d)                                                (e)                                                        (f) 
   
                          (g)                                                  (h)                                                        (i) 
   
Figure 3.4 SEM images of electrospinning PCL onto SIS at different concentrations (a)(b) & (c): 10% PCL. (d)(e) & 
(f): 15% PCL. (g)(h) & (i): 20% PCL. 
 
The three concentrations of PCL solution which were test showed different results 
with only 20% PCL showing consistent and uniform fibres. The samples produced 
using 10% and 15% PCL showed the characteristics of inadequately dried fibres in 
the form of large ―pools‖ and droplets of the polymer when collected (as seen in 
Figure 3.4 a - f ). They also showed inconsistent fibre diameters particularly with the 
distribution consisting of very large fibres (potentially difficult to even classify as 
fibres) or very thin diameter fibres.  
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It was also observed that while the fibres produced at 20% were the most desirable, 
the polymer solution was beginning to reach a viscosity and concentration where it 
developed a  tendency to solidify upon emerging from the needle tip was beginning 
to arise. With any higher concentration unlikely to be successful and it was decided 
that 20% would be the standard for further investigation.  
3.3.1.2 Fibre Characteristics (Concentration) 
 
Figure 3.5 The average diameter for PCL electrospun fibres at the PCL solution concentrations of 10% (n = 67), 
15% (n = 52) and 20% (n = 93).  
 
 
The results of the fibre diameter analysis, as shown in Figure 3.5, show that with an 
increase in the concentration of the PCL solution there was an increase in the 
average fibre diameter. As mentioned previously the fibres present in 20% were all 
generally more uniformly fibre shaped with the large ―pools‖ of polymer largely 
absent. The lower values present for the samples for 10% and 15% were due to the 
vast majority of fibres being exceptionally thin. 
3.3.1.3 Mechanical Properties (Concentration) 
The scaffolds were tensile tested and the results shown in terms of the elastic 
modulus, the yield strength and the failure strain (Figure 3.6). In terms of the 
modulus and the yield stress the results show that all fibre groups had larger values 
than the control SIS, with the yield stress result being particularly relevant (i.e. 
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potentially demonstrating increasingly improved properties over the control 
material). It was also noted that the certain instances the samples with less regular 
fibres, such as the 15% PCL fibres, had some slight mechanical advantages 
particularly in terms of the yield stress.  
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(a) 
 
 
(b) 
 
 (c) 
 
Figure 3.6 Mechanical testing data from the tensile testing of the PCL+SIS  scaffolds (a) Elastic modulus values 
(MPa) (n = 6) (b) Yield stress values (MPa) (n = 6) (c) Failure strain values (%) (n=6). Error bars shown are the 
standard deviation. (n values for SIS (S/T) = 12).  
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All the fibre groups showed a decrease in the failure strain when compared to the 
control. This appears to demonstrate that the addition of the fibres reduced the 
elasticity of the SIS; however none of the values are reduced to below a failure 
strain of 75%, which would still be considered a completely suitable level of 
elasticity. The commercial SIS used in this testing did not fail and therefore did not 
produced results which could be compared however the results from the modulus 
tested did show that there was at least a comparable value to the scaffolds 
produced (Figure 3.6a).  
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3.3.1.4 Attachment 
             (a)                                                     (b)                                                        (c) 
   
                             (d)                                                        (e)                                                         (g) 
   
Figure 3.7 SEM images of 20%PCL electrospun fibres on SIS under different conditions: (a)(b) starting wet    (c)(d) 
constantly  wet (e)(g) primed SIS with acetone  
 
 
Figure 3.8 Graph representing the percentage of 20% PCL+SIS samples where the layers remained attached 
following cutting, exposure to deionised water for 30 m and drying (n=12). Values are calculated percentages and 
so no error bars.  
 
The attachment testing performed after the SEM and mechanical analysis had been 
carried out and consequently only samples of the 20% PCL were tested (as these 
were considered the most suitable). The results here showed that the general 
standard of the fibre-layer attachment using the standard protocol was quite low 
with the average figure being only 25% (Figure 3.8).  
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Variations to this method showed that in the samples which were prepared with the 
SIS starting wet, there was a small increase in the average attachment figure 
(Figure 3.8). While this appeared to slightly improve the attachment it did not 
improve it enough for a useful yield. The fibre layers from this method did not 
appear to be very different from normal dry spun fibres though with SEM imaging it 
was observed that there were larger variations in fibre diameter as seen in Figures 
3.7a & b.  
Another variation was to use constant stopping and rehydrating of the SIS however 
this produced no samples with testable levels of attachment (Figure 3.8). The fibres 
produced using this method also appear to show signs of inadequate drying as seen 
in Figures 3.7c&d whether this was only due the wet condition of the SIS or whether 
the stop-start nature of the method also contributed it is unclear. The additional 
method of applying acetone to the SIS did not show any improvement over the 
conventional dry method though it was noted here that the acetone dried very 
quickly, and the appearance of the fibres resembled that of the default dry method 
(Figure 3.7e&f).  
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3.3.1.5 Alignment  
                           (a)                                                         (b)                                                         (c) 
    
                          (d)                                                           (e)                                                           (f) 
    
                          (g)                                                            (h)                                                          (i) 
    
                            (j)  
 
Figure 3.9 SEM images of 20% PCL electrospun fibres onto SIS at the following different mandrel rotation 
speeds:(a)(b) 540rpm    (c)(d) 1260 rpm   (e)(f) 1440 rpm (g)(h) 1620 rpm (i)(j) 1800 rpm 
Table 3.1 Table listing the variations in speed mandrel speeds for samples of electrospun fibres prepared with 20% 
PCL onto SIS. All samples were prepared using identical protocols (15 cm, 10-15 kV, 5 m per cm) 
Polymer Concentration 
Collection 
method 
Motor Control 
Frequency 
RPM Alignment Observation 
PCL 20% Mandrel 300Hz 540 unaligned 
PCL 20% Mandrel 700Hz 1260 unaligned 
PCL 20% Mandrel 800Hz 1440 unaligned 
PCL 20% Mandrel 900Hz 1620 unaligned 
PCL 20% Mandrel 1000Hz 1800 
Some indication of 
alignment, however not 
sufficient 
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It was investigated whether varying the speed of the mandrel might have the effect 
of changing fibre alignment (Table 3.1). In the three speeds immediately higher than 
the base speed of 540 rpm, there were no visible changes to the fibres which were 
produced (Figure 3.9). However, when the speed was increased to 1800 rpm there 
were some indications of alignment. It should be added that the alignment was only 
observed periodically and was not always be reproducible when required.  
It was also found that increasing the speed of the mandrel any higher was not 
possible with this arrangement. Problems identified were the lack if bearing support 
at the end of the mandrel (space limitation), the use of a rolling ring contact, and a 
basic step motor, all contributing to high degree of resonant vibration which was a 
severe limitation. This arrangement was redesigned for Series 2. 
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3.3.2 Series 2 (PLGA) 
As mentioned in the previous section the summary of the principle spinning 
variations are listed in Table B1 (Appendix B-3). Some preliminary work was carried 
out using PLGA to ascertain the ideal concentration using a flat collector and is not 
included in this chapter. The results of this work found that 15% was the ideal 
concentration, see Figure B2 (Appendix B-4). 
3.3.2.1 SEM Imaging  
                              (a)                                                         (b)                                                        (c) 
     
                              (d)                                                         (e)                                                          (f) 
     
                            (g)                                                            (h)                                                        (i) 
    
                           (j) 
 
Figure 3.10 SEM images of 15% PLGA electrospun fibres onto SIS at the following different mandrel rotation 
speeds:  (a)(b)  10 rpm  (c)(d) 500 rpm (e)(f) 1000 rpm (g)(h) 2000 rpm (i)(j) 3000 rpm 
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With the changes in the materials, equipment and protocols (see Section 3.4.2) 
fibres could be made more consistently and at far higher rotational speeds. With 
faster speeds fibre alignment could be observed and this was taken to be an 
additional parameter to be investigated.  SEM images of the groups tested are 
shown in Figure 3.10. 
3.3.2.2 Fibre Characteristics 
 
Figure 3.11 Mean fibre diameter of PLGA (15% solution) electrospun fibres produced at the following mandrel 
speeds (n value in brackets): 10 rpm (134), 500 rpm (126), 1000 rpm (115), 2000 rpm (113), 3000 rpm (129).   
 
Image analysis of the fibre diameters from the SEM images showed that while there 
was some variation, there were no statistically significant differences between the 
sample groups which were produced (Figure 3.11). Consequently it was concluded 
that increasing the speed of the mandrel did not affect the fibre diameter.  
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3.3.2.3 Alignment  
                            (a)                                                      (b)                                                         (c)  
   
                             (d)                                                       (e)                                                       (f) 
   
Figure 3.12 PLGA electrospun fibre orientation  at the following mandrel rotation speeds (a) 10 rpm (b) 500 rpm 
(c)1000 rpm (d) 2000 rpm (e) 3000 rpm (f) Legend illustrating the relative fibre orientation relative to the mandrel 
axis of rotation (shown in degrees removed from the axis of rotation)  (n = 10). 
 
The alignment of the PLGA electrospun fibres appears perpendicular to the axis of 
rotation of the mandrel. This can be quantified by measuring the angle of the fibres 
relative to the axis (Figure 3.12). At the lowest speed (10 rpm) the highest 
proportion of fibres fall in the ±0 - 30° orientation group, demonstrating that most of 
the fibres are actually aligned largely parallel to the axis. Increasing the rotation 
speed to 500 rpm there is no appreciable difference in alignment. When the speed 
was increased further to 1000 rpm there was some change but again, the highest 
percentage grouping is the ±0 - 30° group. Only when speed was increased to 2000 
rpm was where the majority of fibres began to show alignment with the highest 
percentage grouping being the ±60 - 90° group. This alignment is again further 
evident when the speed was increased to 3000 rpm. The SEM images also show 
clear charges in alignment as the speed increased (Figure 3.10). 
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3.3.2.4 Mechanical Properties 
The mechanical tensile testing was carried out on samples in both the longitudinal 
(parallel to the axis of the mandrel) and circumferential (perpendicular to the long 
axis) shown in Figures 3.13 and 3.14, respectively.  
 (a) 
 
(b) 
 
(c) 
 
Figure 3.13 Mechanical testing data from the longitudinal tensile testing of the PLGA-SIS (a) Elastic modulus 
values (MPa) (n = 8) (b) Yield stress values (MPa) (n = 8) (c) Failure strain values (%) (n = 8). Error bars shown are 
the standard error. (N values for SIS (SDS/TX) = 12). The SIS used was SDS/TX. Statistical analysis was done 
non-parametrically and discussed in the results sections. 
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(a) 
 
(b) 
 
(c) 
 
Figure 3.14 Mechanical testing data from the circumferential tensile testing of the PLGA-SIS (a) Elastic modulus 
values (MPa) (n = 6) (b) Yield stress values (MPa) (n = 6) (c) Failure strain values (%) (n = 6). Error bars shown are 
the standard error. (n values for SIS (SDS/TX) = 12)The SIS used was SDS/TX. Statistical analysis was done non-
parametrically and discussed in the results sections. 
 
With longitudinal tensile testing, it was expected that with an increase in 
perpendicular alignment the effect of the fibres would be decreased. With respect to 
the modulus and the yield stress this trend does appear to be present. There is a 
trend of the modulus and the yield stress average values decreasing as the degree 
of alignment increases. It was also noted that the values for the 1000 rpm group 
were particularly low though this appears more like a due to a single set of low 
0
5
10
15
20
SIS (unaltered) 10rpm 500rpm 1000rpm 2000rpm 3000rpm
M
P
a Modulus - Circumfrential 
0
0.5
1
1.5
2
SIS (unaltered) 10rpm 500rpm 1000rpm 2000rpm 3000rpm
M
P
a 
Yield Stress - Circumfrential 
0
50
100
150
200
250
SIS (unaltered) 10rpm 500rpm 1000rpm 2000rpm 3000rpm
%
 
Failure Strain - Circumfrential 
126 
 
values rather than a reflection of any meaningful difference. In the case of the failure 
strain there did not be any significant difference between the groups, with the 
exception of the two extreme values, i.e. the 10 rpm and 3000 rpm groups.  
In the case of circumferential testing, the modulus data appeared to show a degree 
of variability with no actual trend in relation to the degree of alignment. The yield 
stress was again was very consistent with all groups with the exception of the 3000 
rpm group which was lower. For the failure strain data, with the increase in 
alignment there was a definite trend of increasing failure strain as the alignment 
increased.  It should be state that this trend carried on to the 3000 rpm group, 
however none of the samples tested failed and were limited by the dimensions of 
the testing rig (which approximated to over 300%). Figure 3.15a illustrates a 3000 
rpm sample at full extension with the aligned fibres clearly visible, with figure 3.15b 
showing a further manual extension using forceps illustrating that the sample did not 
appear to be at the failure point when the testing stopped and likely could have 
undergone further strain. It was also observed that the SIS had already failed by this 
point. 
                                                                       (a)                                  (b) 
      
Figure 3.15 (a) Image of highly extended PLGA fibres from 3000 rpm within the mechanical testing arrangement  
(b) the same fibres manually further extended using forceps.
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3.3.2.5 Attachment 
 
Figure 3.16 Graph comparing the percentage of attached samples from different groups after testing. Groups 
shown include those from Series 1 (PCL Dry and PCL Starting Wet, n = 12), Series 2 (PLGA Dry and PLGA 
Starting Wet, n = 24) and a further 4 test group which will form part of the Chapter 4 (all 15% PLGA, n = 24). The 
A1 denote samples produced with Arrangement 1.  
 
 
The attachment data is shown in Figure 3.16, and is includes a collection of groups 
from Series 1, Series 2, and groups which will form part of Chapter 4.  Two of the 
groups (PLGA Dry & PLGA Starting Wet) include PLGA fibres spun using 
Arrangement 1 and using the old SIS shape (see Section 3.2.2.1). These groups 
are all shown in Table B1 (Appendix B-3).  
The culmination of the trial and error work resulted in a change in technique for SIS 
creation and consequently a change in shape and surface features. Once the new 
methods had been used (described in Section 3.2.1.4), then the samples were 
tested at speeds of 10 rpm (random) and 3000 (aligned).  
The results showed that when using Arrangement 1 and the old SIS changing 
polymers or using wet starting SIS did not appear to change the attachment levels 
of the polymer fibres to the SIS (Figure 3.16). What did cause a large increase in 
the levels of attachment was the adoption of the new shape of SIS (the ―Altered 
SIS‖ groups) and consequently this was the SIS scaffold used in Series 2.  Further 
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work carried out showed that the addition of a further  ―base‖ layer of disordered 
fibres, further increased the levels of attachment particularly in case of 3000 rpm 
samples (discussed further in Section 3.4.2.1). Generally speaking, the alignment of 
the fibres does not appear to result in any significant change to the attachment 
levels. The changes in to the SIS are shown in Figure 3.17 and described also 
further in Section 3.4.2.1. 
                 (a)                           (b) 
                   
 
                           (c) 
 
Figure 3.17 Images of the SIS produced using two alternative methods and using two different sizes of tubing. In all 
images A - new method (2.54 cm diameter) and B - old method (1.9 cm diameter). The change in diameter resulted 
in improving the surface smoothness of the SIS. 
 
 
 
3.3.3 Sample Yield 
When electrospinning is used as a production method care needs to be given to the 
fact that the technique is highly sensitive and quite variable and efforts made to 
minimise this. In this work (including this chapter and the next) the temperature and 
humidity were found to be the most difficult factors hindering the process. These 
factors could be mitigated only to certain degree though the use of cooling and 
heating methods applied to the lab environment or locally (such as running the 
tubing through ice packs). Consequently at any given time the yield of suitable 
scaffold produced was only approximately 70%. The criteria used to dictate a 
A 
A 
A 
B 
B 
B 
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suitable sample was informed by trial and error and SEM analysis when samples 
were found to be poor in quality. Generally speaking, when there was a high degree 
of solvent evaporation this was accompanied by intermittent spinning resulting in 
regions of the SIS devoid of fibres and these were discarded. Occasionally there 
was an excess production of polymer droplets (possibly due to inadequate 
evaporation) and when this occurred to a high degree the samples were also 
discarded. In addition to that it was found that the electrospinning could be 
interrupted by periods of electrospraying and this also necessitated sample loss.  
The most important factors of all, however, were the production of a stable Taylor 
cone and a stable stream of polymer being electrospun. Often the appearance of 
one of the previously mentioned criteria could be predicted if stable spinning 
conditions were proving to be excessively difficult to establish and maintain. These 
established criteria were used throughout this work. 
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3.4 - Discussion 
3.4.1 Series 1 (PCL) 
Electrospinning with PCL is a common and well used form of scaffold production.  In 
this work however, the PCL scaffold was also required to attach to, and compliment, 
the SIS and thus form a hybrid scaffold. 
The SEM images of the PCL concentrations tested (Figure 3.4) revealed that only 
the samples from 20% PCL concentration produced consistent and regular fibres. It 
was observed when handling the scaffolds that attachment was noticeably higher in 
the samples produced at concentrations of 10% and 15% PCL when compared to 
20%. This was not quantified due to the poor quality of the fibres however; this was 
an observation which was deemed significant.  
As seen in Figure 3.8, the general state of attachment of the fibres to the scaffold 
was generally very poor with only around 25% of the fibre layers actually remaining 
attached when testing in the 20% PCL group. It should be added here that this 
figure reflected the scaffold being subjected to a fairly rigorous test and that the 
actual percentage of passably attached fibre-layers was likely higher. That said, the 
yield levels were still far too low, and while enough samples were available for 
further testing, alternative methods were explored to improve the attachment levels 
and will be discussed later.  
In terms of the mechanical properties of the scaffolds there was appreciable 
improvement over the control SIS (Figure 3.6). This showed that, in theory, the 
concept of electrospun reinforcement of SIS held some potential for if there could be 
improved attachment. As mentioned previously, some elements of improved 
attachment were observed in the 10% and 15% PCL samples. What was 
speculated here was that with a lack of adequately dried fibres the observed 
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―pooling‖ effect, where globules of polymer form and dry over the SIS (Figure 3.4), 
may have provided some additional attachment. This was in contrast to the samples 
of 20% PCL which had poorer adhesion but a layer of consistent electrospun fibres. 
This could possibly represent the reason why the mechanical properties, particularly 
for modulus and yield stress were higher (Figure 3.6) for these samples than for the 
more regular, yet less attached, 20% concentration layer.  
Attachment improvement was investigated using a number of different starting 
conditions for the SIS (Figure 3.8). While there was a slight improvement when the 
SIS was started wet before the spinning process this did not significantly improve 
the attachment rate to desirable levels.  
Interestingly, the method described by Horst et al. of constantly rehydrating the 
samples produced no attached samples at all (Horst, Madduri et al. 2013). In that 
study decellularised urinary bladder matrix (UBM) was coated with electrospun 
PLGA fibres and it was, as in this work, noted there was an issue was attachment. 
In their work attachment was achieved through a layer by layer spin process where 
the matrix was constantly rehydrated. It should be added that in that case the UBM 
was in flat sheet form. A similar solution was adopted here but as mentioned above 
the result not achieved. However the shape of the SIS in this work and the rotation 
of the mandrel may have prevented this method from working. It was also observed 
that the constant rehydration caused the SIS to sag on the mandrel.  Thus, when 
rotation was recommenced, this created a mobile and less stable surface onto 
which the electrospun fibres could attach. This contrasts significantly with the 
circumstances of a flat matrix where hydration might actually increase the stability of 
the surface of the matrix. Rehydration, by causing expansion, could have removed 
potential ―wrinkling‖ when on a flat surface, and also the increased surface tension 
of the wet matrix to the flat electrode underneath could also have had an effect.  
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The use of acetone to wet the SIS was another attempt to improve attachment; the 
hypothesis here being that the initial fibres which contacted the acetone might 
soften and therefore deform enough to grip the surface. However it was observed 
that with the arrangement being under a slight vacuum, along with the rotation of the 
mandrel, there was an increased air flow around the mandrel. Consequently a 
volatile solvent such as acetone could not remain on the surface of the SIS for any 
appreciable time. Therefore this method was unsuccessful. 
The final analysis of the PCL/SIS scaffold produced was carried out by varying the 
speed of the mandrels rotation (Table 3.1). With increasing the rotational speed of 
the mandrel there was no great increase in the alignment of the fibres produced with 
only a slight increase in the observable alignment at the speed of 1800 rpm. As 
mentioned in the Section 3.3.1.5 it was also noted that when the speeds were 
increased a number of problems arose. Size limitations in the arrangement box 
there was no room to add a bearing at the free end of the mandrel. Consequently at 
higher speeds the mandrel developed some resonant vibration, one of the results 
being that the ring contact would ―bounce‖ while on the mandrel and break contact 
repeatedly or it would vibrate off the mandrel entirely. In addition to this there was 
the physical limitations of the step-motor and switch arrangement which could not 
achieve higher speeds. It was concluded that if faster rotational speeds were 
required a new arrangement would need to be devised (Figure 3.3). 
With the decision to change the arrangement, the selection of the polymer was also 
brought into question. One the potential future issues which might arise through the 
use of PCL was that there would a slow degradation rate when compared to other 
commonly used polymers (Woodruff and Hutmacher 2010). In the case of the 
objectives of this work the polymer would only need to persist in vivo for a number 
of months and not for an extended period. In addition to this the semi-crystalline 
nature of PCL means that in certain solvents such as dimethylformamide it has a 
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low solubility and this results in rapid evaporation which caused potential clogging 
difficulties in electrospinning (Woodruff and Hutmacher 2010). 
PLGA was selected as an alternative to PCL. It is known to have better 
biocompatibility, in addition to have improved effects on cell adhesion and 
proliferation when compared to PCL (Kim and Cho 2009). PLGA also has more 
potential for controlling the properties of the polymer through changing the ratio of 
the copolymers. 
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3.4.2 Series 2 (PLGA) 
3.4.2.1 Adhesion 
A large amount of work went into improving the attachment of the electrospun fibres 
to the SIS. The basis of this work was that it was observed that the early had a very 
wrinkled and uneven surface (Figure 3.17a). The reason for this was due to the 
disparity in the diameter of the SIS and the smaller diameter of the porous 
polyethylene tubing onto which it was placed prior to vacuum drying (Figure 3.1). 
This resulted in ―slack‖ along the SIS lengths becoming compressed and drying in a 
variety of peaks and troughs. This in turn not only provided a rough surface (Figure 
3.17b) onto which to electrospin but the topography also allowed for spans of 
electrospun fibres having no surface contact with the SIS. 
Further work showed by increasing the diameter of the porous tubing enough that 
the SIS was required to be stretched to be placed over the tubing. While this made 
the process slightly more difficult the result was highly apparent (Figure 3.17). It was 
also found that the smoother surface provided by the stretching was further 
enhanced by the action of the vacuum drying as the bag compressed and improved 
the smoothness of the SIS, rather than compressing the excess and exacerbating 
the problem (shown in Figure 2.4b). When the new surface was electrospun onto it 
showed a great improvement in the levels of attachment over fibres spun using 
Arrangement 1, as seen in Figure 3.16.  
As mentioned in the Section 3.4.1, with PCL fibres it was noted that inadequate 
drying resulted in incomplete fibres which has the result of causing some increased 
attachment. It was therefore hypothesized, that the addition of an initial dispersed 
layer of disordered and ―sticky‖ fibres might increase adhesion. Consequently work 
was carried out which tested this theory (Table B1, Appendix B-3). As a result of 
some simple adhesion testing it was shown that the addition of a 2 minute layer of 
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such fibres resulted in an improvement in the adhesion of the fibre layer as a whole 
(Figure 3.16). This was deemed a suitable limit as any longer might have resulted in 
a complete covering, something not desirable as issues such as the porosity of the 
scaffold would come into question. Consequently the 2 minute only laid down a 
loose network of fibre around the scaffold. This additional stage to the method was 
not used in Chapter 3, though would be adopted for all scaffolds produced for use in 
Chapter 4.   
The final result of all this work was to obtain a methodology, which could be finally 
used to make consistent hybrid scaffolds in terms of decellularisation, fibre 
characteristics, and attachment.  
3.4.2.2 Alignment  
The new arrangement increased the capacity for higher speeds of mandrel rotation. 
Improvements also included the addition of a brush earth contact for the metal 
collector (Figure 3.3b) which allowed for constant contact irrespective of the 
rotational speed and is a method commonly used with rotating disc collectors (Xu, 
Inai et al. 2004). Work on Series 1 showed no alignment at lower speeds and this 
was again observed here with the PLGA fibres produced at 10 or 500 rpm 
producing no alignment (Figure 3.12). This agrees with examples seen in the 
literature such as a similar arrangement using PLGA at 500 rpm  producing fibres 
which were unaligned (Stitzel, Liu et al. 2006). 
While some changes in alignment were detected at 1000 rpm it was at 2000 rpm 
where the predominant alignment was perpendicular to the axis of rotation. This 
point of around 2000 rpm was observed to some degree in Series 1 at 1800 rpm 
and has also been described in other work. Alignment has been demonstrated at  
the rotational speed of 1500 - 2000 rpm where a rotating cylinder was used to 
collect polystyrene (PS) and polymethylmethacrylate (PMMA) fibres (Sundaray, 
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Subramanian et al. 2004). Additional work using polyurethane and a 
polyurethane/collagen blend also allowed showed alignment of electrospun fibres at 
2000 rpm (Jia, Prabhakaran et al. 2014). PCL fibres have also been made to align 
with a similar process where the rotational speeds were found to be between 1000 - 
2000 rpm (Zhu, Cao et al. 2010)  
3.4.2.3 Mechanical Properties 
The mechanical properties were not straight forward to analyse with respect to the 
samples produced. When observing the results what needs to be taken into account 
is that for a large number of samples tensile testing resulted in uniquely bi-phasic 
behaviour. Figure 3.18 illustrates the difference between (a) SIS (in addition to most 
non-viscoelastic ―softer‖ materials) and (b) the hybrid scaffolds in question. In the 
case of these materials it appears that the materials often have one layer take part 
in an initial stress yield, the material then recovers its elastic behaviour, and this is 
followed by a second yield.  The failure behaviour is straightforward however as the 
failure of the entire scaffold is singular event. What these means is that the layers 
can fail separately, and a decision was made than all modulus and yield stress data 
would be selection from the first elastic region of the stress/strain curve particularly 
in the context that a yielding of the elastic behaviour of a material is an indication of 
permanent change of the mechanical behaviour. It should also be born in mind that 
these materials will have a degree of redundancy which is useful from an implant 
perspective as failure in one layer will not result in structural compromise of the 
entire scaffold and potentially give rise to perforations.  
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                                                                    (a) 
 
    
 
 
                                                                       (b) 
 
 
 
 
Figure 3.18 Generalised illustration of a typical stress-strain graph for (a) SIS and (b) PLGA-SIS hybrid materials. 
The red arrows denote the yield point occurring at the end of an elastic region of the stress-strain curve. 
 
There is evidence that the alignment has a direct effect on the mechanical 
properties of the hybrid scaffold. The was particularly relevant in the case where the 
high alignment of the PLGA fibres largely prevented samples from the 3000 rpm 
group from failing well past the 300% strain (this figure is by visual observation of 
the testing machine). This result is significant as it represents a clear mechanical 
advantage to having aligned fibres of a particular orientation, here giving rise to a 
situation where if a sudden force were to extend the scaffold, i.e. such as a bolus, 
then that extension would not cause the scaffold to be compromised. It was also 
generally observed with the modulus results, that the randomly aligned scaffolds 
were found to have higher values, which loosely equates to an increased ―stiffness‖. 
Other studies have shown that the mechanical properties will change as the fibre 
alignment changes. Polyurethane and polyurethane/collagen blends showed far 
higher values for ultimate tensile stress and the modulus for aligned samples 
Stress 
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compared to non-aligned. The samples tested were parallel to the fibres and when 
perpendicular tested they behaved as random fibre samples (Jia, Prabhakaran et al. 
2014). In another case using polyacrylonitrile, the stress-strain behaviour of the 
scaffolds changed along with fibre alignment as samples were produced with 
increasing rotational speeds (Heidari, Mosavi Mashhadi et al. 2013). PLGA fibres in 
another study had higher values for aligned fibres in terms of the tensile stress and 
modulus values when compared to randomly orientated fibres (Shang, Yang et al. 
2010). Using electrospun synthetic elastin it was found that aligned fibres produced 
higher values for ultimate tensile stress and strain, however the modulus was found 
to be lower (Nivison Smith and Weiss 2012). This does not match with other 
examples in the literature though it is interesting to note that different polymers, in 
this case elastin, can have different results with respect to mechanical properties 
even with alignment.  
3.4.2.4 Fibre Diameter 
The lack of change of fibre diameter is a commonly found observation. Fibre 
diameters produced with electrospun gelatine over a greater range of speeds, i.e. 
did 200 - 7000 rpm, have been produced with no change in diameter (Ayres, Bowlin 
et al. 2006). It can therefore be said that providing the fibres are fully dried by the 
time they reach the collector any change to their physical dimensions is unlikely. 
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3.4.3 Conclusion 
A number of important things were concluded; firstly that successfully 
electrospinning a polymer layer onto tubular SIS (with two different polymers) was 
possible but that attachment was a limitation. Through further work it was concluded 
that a number of things could be done to improve the level of attachment including; 
changing the shape and surface texture of the ECM to make an even and smooth 
surface, along with the addition of a small amount of poorly dried ―sticky‖ fibres. It 
was also concluded that the speed of rotation of the mandrel could be used to 
create fibre alignment and this, in turn, could be used to change the mechanical 
behaviour of the scaffold.  
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4. Hybrid Scaffolds 
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4.1 - Introduction 
In Chapters 2 and 3 two separate materials have been brought together with the 
aim of producing a true hybrid scaffold for the purposes oesophageal of tissue 
engineering. Improvements were made in the production of the each of two layers 
and the hurdle of adhesion between the two layers was also overcome. Further 
evaluation of hybrid the scaffold would need to be carried out and the final variable, 
the alignment of the fibres within the electrospun layer, also studied in more detail. 
In vascular tissue engineering scaffolds have been used for some time with aligned 
fibres. These are used to induce alignment in smooth muscle cells with the aim of 
encouraging contractility (Jia, Prabhakaran et al. 2014). This concept is important 
here as restoring oesophageal contractility through a similar process of culturing of 
aligned smooth muscle cells seems to be an ideal approach to tissue engineering 
the oesophagus. This is particularly significant as studies with sectional 
oesophageal replacement commonly report lack of significant muscle growth along 
with the more common complications including stricture, dilation and leakage. 
(Doede, Bondartschuk et al. 2009). The work so far has been to address the 
physical aspects of these failures however the potential to also address the lack of 
muscular growth is an appealing one. As a result human oesophageal smooth 
muscle cells were cultured and used to assess the viability of the hybrid scaffolds. 
While it was unfortunately beyond the scope of this work to biopsy, culture and 
implant an intact scaffold in vivo, work was carried out to take steps towards 
achieving that goal. 
In this chapter the scaffolds were created using all the information gathered from the 
previous chapters. Some studies have demonstrated highly aligned fibres at speeds 
higher than the maximum of 3000 rpm used in Chapter 3, examples include highly 
aligned PCL/gelatin blend fibres produced at 4000 rpm (Gupta, Venugopal et al. 
142 
 
2009) and highly aligned collagen fibres at 4500 rpm (Matthews, Wnek et al. 2002). 
Consequently the maximum speed of rotation was increased up to 5000 rpm.  
The final change to the overall scaffold design was the addition of VEGF to the 
scaffold (the benefits of VEGF are outlined in Chapter 1). The decision was made in 
an effort to maximise the potential long-term performance of the hybrid scaffolds, 
the lack of angiogenesis being a common reasons for scaffold failure (Laschke and 
Menger 2012). The addition of a pro-angiogenic agent was seen as a logical step to 
improve a scaffold design.  
The aim of this chapter is to assess the hybrid scaffold as a whole through physical, 
in vitro and in vivo means. The different alignment variations would also be 
assessed to see if an optimal alignment could be chosen. Finally the effectiveness 
of the incorporation of VEGF would also be assessed. 
 
143 
 
4.2 - Materials and Methods 
4.2.1 SIS Preparations 
4.2.1.1 SIS Preparation 
The SIS was prepared as described in Chapter 2. Briefly, the jejunum/ileum 
samples were cut into lengths of 20 cm, and prepared as described previously. 
Following preparation, the SIS was then carefully washed twice in deionised water 
for 5 minutes. The SIS was then stored in PBS (phosphate buffered saline: 0.01 M 
phosphate buffer 0.0027 M potassium chloride and 0.137 M sodium chloride, pH 
7.4, at 25 °C).  
4.2.1.2 Decellularisation 
The SIS was decellularised with a variation of the SD/DNase (perfusion) method of 
decellularisation described in Section 2.2.2.  There were a few changes made to the 
protocol made as it was described previously to reflect the findings of the Chapter 2. 
The method was altered in that the DNA was eliminated from the protocol as was 
shown to have no discernable effect on the levels of decellularisation of the SIS 
produced. 
Each container was filled with 350 ml of 4% SD (Sigma-Aldrich Company Ltd., 
Dorset, UK) then the pump run 500 ml h-1 for 12 h at room temperature. The 
samples rinsed with deionised water followed by a perfusion wash for 15 minutes, 
also with deionised water.  
4.2.1.3 SIS Washing 
Following the initial rinse the SIS was washed using a variation of the altered 
washing method outlined in Appendix A-2. In this method the containers were filled 
with deionised water, and the input channels connected to a large separate 
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reservoir of deionised water. The pump was then run for a further 5 hours. With this 
arrangement deionised water was allowed to overflow out of the vessels creating a 
one way flow to allow constant washing with fresh deionised water. The SIS was 
then rinsed and placed into a further container containing deionised water for a 
short rinse. All decellularised SIS was stored at 4°C in PBS. 
4.2.1.4 - Post Decellularisation Processing  
The SIS sections were stretched over a 2.54 cm diameter (described by the 
manufacturer as 1 inch) porous polyethylene tubing (60 µm pores) (Porex 
Corporation, Fairburn, United States). These samples were vacuum-dried in sealed 
sterile specimen bags and placed under low vacuum conditions (approximately 10 
mbar) for 12 h to compress and dry the samples. The dried SIS samples were 
subsequently lyophilised by immersing in liquid nitrogen for 1 minute and then 
placed into a vacuum freeze-drier (Heto Dry Winner) for 12 h.  
 
4.2.2 Electrospinning  
Electrospinning was carried out using the same arrangement described in Section 
3.2.2.3 (Arrangement 2). For the actual spinning process the tubular SIS was cut to 
lengths of 3.5 cm and secured to the mandrel using a small quantity of adhesive 
tape. The polymer used was PLGA (85/15 L-lactide/glycolide copolymer). The 
polymer granules were dissolved into dichloromethane (DCM) and 
dimethylformamide (DMF) at an 8:2 ratio using a magnetic stirrer for at least 3 hours 
to make a 15 % weight by volume solution. The solution was prepared in small 
quantities of 10 ml to prevent solvent loss through the re-use of the polymer 
solution. The polymer solution was then stored at 8 °C.  
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The electrospinning was carried out in 2 stages. The first stage was a thin coating 
layer for which the polymer solution was pumped at flow rate of 7 ml h-1 for 2 m at a 
voltage of 20 kV and with the mandrel rotating at 10 rpm. Following this the actual 
spinning was carried out where the polymer solution was carried out with a flow rate 
of 1 ml h-1 at a voltage of 14 kV for 45 minutes (the complete parameters are listed 
in Table B1, Appendix B-3). The mandrel was advanced at an increment of 1 cm 
every 15 minutes. The samples were vacuum dried to remove any excess solvent. 
 
4.2.3 Mechanical Testing 
Uniaxial tensile testing was carried out using a dynamic mechanical analyser (DMA 
7e, Perkin-Elmer Instruments, USA). Test sections were cut into rectangular shapes 
of dimensions 8 - 14 mm in length and 5 - 8 mm in width, and in both the 
longitudinal and circumferential directions (relative to the axis of the mandrel). The 
ends of the samples were enclosed in wire gauze to provide grip and stability and 
the samples were then clamped into the DMA. The dimensions of the samples were 
entered into the software (Pyris) and the distance between the two clamps was 
taken as the length. The tensile test was run with an increasing force value of 500 
mN min-1. From the stress-strain graph produced the elastic modulus was calculated 
as the gradient of the elastic region of the curve (E = stress/strain). The scaffolds 
were rehydrated with deionised water for 30 minutes, prior to testing. Samples 
which separated during the rehydration were discarded. Samples which slipped or 
failed near to the clamps were ignored. Any samples which showed rapid separation 
of the layers during the mechanical testing was noted.  
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4.2.4 SEM Imaging 
The spun fibres on the SIS was cut into 1 cm sided squares and directly mounted 
on aluminium stubs using fast drying epoxy adhesive. The stubs were then placed 
in a desiccator cabinet for at least 12 h to ensure any acquired moisture was 
sufficiently removed. All sections were then sputter coated with gold/palladium 
(Polaron E5000, Quorum Technology, UK) and then imaging was carried out using 
a scanning electron microscope (Philips XL 30 SFEG, Netherland). Digital images 
produced were analysed using software (ImageJ).  
 
4.2.5 Porosity 
Samples of the scaffold were weighed out to a weight of 1 g. The scaffold samples 
were rolled into a consistent shape and were placed into the glass testing vessel of 
a mercury intrusion porosimeter (Micromeritics Autopore, Micromeritics Instrument 
Corporation, Norcross, USA). The porosity measurements were carried out using an 
automated testing cycle (n = between 4 and 6 for each sample). Statistical testing 
was carried out using a 2-tailed student’s t-test to a 95% confidence interval using 
SPSS version 20 (IBM, Armonk, New York, US). 
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4.2.6 Biocompatibility 
4.2.6.1 Cell Culture 
Primary human oesophageal smooth muscle cells (HESMC, ScienCell Research 
Laboratories, Carlsbad, CA, USA) were cultured in Dulbecco’s modified Eagle 
medium (Gibco, Life Technologies, Paisley, UK) supplemented with 10% foetal 
bovine serum (Gibco) and 1% penicillin-streptomycin (Gibco) at 37°C in air with 5% 
CO2 and 95% relative humidity. Cells from passages 2 - 6 were used for 
experiments.  
4.2.6.2 Biocompatibility Assay 
A CellTiter 96 AQueous Non-Radioactive Cell Proliferation Assay (Promega, 
Southampton, UK) was used to assess the enzymatic activity of HESMC’s as an 
indication of biocompatibility, in accordance with ISO 10993 parts 5 and 12 
(Appendix A-4) and the manufacturer’s protocol. Briefly, HEMSC were seeded at a 
density of 100,000 cells/cm2 on the hybrid scaffolds with the PLGA fibres spin at 10 
rpm, 1000 rpm, 3000 rpm, 5000 rpm, a commercial scaffold and control TCP 48-
wells. The commercial scaffold was Biodesign® (Cook Medical, UK) and was used in 
this instance only to provide a potential alternative to TCP as a control.  
Cell culture inserts (CellCrown, Scaffdex Ltd., Tampere, Finland) were used to pull 
the samples taut and suspend them within the 24-well plates with the cells seeded 
on the PLGA nanofibre surface with the exception of the commercial scaffold which 
did not have a specified orientation. For sterilisation the scaffolds were immersed in 
a 70% ethanol solution and then allowed to dry completely in a sterile fume hood. 
The scaffolds were all hydrated with 200 µl of medium approximately 30 m prior to 
seeding cell.  
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After 24 and 96 hours incubation, medium was aspirated from the cells and 
replaced with one part MTS solution in six parts medium, which consists of (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) 
(MTS dye) and electron coupling agent phenazine methosulfate. MTS is 
metabolised to form formazan in the mitochondria of living cells, resulting in colour 
change from yellow to brown that is indicative of cell number. After sufficient colour 
change was observed (following 1 - 1.5 h incubation), absorbance was measured at 
490 nm, with a reference wavelength of 630 nm at each time point using an 
absorbance plate reader (M200, Teccan, Männedorf / Switzerland). The plates were 
measured along with a standard plate of known cell concentrations prepared for 
each time-point (Figure 4.1). 
 Between time-points, MTS-containing medium was aspirated, the cells rinsed with 
PBS, and replaced with fresh cell culture medium. The metabolic activity of the cells 
was normalised to the TCP control at the end of experiment.  
 
Figure 4.1 MTS calibration plate using known cell concentration values. 
 
4.2.6.3 Live-Dead Assay 
The scaffolds (10 rpm, 1000 rpm, 3000 rpm and 5000 rpm) and the commercial SIS 
were prepared as described previously and in placed in identical arrangements 
using 24-well plates and CellCrown inserts. The control wells used in this instance 
were 24-wells with sterile glass coverslip inserts. The glass inserts were simply 
placed at the bottom of the wells. HEMSC were seeded at a density of 100,000 
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cells/cm2. The cells were cultured for 1 day, 7 days and 14 days.  At the relevant 
time points the medium was removed from the wells and a mixture of Calcein AM at 
a concentration of 4 µM along with Propidium Iodide (PI) at a concentration 20 µM 
were added in a total volume of 1 ml. The time of incubation was 30 m in the dark 
and care was taken to ensure that the labelling dyes were not overly exposed to 
light. The scaffolds were washed with PBS twice and then removed and placed in 
50 mm individual wells and then immersed in PBS. The scaffolds were then 
analysed using a Olympus BX51 confocal microscope. The software used was 
Lasersharp 2000 and image stacks of the scaffolds were generated.  The outputs of 
the image stacks were merged and then projected into 3D using ImageJ. The 3D 
projection allowed for direct cell counting within the 3D structure of the scaffolds.  
 
4.2.7 VEGF Incorporation 
4.2.7.1 Sample Preparation  
SIS/PLGA sample were cut to dimensions 6 mm × 6 mm as used in previous 
analysis studies.  A quantity of 10 µl VEGF (Human Recombinant VEGF, Invitrogen, 
Camarillo, CA, USA) was added to a solution of 0.1% Bovine Serum Albumin 
(Sigma) which has been filtered through a 0.22 µm pore sterile filter  (Millex®GP, 
Merck Millipore Ltd. Tullagreen, Co. Cork, Ireland). In sterile conditions the solution 
was added in very small increments of a maximum of 15 µl to each SIS/PLGA 
sample up to the required quantity of 500 ng of VEGF per scaffold sample. 
Following each addition of 15 µl the solution was allowed to dry in the fume hood 
prior to the addition of the next 15 µl.  
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4.2.7.2 VEGF Release 
The VEGF was added to samples of the PLGA-SIS scaffolds from the 3 sample 
groups consisting  of 10 rpm, 3000 rpm, 5000 rpm, 10 rpm (+VEGF) , 3000 rpm 
(+VEGF), 5000 rpm (+VEGF) and a commercial SIS. The scaffolds were then 
individually placed in 15 ml falcon tubes and immersed in 3 ml of solution of PBS 
with 1% Penicillin-Streptomycin. All tubes were then placed on an orbital shaker 
(Stuart Model SSM1) and then placed inside an incubator at 37°C and run for 14 
days. At days 1, 7 and 14 aliquots of 150 µl were taken and frozen at -80°C.  
The VEGF was quantified using a VEGF Human ELISA Kit (Invitrogen, Camarillo, 
CA, USA). The aliquots were diluted by a factor of 100 to bring the concentration of 
VEGF into the range of the specific kit (range of kit sensitivity was 0 to 1500 pg mL-1 
Hu VEGF). The concentration was established through the use of an absorbance 
plate reader (M200, Teccan, Männedorf / Switzerland). The values were obtained 
through the use of a standard curve.  
 
4.2.8 CAM Assay 
The samples were prepared to a size of 6 × 6 mm cut from the scaffolds. The 
samples tested in this experiment were the PLGA-SIS scaffolds produced at speeds 
of 10, 3000, and 5000 rpm. The scaffolds were also separately tested with the 
addition of VEGF. The addition of VEGF was carried out by first adding the VEGF 
(recombinant human VEGF; Sf21-derived, 293-VE, R&D Systems, Inc, Minneapolis, 
USA), to a solution of 0.1% Bovine Serum Albumin (Sigma). In sterile conditions the 
solution was added in very small increments of a maximum of 15 µl to each 
SIS/PLGA sample up to the required quantity of 500 ng of VEGF per scaffold 
sample. Following each addition of 15 µl the solution was allowed to dry in the fume 
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hood prior to the next quantity. All samples were sterilised by ethylene oxide at 37°C 
(Person EO50, Person Medical Co., Ltd., Gunpo-si, Gyeounggi-do, South Korea). In 
addition to the test samples a negative control group was also tested (for all 
samples n = 5).  
The method carried out was a modification of the basic methods which have been 
described previously (Storgard, Mikolon et al. 2005). The eggs were first incubated 
for 12-days in a custom built incubator with care taken to rotate the eggs regularly 
(Figure 4.2a). Following incubation the eggs were removed and the air pocket was 
identified by shining a small light source at the egg in a darkened room. Over this air 
pocket, following a wipe with 70% ethanol, a small hole was bored in the egg shell 
with care taken not to perforate the inner membrane. Using a sterile needle 2 ml of 
albumin was removed through the air pocket from the egg and discarded. Any eggs 
in which the yolk was perforated were discarded. 
 Following a further wipe with 70% ethanol the holes were sealed up with porous 
surgical tape and the eggs were returned to incubation for a further 24 hours. 
Following this period the removal of the albumin would have facilitated the creation 
of a larger air pocket. The hole was then opened and following a further wipe with 
70% ethanol, a larger hole was cut with approximately a 1 cm diameter. It was 
important at this stage to confirm the viability of the eggs as a reasonable proportion 
of the eggs were expected to fail due to the procedure being highly technique-
sensitive. This was mitigated by the preparation of twice the amount of eggs than 
experimentally required. Through this hole the scaffold samples were carefully 
placed onto the CAM using a pair of sterile forceps (Figure 4.2b).  
This hole was then covered with a piece of shell with intact inner membrane taken 
from discarded eggs and then fixed into place using surgical tape. The eggs were 
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placed in a different incubator (Kingsuro max20, Rcom, Seoul, Korea) with a rocking 
rotational method and more accurate incubation conditions as shown in Figure 4.2c  
                                                        (a)                                                                    (b) 
   
                                                          (c)                                                                   (d) 
   
Figure 4.2 Stages of the CAM assay (a) Initial incubation of the eggs (b) Images shows scaffolds prior to insertion  
(c)  Tilting incubator for post implantation incubation (d) Example of the final appearance of a CAM on a portion of 
egg shell. Yellow arrow indicated the remnants of the scaffold  
  
After incubation the holes were exposed and them 10 - 15 ml of 10% formalin (in 
PBS) where then injected into the vital part of the eggs. The eggs were then left at 
room temperature for 24 h. Following this the contents of the eggs was discarded 
and the shells with the intact CAM’s were preserved (as seen in Figure 4.2d). High 
resolution digital images were then taken of the CAM’s. Image analysis was carried 
out using  a custom software package Angioquant (Niemisto, Dunmire et al. 2005). 
The quantification processes the images to identify vessel complexes and produce 
a vessel ―skeleton‖ from which the calculations are derived. The calculations are 
carried out using a stepwise imaging processing methodology involving 
thresholding, segmentation and further modifying processes (Figure 4.3).  
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                                                              (a)                                                   (b) 
    
Figure 4.3 Examples of test images taken from the work utilising the Angioquant software (a) Pre-processed image   
(b) Post-processed image showing highlighted ―skeleton‖ of the vessel complex (Niemisto, Dunmire et al. 2005) 
 
4.2.9 In Vivo Study 
4.2.9.1 Scaffold preparation 
The samples were loaded with 35 µl of the VEGF solution to give each sample 500 
ng of VEGF. The samples were dried in a sterile fume hood for 24 h. 
4.2.9.2 Implantation  
This study was approved by and carried out to the standards of Dankook University 
Institutional Animal Care and Use Committee, South Korea (Appendix C-3). The 
study was carried out using 22 10-week-old male Sprague–Dawley rats. The rats 
were kept in a temperature (20 - 24 °C) and humidity (30 - 70%) controlled 
environment (30 - 70%), with 12 hour light and dark cycles, and provided with 
standard pellet foods and water ad libitum. Prior to implantation each rat received 
general anaesthesia via an intramuscular injection of ketamine at 80 mg/kg body 
weight and xylazine at 10 mg/kg body weight. All surgical procedure was performed 
under vigorous sterile conditions and within a controlled sterile environment.  
For the implantation, the rats were shaved and following a surface wash with iodine 
solution, a centrally located 2 cm incision was cut along the back of the animal using 
a scalpel and mayo scissors. From this incision four separate subcutaneous 
pouches were created by careful instrumentation with the additional use of forceps.  
Each pouch was located in the region of one of the animal’s limbs. In animals which 
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received samples which were impregnated with the VEGF, only two pouches were 
created. Within each pouch a single scaffold sample was placed with care taken to 
place the sample quite deep within the pouch to prevent migration of the sample 
post implantation. The incision was sutured using monofilament 4-0 absorbable 
suture material (Prolene). The animals were then returned to the conditions 
previously mentioned. 
During and after surgery, the rats were kept in a temperature controlled environment 
with rats housed two per cage (identical samples groups but euthanized at different 
time points). The animals were provided with standard pellet food and water ad 
libitum. 
4.2.9.3 Histological Assessment  
The animals were sacrificed at 7 days and 14 days post implantation. The tissue 
samples were harvested and then fixed in 10% neutral buffered saline for 24 hours. 
The tissue samples were then immersed in a graded ethanol series for dehydration, 
and then were embedded in paraffin. Histological sections were cut at a 5 µm 
thickness from the paraffin blocks using a rotary microtome (Leica RM2245, 
leicabiosystems, Germany) and were then stained with haematoxylin and eosin 
(H&E). 
4.2.9.4 Digital Image Acquisition and Analysis 
The stained slides which were the digitally scanned using a digital slide scanner 
(Nanozoomer, Hamamatsu, Hamamatsu Photonics K.K., Shizuoka, Japan). Very 
large high resolution images were then produced of the samples with easily 
identifiable ―encapsulated scaffold‖ and ―surrounding granulation tissue‖ regions. 
These images were then sliced into smaller images and categorized according to 
the regions mentioned. This allowed analysis to be carried out on images which 
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were of manageable resolution which could be handled by the software used. For 
region analysis slices were randomised and analysed for each sample group. Cell 
type counting was carried out using the ImageJ manual cell counting tool. 
Nuclei counting was carried out to approximate the number of cells present. The 
presence of foreign body giant cells made this difficult as these cells could have 
large numbers of nuclei all of which could not be distinguished from single nuclei by 
the software methodology. However with the developmental path of FBGC’s 
originating with single macrophages this was deemed a suitable approximation for 
cell number. Nuclei counting was carried out using Image J. Images were first run 
through a colour threshold to isolate the stained nuclei. The images were then 
converted to 8-bit black and white images. The watershed feature allows for 
clustered particles to be split into individual ones.  A particle count was then carried 
out using the Analyse Particle feature with the parameters defining the size and the 
circularity expected of a nuclei.  
(a)                                                                              (b) 
  
Figure 4.4 Histological image before (a) and after (b) processing to allow for nuclei (particle) counting. The process 
was carried out using ImageJ software and using mutilple stages described in Section 4.2.9.4. 
 
 
4.2.10 Analysis 
Normal distribution statistical testing was carried out using a 2-tailed student’s t-test 
to a 95% confidence interval. In the case of the mechanical testing basic statistical 
assessment of the data showed that it did not fit normal distribution models and 
therefore non-parametric statistical analysis methods were utilised.  The median 
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was found to be a better measure of central tendency than the mean for this type of 
data and is used in all the mechanical analysis. The group sample data was 
compared for significant differences using Kruskal-Wallis non-parametric analysis 
which indicates the presence of significant statistical differences between individual 
groups. Further analysis was also carried out by post hoc pairwise analysis 
(Dunnett’s Test). All statistical significance tests were done using SPSS versions 20 
or 21 (IBM Corporation) 
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4.3 - Results 
4.3.1 SEM Analysis 
Analysis was carried out on SEM images a sample of which are shown below in 
Figure 4.5. All electrospinning variations are listed in Table B1 (Appendix B-3). 
(a) 10rpm 
  
 
  
 
(b) 1000 rpm 
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(c) 2000 rpm 
  
 
  
 
(d) 3000 rpm 
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 (e) 4000rpm 
  
 
  
 
(f) 5000 rpm 
  
 
  
 
Figure 4.5 SEM images of the PLGA electrospun fibres spun onto SIS at varying mandrel rotational speeds; (a) 10 
rpm (b) 1000 rpm (c) 2000 rpm (d) 3000 rpm (e) 4000 rpm (f) 5000 rpm. All images are aligned perpendicular to the 
mandrel with fibres running left to right being parallel with the mandrel. 
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4.3.1.1 Fibre Diameter  
 
 
 
Figure 4.6 Frequency histograms of the fibre diameter data for the samples of PLGA fibres collected on a rotating 
mandrel at different speeds of rotation. The histograms are overlaid with an ideal normal distribution. 
 
 
 
 
Figure 4.7 The average fibre diameter of electrospun PLGA fibres collected on a rotating mandrel at different 
speeds of rotation. Analysis was carried out on SEM and the diameters measured using software (Image J) (n = 
50+). Error bars are standard deviation.   
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The analysis of the fibre diameter was carried out to ascertain whether the higher 
rotational speeds in this chapter would result in changes in the diameter of the 
PLGA fibres.  
The first observation of the data was that all groups produced a range fibre 
diameters which were normally distributed (Figure 4.6). Further analysis of average 
fibre diameters, shown in Figure 4.7, showed that throughout the entire range of 
rotational speeds investigated in this work there were no statistically significant 
differences in the diameter of the fibres produced (the test was carried out with a 
two tailed T-test). The values of the mean fibre diameters were in the range of 1700 
- 2700 nm, with the actual values of fibre diameters being in the 800 - 3000 nm 
range. The reason for the fibres to be characterised as nanofibres, as opposed to 
the alternative classification of ―microfibres‖, is that the range of fibres are all found 
to be less than 3 micrometres which represents a very small fraction of the µm 
scale, and a large proportion actually being in the actual nano-scale range.  
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4.3.1.2 Fibre Alignment    
                              (a)                                                      (b)                                                     (c) 
  
                              (d)                                                     (e)                                                        (f)  
  
                                                                                         (g) 
 
Figure 4.8 PLGA fibre orientation  when  electrospun onto SIS at different mandrel rotation speeds (a) 10 rpm  (b) 
1000 rpm (c) 2000 rpm (d) 3000 rpm (e) 4000 rpm (f) 5000 rpm (g) Legend illustrating the fibre orientation relative 
to the axis of rotation of the mandrel (shown in degrees removed from the axis of rotation)  (n = 10 - 20). The error 
bars are standard deviation. 
 
The fibre alignment data shows a very clear trend in the alignment of the fibres 
(Figure 4.8).  As in the previous chapter, it was confirmed that increasing the 
mandrel’s speed of rotation results in an increase in the alignment of the 
electrospun fibres PLGA fibres perpendicular to axis of rotation. The higher speeds 
above 3000 rpm showed an increase in alignment however there was little 
difference the samples produced at 4000 and 5000 rpm. 
0
10
20
30
40
50
60
±60-90° ±30-60° ±0-30°
%
 
Orientation  
10rpm 
0
10
20
30
40
50
±60-90° ±30-60° ±0-30°
%
 
Orientation  
1000rpm 
0
10
20
30
40
50
60
70
±60-90° ±30-60° ±0-30°
%
 
Orientation  
2000rpm 
0
10
20
30
40
50
60
70
±60-90° ±30-60° ±0-30°
%
 
Orientation  
3000rpm 
0
20
40
60
80
100
±60-90° ±30-60° ±0-30°
%
 
Orientation  
4000rpm 
0
10
20
30
40
50
60
70
80
±60-90° ±30-60° ±0-30°
%
 
Orientation  
5000rpm 
 
-90 
90 
-60 
60 
-30 
30 
0 Mandrel Axis of Rotation 
163 
 
Some additional work was carried out to ascertain whether the aligned fibres 
produced aligned cells when cultured on the scaffolds.  However due to the three-
dimensional nature of the scaffold and the propensity for the calls to grown down 
into the scaffold, cells growing on the surface of the scaffold were difficult to fix and 
view from a top-down SEM perspective. While this was attempted this method was 
found to be inconclusive. That said, there was some partial indication of the 
orientation of the cells following the direction of the fibres onto which they were 
cultured in a few images (Figure 4.9).  
 
                                                   (a)                                                                         (b) 
     
Figure 4.9 SEM images demonstrating a degree of HESMC orientatation with the direction of the fibres when 
cultured onto the scaffolds produced at (a) 10 rpm and (b) 3000 rpm. 
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4.3.1.3 Scaffold Thickness   
 
Figure 4.10 The average thickness of the PLGA electrospun layers produced at different mandrel  rotational 
speeds and onto SIS (n = 15+). The error bars are standard deviation. Important values differing significantly from 
each other are denoted by *; p < 0.05. 
 
 
The data here was averaged from SEM image measurements. In some instances,  
if the thickness of the electrospun layer was not clear but the  total scaffold and SIS 
thickness were clear and thickness were, the value could be calculated. The 
thickness of the electrospun layer ranged from 11 - 36 µm, as seen in Figure 4.10. 
The largest values were the for the 10 rpm sample group. This difference was not 
found to be statistically significant when compared to the aligned fibres from the 
3000-5000 rpm range, quite likely due to the levels of variation, however the 
difference was definitely substantial and noticeable on visual inspection. Care was 
taken to ensure that the thickness of the electrospun layer was not allowed to get 
too large and all the samples were produced without the scaffold thickness affecting 
the electrospinning process. Earlier test work demonstrated that at higher thickness 
levels the spinning behaviour of the arrangement would change. 
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4.3.2 Mechanical Testing 
 
(a) 
 
(b) 
 
(c) 
 
Figure 4.11 Mechanical testing data from the longitudinal tensile testing of the PLGA-SIS showing (a) Elastic 
modulus values (MPa) (n = 12) (b) Yield stress values (MPa) (n = 12) (c) Failure strain values (%) (n = 12). Error 
bars shown are the standard error. Statistical analysis was done non-parametrically and discussed in the results 
sections. 
 
0
5
10
15
20
25
SIS 10rpm 1000rpm 2000rpm 3000rpm 4000rpm 5000rpm
M
P
a Modulus - Longitudinal 
0
2
4
6
8
10
12
SIS 10rpm 1000rpm 2000rpm 3000rpm 4000rpm 5000rpm
M
P
a 
Yield Stress - Longitudinal 
0
50
100
150
200
250
SIS 10rpm 1000rpm 2000rpm 3000rpm 4000rpm 5000rpm
%
 
Failure Strain - Longitudinal 
166 
 
 
 
 
(a) 
 
(b) 
 
(c) 
 
Figure 4.12 Mechanical testing data from the circumferential tensile testing of the PLGA-SIS showing (a) Elastic 
modulus values (MPa) (n = 8) (b) Yield stress values (MPa) (n = 8) (c) Failure strain values (%) (n = 8). Error bars 
shown are the standard error. Statistical analysis was done non-parametrically and discussed in the results 
sections. 
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A general observation made in the mechanical testing in this chapter was that a 
lower proportion of the stress-strains curves produced with the scaffolds were of the 
distinct two stage type which was observed in earlier work in Chapter 3. There were 
also a number of curves which had features of both categories and produced 
―stepped‖ curves which could fall into either category. The criteria for choosing the 
category into which they fell was unclear and with any distinction being arbitrary it 
was decided that this could not be quantified. A further general observation was that 
in nearly all instances of modulus or yield stress the values were higher than those 
observed in Chapter 3. 
As observed in the previous Chapter it was expected that there would again not be 
large differences between the non-aligned and the highly aligned samples with the 
longitudinal tensile testing and this was largely again the case (Figure 4.11). While 
the differences in the modulus did not follow a direct trend all the values were higher 
than the base SIS so there was an increase with the addition of the PLGA.  Yield 
stress also did not show any distinct trend other than all values being nearly twice 
as high with the SIS alone. The increase had no trend associated with alignment 
and was quite constant with the exception of the 2000 rpm sample group which had 
an elevated value. For the failure strain the values of the test groups were again all 
higher than the SIS though it was observed that the 4000 rpm sample was only very 
slightly higher and could be described as having a failure strain value close to that 
of the control SIS.  
In the case of circumferential testing, the modulus values followed a similar lack of 
trend found in to that found in Chapter 3 (Figure 4.12). Again it was observed that all 
the values were higher than the SIS alone. It was also observed that for the 5000 
rpm sample that the modulus value was found to be extremely high. However, given 
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the pattern of the other samples it is more reasonable to state that there was no 
clear trend particularly as the difference in the degree of alignment between the 
4000 and 5000 rpm samples is non-existent. In the case of the yield stress there 
does appear to be evidence of the values generally increasing with the increased 
alignment of the fibres. For the failure strain values there did not appear to be any 
trend and with all samples being at levels of at least 85% strain at failure so it could 
be said that no sample group performed poorly.  
 
4.3.3 Porosity 
                                            (a)                                                                                      (b) 
   
Figure 4.13 (a) Graph representing the porosity of the hybrid scaffolds produced using mercury intrusion porometry 
(n= 4-6). The errors are bars are standard deviation. (b) Graph illustrating the potential trend between fibre 
alignment and the porosity of electrospun scaffolds. 
 
The results of the mercury intrusion are shown in Figure 4.13a.  The differences 
between the 10 and 3000 rpm samples, along with the 3000 rpm and 5000 rpm 
samples, were not found to be significant. However the difference between the 10 
rpm and 5000 rpm samples was statistically significant demonstrating that the more 
random the orientation of the fibres, the higher the degree of porosity. It should also 
be noted that the porosity levels of all the scaffolds in question were generally quite 
high and even in the instance of the 5000 rpm sample the porosity was as high as 
83.13%. 
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A further graph was made to assess any relationship between the actual degree of 
alignment and the porosity and is shown in Figure 4.13b. While there could 
potentially be indications of a trend for it meaningful a larger sample size would 
likely be required. That said, the results do show, in part, that the degree of 
alignment correlated negatively with the porosity.  
                        (a)                                                          (b)                                                          (c) 
   
 
 
                           (d)                                                          (e)                                                     (f) 
   
                          (g)                                                          (h)                                                               (i) 
   
Figure 4.14 Pore size distribution for the scaffolds produced different mandrel rotational speeds:  (a) b) (c) 10 rpm   
(d) (e) (f) 3000 rpm (g) (h) (i) 5000 rpm. The left of the x-axis represents the diameter of the pores in µm. Full size 
versions of these graphs are in the Figure C2 (Appendix C-2).  
  
In the case of pore size distribution (Figure 4.14), it is quite clear to see that for the 
randomly organised 10 rpm fibre scaffolds that the values represent a largely 
10 rpm 
3000 rpm 
5000 rpm 
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normal distribution of the diameter values centred in the 100-150 µm region. In the 
case of the 3000 rpm samples the distributions are separated into 2 peaks with a 
potentially higher peak at the 5 - 7.5 µm region, which shows a large increase in the 
proportion of very small diameter pores and a reduction in the larger diameter. This 
trend of 2 peaks continues with the 5000 rpm samples however there does appear 
to a slight increase in proportion of the larger diameter peak potentially showing a 
shift to an increase in the proportion of larger pores. It should be emphasized that 
the distribution of the pores is independent of the total porosity of the scaffold. For 
clarity, larger versions of the graphs are shown in Figure C2 (Appendix C-2). 
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4.3.4 Smooth Muscle Actin 
 
Figure 4.15 Histological images staining for smooth muscle actin (SMA) showing HESMC’s cultured on the PLGA-
SIS scaffolds at Days 1, 4, 7 and 10, and in 24-well plates. The presence of SMA was detected in all samples and 
at all time-points. 
 
The scaffold were cultured with HESMC’s for the purpose of analysing whether the 
scaffold impeded the ability of smooth muscle cells from producing smooth muscle 
actin which is vitally important for the formation of functioning smooth muscle tissue 
(Rayatpisheh, Heath et al. 2013). The results of the SMA staining (Figure 4.15) 
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demonstrated that SMA was found to be present for all the scaffolds tested and at 
all the time points.  
 
4.3.5 Biocompatibility 
4.3.5.1 Metabolic Activity Assay 
 
 
Figure 4.16 Graph representing the normalised levels of metabolic activity as measured by the use of an MTS 
assay of HESMC’s cultured on the scaffold groups at Days 1, 4 and 7. The values are expressed as a percentage 
of the control (in this case the HESMC’s cultured on TCP). 
 
The results of the metabolic activity analysis carried out using MTS were used to 
evaluate the biocompatibility of the scaffolds (Figure 4.16). What was found was 
that all the scaffold groups generally performed as well as the control and the 
commercial (control) SIS. The values of the 3000 rpm scaffold were found to be 
higher than the other sample groups at days 1 and 7. 
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4.3.5.2 Live-Dead Analysis 
      
Figure 4.17 Series of confocal images (10 rpm) showing the 3D projections of a stack of confocal images for the 
purpose of live-dead analysis 
 
Figure 4.18 Graph representing the percentage of live cells observed by performing a Live-Dead assay on 
HESMC’s cultured on the scaffold groups at Days 1, 7 and 14. The values were obtained cell counts from confocal 
microscopy images and image stacks (n is between 9 and 20 images or image stacks) 
 
As mentioned in Section 4.3.6.3 of the Materials and Method the confocal images of 
the Live-Dead Assay were created into a 3D projection using Image J a sequence of 
which is shown in Figure 4.17. What is demonstrated in these images and is that the 
cultured cells were often found in ―seams‖ which lay inside the 3D structure of the 
electrospun fibres. There were also a higher concentrations of cells at the base of 
the scaffold where the SIS was present.  
The results of the live-dead assay show a number of important facts (Figure 4.18). 
Firstly that there was no difference detected between the PLGA-SIS scaffolds which 
were tested. Secondly, that the PLGA-SIS scaffolds had a similar level of inferred 
cytotoxicity to the control TCP and the commercial SIS. A final observation was that 
at day 14 the commercial SIS and the control TCP had higher levels of cell death 
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though it was noted that the surface area of the TCP wells and the commercial SIS 
was lower than that of the PLGA-SIS scaffolds.   
A further observation was that using the confocal it was easy to identify the 
alignment of the cells along the orientation of the fibres as seen in Figure 4.19 
                                                       (a)                                                              (b) 
  
Figure 4.19 3D projection of image stacks taken using confocal  microscopy. The cells were HESMC’s and cultured 
in 24-well plates and demonstrate the orientation of the cells within two scaffolds containing different  fibre 
orientations (a) random fibres (10 rpm Day 7)  and (b) aligned fibres ( 5000 rpm Day 14) 
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4.3.6 VEGF Assay 
(a) 
 
(b) 
 
Figure 4.20 (a) Graph representing the concentration of VEGF in solution following scaffold immersed at day intervals of 1, 7 
and 14. The ―T‖ denotes a trace amount of VEGF detected in the commercial VEGF on day 7(n = 4 and the error bars are 
standard deviation). (b) Graph representing the calculated quantity of VEGF present in solution at the same time intervals.  
 
The VEGF assay was carried out to find  out i) if the VEGF added to the scaffolds was 
actually retained and ii) to assess the release profile of the VEGF. The first observation 
made of the graph shown in Figure 4.20a, is that shows that VEGF was present at 
detectable levels in all samples to which it added. The VEGF levels did not vary significantly 
between the samples or over time. It was also noted that a trace amount of VEGF was 
detected from the commercial control at day 7.  
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The second graph (Figure 4.20b) shows the same sample data but instead represented as 
the total calculated quantity of VEGF present in each solution. Here it shows that even the 
highest average quantity is a little over 100 ng of VEGF. This contrasts with the initial 
quantity of the VEGF which was 500 ng per sample. This graph also indicated a small fall in 
the VEGF levels in two of the samples groups between day 7 and day 14. 
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4.3.7 CAM Assay 
 
Figure 4.21 The mean length of vessel complex on the CAM as identified by quantification software. The sample groups shown 
are: Control (n = 24), 10 rpm (n = 21), 3000 rpm (n = 15),   5000 rpm (n = 21),   10 rpm + VEGF (n = 20),   3000 rpm + VEGF (n 
= 26),   and 5000 rpm + VEGF (n = 25).    The error bars are the standard deviation. Important values differing significantly from 
each other are denoted by *; p < 0.05. 
 
 
 
 
Figure 4.22 The mean number junctions found per vessel complex on the CAM as identified by quantification software. The 
sample groups shown are: Control (n = 24), 10 rpm (n = 21), 3000 rpm (n = 15),   5000 rpm (n = 21),   10 rpm + VEGF (n = 20),   
3000 rpm + VEGF (n = 26),   and 5000 rpm + VEGF (n = 25).    The error bars are the standard deviation. The error bars are 
the standard deviation. Important values differing significantly from each other are denoted by *; p < 0.05. 
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As mentioned previously the main method of analysis for this experiment were quantified 
values produced by the Angioquant software. Through this method the data produced was 
figures for the mean number of junctions and the mean length of blood vessel within each 
identified vessel complex on the CAM. 
Statistical analysis of the data from the average length of the complex (Figure 4.21) found 
that all samples which lacked VEGF did not differ significantly from the control. It was also 
found that the samples with VEGF were all statistically larger than the control. When it came 
to the difference between identical scaffolds with and without VEGF two out of the three 
were to have larger values with VEGF (the exception being the 5000 rpm groups which was 
not found to be significantly different). A final analysis was performed where all the non-
VEGF samples were combined and were compared with the samples with VEGF and the 
difference was found to be statistically significant.  
The data which was from the mean number of junction is shown in Figure 4.22. Here it was 
found that in two out of the three samples with VEGF showed no difference with the control 
(the exception being the 5000 rpm which was found to be larger than the control). All the 
samples which had VEGF were found to have higher values than both the control samples 
and their identical non-VEGF samples. It was also found that when the non-VEGF scaffold 
were combined and compared with the VEGF scaffolds the difference was statistically 
significant.  
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4.3.8 In Vivo Study 
With analysis of the images there was it was observed that there was a district encapsulation 
of cells around the scaffolds upon implantation. This encapsulation is referred to in this work 
as the ―capsule‖ and should be differentiated from the fibrous capsule which is a distinct 
biological formation as the final phase of the inflammatory process. This also differentiates 
this region form the associated surrounding granulation tissue which was also easily 
identifiable (Figure 4.23). The cells types and the blood concentration of blood vessels 
varied in both these regions so they were both analysed independently.  
 
Figure 4.23 Histological image (3000rpm - 4 Weeks) illustrating the general observations of the in vivo samples (A) Indicates 
the underlying muscular tissue (B) The blue line outlines the surrounding granulation tissue (with the encapsulated scaffold 
within it) (C) The yellow line outlines the ―capsule‖ of cells which forms around the scaffold.  
 
Four cell types were chosen for analysis; eosinophils, lymphocytes, foreign-body giant cells 
(FBGC) and monocytes (Figure 4.24).  It was also observed that the surrounding connective 
(granulation) tissue was predominately where the blood vessels were located with the 
capsule region having very low numbers. The importance of this was vital particularly as the 
effectiveness of VEGF was dependant on the actual number and character of the blood 
vessels. This difference is illustrated with images in Figure 4.25.  
The degree of cellular infiltration also varied between different sample types and this was 
considered for further analysis. In Figure 4.26, some of the differences in the cellular 
A 
B 
C 
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responses are shown. For porous, degradable scaffolds to function cells from the host, both 
immune and otherwise, are required to infiltrate into the scaffold. This is vital for remodelling 
of the SIS and the eventual resorption of the PLGA fibres. In certain instances it was found 
that the fibres would form an impentrable barrier with very few cells able to infiltrate (Figures 
4.26 c & d). Generally speaking all the pure SIS scaffolds were readily infiltrated, the 
commercial scaffold were largely poorly infiltrated, though the PLGA-SIS scaffolds varied 
(Figure 4.26). 
The level of infiltration of  cells into the scaffolds was quantified using a scale of 0 - 4, with 0 
being very poor and 4 being highly infitrated and was averged between 4 different sample 
images (Figure 4.27). A number of things were observed  here; firstly the comercial SIS and 
the random fibre orientation fibre group (10 rpm) had the lowest infiltration rates. Secondly, 
there appears to be a trend where that with increasing aligment there was also increasing 
levels of infiltration with the 5000 rpm being the highest of the PLGA-SIS scaffols. Thirdly, 
the pure SIS was highest infiltrated with the scaffold sometimes being difficult to clearly 
define (Figures 4.26a). Finally, it appears that the addition of VEGF did not affect the degree 
of cellular infiltration  (A seletion of the histological images are shown for wach sample group 
in Figure C1 in Appendix C-1). 
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                                               (a)                                                                                              (b) 
    
                                                    (c)                                                                                          (d) 
    
 
Figure 4.24 Images illustrating the cell types chosen for histological analysis;  (a) A1-Eosinophils (b) B3-Lymphocytes, also 
shown B1- Blood Vessel and B2-Erythrocyte (c) C1-Foreign Body Giant Cells (d) D1-Monocytes. All images are stained with H 
& E. 
(a)                                                                                                      (b) 
 
 
  
 
 
Figure 4.25 Images contrasting the difference in the of density of  blood vessels in surrounding granulation tissues for samples 
with identical fibres and time-points and differing only in the presence of VEGF (a) 5000 rpm at Day 14 without VEGF and (b) 
5000 rpm Day 14 with VEGF. Note: The yellow arrows indicate the presence of a blood vessel and may overlay rather than 
point to the vessel itself. 
(b) 
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                                                  (a)                                                                                               (b) 
   
                                                 (c)                                                                                              (d) 
   
 
 
Figure 4.26 Images of features observed in historical analysis; (a) Pure SIS (Day 7), A1-Pink stained collagen-based  SIS 
which is well infiltrated, A2- Boundary between the capsule and the underlying muscle tissue (b) PLGA-SIS 5000 rpm  (Day7), 
B1-Well infiltrated PLGA Fibres ,B2- Well infiltrated SIS (c) PLGA-SIS 5000 rpm  (Day7), C1-Poorly infiltrated electrospun 
fibres, C2- Poorly infiltrated SIS (d) PLGA-SIS 5000 rpm  (Day7), D1- Highly visible electrospun fibres (poorly infiltrated) 
 
 
Figure 4.27 Graph of the mean cellular infiltration score for the in vivo samples for all the scaffold groups at both 2 and 4 weeks 
(the point points are differentiated by colour. The images were scored from 0-4 with 0 being poor infiltration and 4 being highly 
infiltrated (n = 4 and the error bars are the standard deviation).  
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4.3.8.1 Nuclei Density 
 
Figure 4.28 The mean number of nuclei per mm
2
 of histologically visible capsule tissue averaged  from H&E 
stained images of the scaffold groups at both 2 and 4 weeks (n = 4 and the error bars are the standard deviation). 
 
 
 
 
 
Figure 4.29 The mean number of nuclei per mm
2
 of histologically visible capsule-surrounding tissue averaged  from 
H&E stained images of the scaffold groups at both 2 and 4 weeks (n = 6 and the error bars are the standard 
deviation). 
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The results of the nuclei counting of the capsules indicates that after a two week 
period the density of nuclei present was largely the same for all sample scaffolds 
tested (Figures 4.28). The highest value was also observed to be for the control 
SIS.  At four weeks all the samples showed a reduction in the average cell number 
with the numbers again all being largely similar. 
The results of the nuclei counting for the surrounding tissue firstly show that in all 
instances the nuclei density was lower in the surrounding granulation tissues than 
within the actual capsules themselves (Figure 4.29). It was also observed that the 
density was also largely similar across all sample groups after two weeks with the 
highest numbers again found in the control SIS sample group. After four weeks all 
the samples were again found to have similar values across all the samples and 
which were found to be lower than at two weeks.  
4.3.8.2 Cell Types 
 
With the nuclei counts being quite similar the observation of the cells types present 
became more significant. It became clear that there were differences in the ratio of 
the easily identifiable cells which were present and that this might be useful for 
analysis. The cells were counted using sectional images of the capsule (Figure 
4.30) and the surrounding tissue (Figure 4.31) and both were analysed separately. 
The first general observation which was made was that there was largely a lack of 
FBGC’s with the control SIS scaffolds and this was easily identifiable through 
observation at low magnification. Other observations are better described along with 
immunological explanation and are described in Section 4.4 (Discussion). 
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Figure 4.30 The average number of cells per mm
2
 of histologically visible capsule tissue for all scaffold groups and 
at the time points 2 and 4 weeks; the cell types analysed were: (a) Eosinophils (b) Lymphocytes (c) FBGC’s (d) 
Monocytes (n = 3 and the error bars are the standard deviation). 
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Figure 4.31 The average number of cells per mm
2
 of histologically visible capsule sounding tissue for all samples 
and at time-points 2 and 4 weeks. The cell types analysed were:(a) Eosinophils (b) Lymphocytes (c) FBGC’s (d) 
Monocytes (n = 3 and the error bars are the standard deviation) . 
 
0
20
40
60
80
100
120
Commercial  SIS  Control 10rpm 3000rpm 5000rpm 10rpm + VEGF 3000rpm +
VEGF
5000rpm +
VEGF
N
u
m
b
e
r 
o
f 
ce
lls
 /
 m
m
² 
o
f 
ti
ss
u
e
  (a) Eosinophils (SUR) 
2 weeks 4 weeks
0
50
100
150
200
Commercial  SIS  Control 10rpm 3000rpm 5000rpm 10rpm + VEGF 3000rpm +
VEGF
5000rpm +
VEGF
N
u
m
b
e
r 
o
f 
ce
lls
 /
 m
m
² 
o
f 
ti
ss
u
e
  (b) Lymphocytes (SUR) 
2 weeks 4 weeks
0
2
4
6
8
10
12
14
Commercial  SIS  Control 10rpm 3000rpm 5000rpm 10rpm + VEGF 3000rpm +
VEGF
5000rpm +
VEGF
N
u
m
b
e
r 
o
f 
ce
lls
 /
 m
m
² 
o
f 
ti
ss
u
e
  
(c) FBGC (SUR) 
2 weeks 4 weeks
0
20
40
60
80
100
120
Commercial  SIS  Control 10rpm 3000rpm 5000rpm 10rpm + VEGF 3000rpm +
VEGF
5000rpm +
VEGF
N
u
m
b
e
r 
o
f 
ce
lls
 /
 m
m
² 
o
f 
ti
ss
u
e
  (d) Monocytes (SUR) 
2 weeks 4 weeks
187 
 
4.3.8.3 Blood Vessel Density 
 
Figure 4.32 The number of histologically visible blood vessels per mm² of tissue based on histological analysis for 
all sample groups and at 2 and 4 weeks (n = 4 for the number of sample images and the error bars are the standard 
deviation). The bars are alternatively shaded between groups at weeks 2 and 4. Important values differing 
significantly from each other are denoted by *; p < 0.05. 
 
 
Figure 4.33 The average cross-sectional area of blood vessels of the blood vessels counted in Figure 4.32  (n = 4 
for the number of sample images and the error bars are the standard deviation). The bars are alternatively shaded 
between group at weeks 2 and 4.  
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When the data from the blood vessel density is viewed only in terms of the vessels 
within the capsules the values were largely the same for all groups, which was not 
the case for the surrounding tissue (Figure 4.32). As expected, all the sample 
groups were higher blood vessel density in the surrounding connective tissue than 
within the capsules themselves.  
As mentioned previously, the main area of focus was the surrounding granulation 
tissue. For the PLGA-SIS scaffolds without VEGF, there was no difference between 
these samples and the commercial or the control SIS. The main difference observed 
here were between the PLGA-SIS scaffolds with and without the inclusion of VEGF.  
Statistical testing of the data showed that when each of the three PLGA-SIS scaffold 
groups (10, 3000 and 5000 rpm) were compared to the identical group with VEGF 
then all samples, at both time points, had a significantly higher blood vessel density 
when compared to the non-VEGF samples (with the single exception being the 
sample set from 5000 rpm at 2 weeks, though the corresponding sample with VEGF 
also had a higher values).  
A trend with the diameter of the blood vessels was more difficult to ascertain (Figure 
4.33). What can be said is that for the samples with VEGF there was a degree of 
consistency with which diameters remained quite small across all three samples, at 
both time points, and both in the capsules and the surrounding tissues. This was 
reinforced by visual observation where the increased density which was observed 
appeared to be due to an increase in the number of small diameter vessels only. 
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4.4 - Discussion 
4.4.1 General Discussion 
The aim of this chapter is to combine the data and findings from the previous three 
chapters and to create and assess an improved hybrid scaffold for oesophageal 
tissue engineering from the perspectives of its physical and biological suitability.  
With respect to Chapter 2, a limitation of the decellularisation work was that there 
was the potential to expand the histology work to include staining for basement 
membrane and this was not carried out. Basement membrane components are 
important extracellular molecules and serve as attachment sites for cell populations 
to adjacent tissues. Some basement membrane molecules such as collagen I, 
collagen IV, laminin, and fibronectin, have been used as surface coatings for 
biomaterials to facilitate cell attachment and growth and to promote biocompatibility. 
Processing ECM materials, by decellularization, lyophilization, disinfection, and 
terminal sterilization can result in disruption to the basement membrane (Brown, 
Lindberg et al. 2006) 
Numerous studies show that ECM scaffolds retain  basement membrane proteins 
such as collagen I ,collagen IV and laminin-rich basement membrane after certain 
types of processing including decellularisation (Badylak, Taylor et al. 2011; Barnes, 
Brison et al. 2011). The level of disruption can vary according to the processing the 
ECM material undergoes including. Given this, the addition of immunostaining for 
these components would have given vital information on the level of disruption by 
the decellularisation and processing of the SIS produced here. 
In Chapter 2 the fibre diameter was shown to not be affected by rotational speeds 
up to 3000 rpm and in this chapter this was reconfirmed up to a speed of 5000 rpm. 
This observation has been confirmed previously and the rotational speed of the 
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mandrel has been shown not to affect the fibre diameter (Ayres, Bowlin et al. 2006). 
This was important to ascertain as there are examples where a high enough 
rotational speed can cause a spooling effect where the fibres are thinned by the 
process (Yang, Murugan et al. 2005). The regularity of shape and the consistency of 
the diameter at different speeds indicate that the fibres were dried and fully-formed 
when reaching the SIS where the collection took place.  
Another physical aspect of the scaffold that had to be monitored was the thickness 
of the electrospun layer. It has been reported that with an increase in the thickness 
of the electrospun layer, fibres become disordered as the residual charge 
accumulation on the deposited fibres interferes with the alignment of incoming fibres 
(Teo and Ramakrishna 2006; Zhu, Cao et al. 2010). At early stages of this work 
when alignment was not a consideration, it was observed that when the electrospun 
layer reached a certain thickness then the combined materials eventually had an 
insulating effect and this caused the fibres to be laterally deflected away from the 
SIS to the exposed metal mandrel. The results of the thickness shows that for a 
given time of spinning, i.e. a fixed volume of PLGA per length, of SIS the 
electrospun layer was found to be thicker for the 10 rpm samples (Figure 4.10). This 
was not entirely an unexpected result as the more random orientation created a 
more diffuse structure and would suggest a higher porosity of the scaffold. The 
porosity of an in vivo scaffold presents an important consideration beyond structural 
properties. For a scaffold to support cell viability in addition to tissue growth and 
development it must have sufficient porosity to allow for transport of nutrients and 
the removal of waste products (Sharma and Elisseeff 2004).   
Scaffolds which are produced through electrospinning have been described as often 
being limited in their pore size particularly when consisting of nanofibres (Nguyen, 
Chen et al. 2013). Fibre alignment presents a further challenge as this has been 
observed to decrease porosity (Ayres, Bowlin et al. 2006). The porosity data found 
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that all the scaffolds produced had a porosity level which was above 80% and that 
the level of the porosity decreased with the alignment which reinforces the findings 
in the literature (Figure 4.13a). A potential trend was also observed when the 
porosity data was plotted against the alignment (further assessment of the effects of 
alignment will be discussed later) (Figure 4.13b). The highest porosity was observed 
in the 10 rpm samples which represented completely random fibres and which also 
explains the observation of why the thickness of the 10 rpm scaffold was the 
highest. This agrees with the literature and does make logical sense in that the 
stacking efficiency of aligned fibres is likely to be higher than that that of randomly 
organised fibres. 
Another aspect of the porosity was the pore size distribution. This was shown to 
change when varying the alignment of the fibres, as observed in Figure 4.14. There 
were proportionally far fewer small diameter pores within the 10 rpm samples and 
as the fibres became more  aligned there was an increase in the proportion of small 
diameter pores which also agrees with the idea that better alignment increases 
packing efficiency, reducing both the pore size and the total porosity. That said in 
the case of the more aligned scaffolds the total porosity was not at a particularly low 
level and the presence of smaller pores has been known to have additional benefits 
and so a decreased overall porosity does not necessarily make the aligned scaffold 
less biologically effective. 
As described in Chapter 1 (Section  1.1.3.1) for scaffolds to work for tissue 
engineering an outer pore sizes in the range of 50 to 200 μm is able to facilitate cell 
seeding, and transport of waste and nutrients, and smaller pores in the range of 35 
to 70 μm are considered important in the promotion of angiogenesis (Ritchie, Chian 
et al. 2006; Poghosyan, Gaujoux et al. 2011; Kuppan, Sethuraman et al. 2012; Tan, 
Chua et al. 2012). What was observed here is that there was a fairly broad spread 
of pore sizes. The two main peak ranges observed, were in the 100 - 150 µm region 
192 
 
for all samples and a second peak for the 3000 and 5000 rpm samples in the 5 - 7.5 
µm region. This second peak if taken in isolation could be seen as a problem as it 
has been shown that that in scaffolds consisting of nanofibres that have small pore 
sizes (10 µm and below) can act as a barrier to cellular migration (Bye, Bissoli et al. 
2013). However this effect is mitigated by the first peak showing the presence of 
larger pore sizes.  
The fact that all the scaffolds fall within the aforementioned range established by the 
literature is a positive one. However, it could be said that the more aligned samples 
better reflect the actual criteria. The effect of the pore size on the in vivo 
performance will be discussed later. 
Another physical aspect of the scaffold was the alignment of the fibres. Culturing 
cells on an underlying substrate with some form of aligned structure is a well-
established method for producing aligned cells with follow the orientation of the 
substrate through the processes of contact guidance (Shang, Yang et al. 2010). 
Very early work in this area was carried out using smooth muscle cells as early as 
1982 (Buck 1982). This phenomenon may not necessarily involve the use of fibres 
and alternative methods have also been shown to produce these effects. An 
example of this is the use of a lithographically grooved surface to influence the 
orientation of cultured human aortic smooth muscle cells on the surface of a hollow 
cylindrical polydimethylsiloxane (PDMS) substrate (Choi, Piao et al. 2014). 
This effect has been well-observed in electrospun fibrous scaffolds and has been 
applied to a variety of cell types. Aligned scaffolds of poly(l-lactide) composite were 
cultures with mouse osteoblast-like cells (MC3T3-E1 cells) and the cells were 
observed to orientate themselves along the lengths of the fibres (Tujunen, Fujikura 
et al. 2013). This behaviour has also been observed with the use of mouse 
fibroblasts which were cultured onto aligned scaffolds of  PLGA (Hwang, Park et al. 
193 
 
2009). Additionally the orientation of mouse periodontal ligament cells was induced 
when cultured on aligned PLGA scaffolds (Shang, Yang et al. 2010). This effect has 
even been shown using mouse Schwann cells for applications in neural tissue 
engineering on aligned PLGA fibres (Subramanian, Krishnan et al. 2011) 
The use of aligned electrospun fibres with contact guidance dictating the orientation 
of smooth muscle cells has become a relatively common one in the field of arterial 
tissue engineering. Here it is a well-established method for getting smooth muscle 
cells to orientate themselves circumferentially to a cylindrical scaffold with the 
theoretical aim of establishing contractility. After all, if cells are to contract the vessel 
radially and then relax to allow for vessel expansion, they must be oriented 
circumferentially (Bell 2007). 
Smooth muscle cells have demonstrated alignment when cultured onto aligned 
electrospun fibres (polyurethane and collagen) for use in arterial tissue engineering 
(in this case human aortic smooth muscle cells) (Jia, Prabhakaran et al. 2014). 
Aligned smooth muscle cells were also observed when cultured on synthetic elastin 
fibres (Nivison Smith and Weiss 2012). In further work, human umbilical artery 
smooth muscle cells were cultured onto aligned PCL fibres and here it was found 
that and not only was the orientation and the morphology of the cells influenced by 
the fibre alignment, but  that also the distribution and the organisation of the  
cytoskeletal proteins within the SMC’s were also found to be parallel to the direction 
of the fibres (Zhu, Cao et al. 2010). In addition to orientation, smooth muscle cells 
cultured in this way have also been shown to express the genes for the contractile 
proteins (calponin, smooth muscle α-actin (SMA), SM22, and smoothelin) 
(Rayatpisheh, Heath et al. 2013). Furthermore, it has also been observed that 
following cellular orientation there is also fibrous extracellular matrix formation which 
also follows the same alignment (Glass-Brudzinski, Perizzolo et al. 2002). These 
phenomena all contribute to potentially addressing the issue prevalent in a wide 
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variety of regenerative applications where the tissues produced are only in the form 
of disorganised fibres.  
The extension of this concept to oesophageal tissue engineering is a logical one. 
Arteries and the oesophagus share the same tubular shape and multi-layered 
structure; with arteries actually performing under slightly more challenging 
conditions. With constant rise and fall of fluid pressure and with the requirement to 
contain a complex fluid such as blood a complex challenge is presented (Wong, Liu 
et al. 2013). By contrast, the oesophagus represents a more relatively 
straightforward challenge, if not a simple one. As mentioned previous in Chapter 1 
(Section 1.1.3.2), when tissue engineering constructs have been applied to 
oesophageal tissue engineering in vivo the lack of smooth muscle growth was 
observed (Doede, Bondartschuk et al. 2009). To prevent this it has been suggested 
here that smooth muscle cells could be cultured onto the construct prior to use. In 
effect, principles applied to blood vessel tissue engineering also apply to the 
oesophagus as restoring contractility also represents an ideal target. 
In this chapter consistently PLGA aligned fibres were produced and were made to 
adhere to the underlying SIS to produce the hybrid scaffolds. Smooth muscle cells 
(HESMC’s) were cultured on these scaffolds and through the use of SEM imagining 
(Figure 4.9) and confocal imaging (Figure 4.19) it was confirmed that in the case of 
both the 3000 rpm and the 5000 rpm scaffold there was visible evidence of the 
alignment of the HESMC’s.  
Another physical consideration for a tissue engineering scaffold are its mechanical 
properties. As mentioned previously the requirements of an oesophageal scaffold 
would have to reflect its unique mode of functioning. In blood vessels the 
differences in mechanical properties (defined in terms of compliance) between graft 
and tissue can create compliance mismatches resulting in zones of hydrodynamic 
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instability. This form of consistent  instability causes cell signalling cascades 
resulting in localised cell proliferation and eventual loss of patency (Rapoport, Fish 
et al. 2012). This does not happen with the oesophagus as it acts only intermittently, 
and does not maintain a constant flow; however it does have to deal with both solids 
and liquids. The mechanical properties of a graft therefore are not likely to require a 
very accurate match to the surrounding oesophageal tissue as would be the case 
with a more sensitive organ such as an arterial blood vessel. 
What the results of the mechanical testing show, above, was that with the addition 
of an electrospun PLGA layer there were improvements to the modulus, yield stress 
and failure strain over the unaltered SIS in both the longitudinal and the 
circumferential direction (Figures 4.11 and 4.12). This is a vitally important result 
and falls in line with the originally stated goals with respect the application and use 
of SIS in oesophageal tissue engineering and how its short-comings could be 
overcome (Section 1.3.3.5). More specifically it was found that for the highly aligned 
scaffolds, in the circumferential direction, the high yield stress values along with the 
lack of any significant compromise in the failure strain were  important result 
because that is likely to be the fibre direction that would be ideal for smooth muscle 
bioreactor culture for potential in vivo applications. In general the relative 
mechanical properties of the scaffolds do appear quite favourable when compared 
to both electrospun materials by themselves and to ECM materials.  
Aside from the physical aspects of the scaffolds the biocompatibility was an 
important consideration for their overall functioning. Biocompatibility was first 
evaluated using a metabolic activity assay and here it was found that all the scaffold 
groups performed as well as the control and the commercial SIS. This was an 
important result particularly when compared to a commercial SIS which is currently 
in use in the market. With metabolic activity it is necessary to ascertain whether 
differences in the activity levels are due to scaffold biocompatibility or due to other 
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effects such as cytotoxicity and/or an increase in cellular activity levels. For this 
reason a Live-Dead assay was performed and here it was observed that there was 
no major differences detected between any of the PLGA-SIS scaffolds and both the 
commercial SIS or the control. At day 14 the MTS assay of the commercial SIS and 
the control did have slightly lower levels but these can be accounted for by the 
relatively rapid expansion rate of the cells and that there was a lower surface area 
present in those samples (lacking electrospun fibres). The scaffolds were also 
cultured and tested for the presence of smooth muscle actin, a vital component of 
smooth muscle cell contractility (Figure 4.15).  In all instances the presence or 
alignment of the scaffold neither inhibited nor improved the in vitro performance of 
the scaffold.   
When the samples were implanted in vivo there results were a little more complex to 
evaluate. All samples elicited an immune inflammatory reaction around the scaffold 
and provoked the formation of surrounding granulation connective tissue. Close 
inspection revealed differences in the immune reactions even though an 
approximation of the cell numbers showed very little differences between groups. 
Consequently it could the viewed that the differences were in the nature of the 
immune reactions rather than the scale.  
The first clear observation is that there was cellular infiltration and encapsulation of 
all samples as expected of a foreign body being placed subcutaneously. The in vivo 
reactions to the scaffolds can be observed from the perspective of the foreign body 
reaction and mainly concerns the encapsulated scaffolds and not the surrounding 
granulation tissue though this does have some importance later. Upon implantation 
there is an immediate reaction which leads to a phase of acute inflammation, which 
can last up to a week, and which is characterised in its very earliest phases by 
neutrophils (polymorphonuclear leukocytes). Mast cell degranulation releases 
histamine (along with the critical Interleukins 3 & 4) and this along with fibrinogen 
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adsorption on the implanted biomaterial surface, are known to mediate acute 
inflammatory responses (Zdolsek, Eaton et al. 2007). 
This is followed by a chronic phase of inflammation which occurs for a longer and 
more variable period. These overlap and can be better understood as a continuum 
of overlapping processes. This phase is considered to be defined by the presence 
of mononuclear cells, i.e. monocytes and lymphocytes, at the site of implantation 
and is the phase than concerns this work. By this stage of inflammation a number of 
processes are simultaneously taking place, such as granulation tissue deposition 
and critical cellular actions, like monocyte adhesion to the surface of the biomaterial, 
both of which occur after a few days and continue throughout. When chronic 
inflammation is used to describe the foreign body reaction it is often described as 
when monocytes, macrophages, and foreign body giant cells are all present at the 
biomaterial interface. Granulation tissue being present is also a feature with the 
granulation tissue being considered a precursor to the formation of the fibrous 
capsule (Anderson, Rodriguez et al. 2008).  
The formation of FBGC’s is an important indicator of the foreign body reaction. 
Towards the end of the acute phase of inflammation monocytes adhere to the 
surface of the material; interaction at the material surface causes their differentiation 
into macrophages. If further conditions are met then these macrophages begin a 
process of fusion, with the eventual outcome being FGBC’s. FBGS’s have been 
shown to exhibit an antigenic phenotype similar to both monocytes and 
macrophages reflecting their formation from the fusion of monocyte-derived 
macrophages (Athanasou and Quinn 1990). It has also been shown that 
lymphocytes also have a role to play in the foreign body reaction. Adherent 
lymphocytes have been shown to predominately associate with macrophages and 
FBGC’s rather than the surface of the biomaterial itself (Macewan, Colton et al. 
2005). In in vitro co-cultures, lymphocytes have been shown to enhance 
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macrophage adhesion and fusion while the presence of the macrophages 
stimulated lymphocyte proliferation (Macewan, Colton et al. 2005).   
Histological evaluation of the samples here showed that the control SIS did not 
cause a foreign body reaction. This is quite a significant result in that a largely 
collagenous xenogeneic decellularised tissue functioned well in vivo. The 
commercial SIS undoubtedly had all the early indications of a foreign body reaction 
at 2 weeks however by 4 weeks this had resolved itself and the numbers were very 
low. This again is an important result due to the fact that it appears to indicate a 
reduction in the foreign body response and this not being observed in the PLGA-SIS 
samples. 
In all test groups the numbers of monocytes fell between weeks 2 and 4. In the case 
of the control SIS and commercial SIS this could indicate a reduction in the 
inflammatory process however for the PLGA-SIS samples this could potentially be 
due to a persistent foreign body reaction as indicated by the increase in the 
numbers in FBGC’s and the reduction in the number of monocytes due to 
differentiating to macrophages (and, in turn, FBGC’s). 
In the case of the pure and commercial SIS the numbers of lymphocytes decrease 
from weeks 2 to 4. This could again be an indication of a decrease in the 
inflammatory processes. It was also observed that for both the numbers of 
monocytes and lymphocytes present on the commercial product were far lower than 
with control SIS. In the case of the control SIS, with high numbers of both these cell 
types present  at 2 weeks it was remarkable that very few FBGC actually formed 
especially as both being key cells in FBGC formation. The control SIS also 
appeared to have high numbers of eosinophils, also reflected in its surrounding 
tissue, in addition to also having the highest monocyte numbers. This could suggest 
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a mechanism at work, possibly with respect to the rapid remodelling process, which 
attracts these cells, but however does not, critically, illicit the foreign body reaction.  
For all the PLGA-SIS samples the lymphocyte numbers fall from 2 to 4 weeks (the 
exception being the 3000 rpm sample however high variability with at least one 
sample showing an almost unique proportion of cells potentially skewing the mean 
value). This appears to indicate that by 4 weeks the roles of the lymphocytes in any 
on-going inflammatory processes were quite reduced. What can also be said is that 
on visual assessment of the images, that in all samples there was a high number of 
plasma cells (involved in antibody production). These are successor cells to 
lymphocytes and could also account for the reduction in number.  
Eosinophils were present in all samples and at relatively high numbers in some 
instances. It is not exactly clear what role these would play in the foreign body 
reaction. Eosinophils are well known to have immunologic effects though they are 
often described in specific conditions where there presence, usually in high 
numbers, is either a symptom or potentially a cause, such as pulmonary 
eosinophilia, eosinophilic esophagitis, hypereosinophilic syndrome, Churg-Strauss 
syndrome, eosinophilic granulomatous vasculitis (Akuthota and Weller 2015).  
With respect to their actions, eosinophils have the capacity to work in association 
with T-lyphocytes in a variety of immunologic conditions. Eosinophils have also 
been shown to be able to selectively produce Th1 or Th2 cytokines, depending 
upon the immune response present (Alam 2009).  
When all the sample groups are consider together it becomes quite clear that the 
cause of the foreign body reaction to the PLGA-SIS scaffolds is the presence of the 
PLGA electrospun layer. What should be emphasized here is that this was not an 
aggressive response and compared well with other instances with other PLGA 
scaffold which have been implanted in vivo (Blackwood, McKean et al. 2008; Han, 
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Jia et al. 2013). That being said, there was a limited foreign-body reaction and there 
are a number of possible reasons for this. During the acute phase of inflammation 
as mentioned earlier monocytes enter the site of implantation and adhere to the 
surface of the biomaterial. While they initially adhere to most surfaces quite well 
they often fail to maintain adhesion over time (McNally and Anderson 2002). The 
result of this is that materials which do not have the surface properties which 
encourage attachment can lead to increased levels of detachment, which in turn can 
lead to anoikis. Anoikis being a type of apoptosis caused by disruption of adhesion 
signals in cells which are programed to remain adhered to a surface or the cells 
local environment (Frisch and Screaton 2001). When macrophage fusion levels are 
high, anoikis levels are low, and it is theorised that under certain conditions when 
the levels of detachment are high, the cells take an alternative pathway and end up 
undergoing fusion (Brodbeck, Shive et al. 2001). This was not observed with the 
control SIS and as this consists predominantly of collagen, the main constituent of 
all extracellular matrices, it could be fair to assume that these cells can adhere to 
the SIS collagen without undergoing this process. 
Given the large number of cells present during an inflammatory reaction even if the 
rate of detachment is high, there are still a large number of cells which are still 
attached. Here the surface chemistry of the material can also play a part here as it 
has been shown that biomaterial surface chemistry can influence apoptosis of 
adherent macrophages both in vitro and in vivo (Brodbeck, Shive et al. 2001; 
Brodbeck, Colton et al. 2003). With this in mind it has to be said that the surface of 
PLGA fibres cannot be considered great sites for adhesion. This could be the case 
here as macrophage fusion has been shown to be material dependant with surfaces 
requiring an array of absorbed proteins in order for adherent cells to undergo the 
necessary phenotypic change to fuse into foreign body giant cells (Brodbeck, Shive 
et al. 2001). There is also evidence that in in vitro testing that the surface properties 
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of the material (i.e. composition and charge) can actually affect the phenotypic 
expression of foreign body giant cells and even alter the interleukin-4 induced fusion 
of macrophages to form them (McNally and Anderson 2015). 
Another physical aspect of the immune reaction is that macrophages are only 
capable of phagocytosing very small particles (<5 μm) and the presence larger 
particle sizes (>10 μm) or large fibres, can induce the formation of foreign body 
giant cells (Anderson, Rodriguez et al. 2008). It is also crucial to note that in the 
case of the PLGA-SIS scaffolds the PLGA was in the form of nanofibres and so with 
a very high surface area all these effects would be exaggerated and contribute 
greatly to the foreign body reaction.  
With these inflammatory processes in effect it is important to emphasize that the 
―biomaterial‖ which is primarily the cause, i.e. the PLGA scaffold, is intended to be a 
temporary feature. This falls in line with the main objectives of this work in that the 
PLGA is required to maintain its mechanical integrity for 3-4 weeks and then begin 
to be degraded as the scaffold gives way to regenerated oesophageal tissue.      
The PLGA is designed to degrade, and the monomer components, lactic and 
glycolic acid, degraded in Krebs’ cycle. The adhesion of macrophages and FGBC’s 
at the surface of the material produce a distinct microenvironment between the cell 
membranes and the biomaterial. These cells release degradation mediators such as 
reactive oxygen intermediates (ROIs, oxygen free radicals), degradative enzymes, 
and acids into the microenvironments. (Anderson, Rodriguez et al. 2008).-[How 
temporary? Again relate to the product specification.]   
In these shielded microenvironments buffering or inhibition of these mediators are 
delayed or reduced (Anderson 2011). The phagolysosomes found in macrophages 
have been found to have acidity as low as pH 4 (Haas 2007). The surfaces of 
biomaterials are exposed to high concentrations of these degradative agents and 
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thus the biochemistry of the biomaterial will affect how rapidly it is degraded. In the 
case of PLGA there is the additional problem of the degradation products also being 
acidic which can contribute to lower the pH of the microenvironments further. 
As mentioned previously, for a scaffold such as this to succeed the degradation 
process is an essential part of the function of the implant. Consequently for this 
process to actually occur it is essential that the scaffold be infiltrated by the immune 
cell so that these degradative processes can take place. Large sections of the 
scaffold which are not infiltrated risk becoming isolated and this will be discussed 
later. It is also an important result that the fibres were intact at 4 weeks as this is the 
approximate time scale which was quoted for stent-type material to be required to 
support SIS after implantation (Doede, Bondartschuk et al. 2009).  
What was also observed in the cellular infiltration data (Figure 4.27) is that there 
appears that there was a higher degree of cellular infiltration in the scaffolds with 
aligned fibres, particularly at 5000 rpm. This result is not what was expected as the 
smaller pore size and more compact structure could be hypothesized to prevent 
cells and nutrients from becoming distributed throughout the scaffold. However 
there is agreement in the literature, in one study scaffolds were inserted in vivo and 
compared in terms of alignment, with the aligned fibres demonstrating better cellular 
infiltration than random orientation (Kurpinski, Stephenson et al. 2010). It has also 
been shown that fibre alignment does not affect integration (Ionescu and Mauck 
2013). The alignment of the fibres have also been described as facilitating cell 
movement within scaffolds (periodontal cells used in this instance) (Shang, Yang et 
al. 2010).  
When considering alignment there is also the question of how this affects the 
porosity. As mentioned previously, fibre alignment change was found to alter the 
nature of the porosity. While the more aligned scaffolds were less porous they 
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actually possessed a more split pore diameter distribution between larger and very 
small pores and this appears to produce better cellular infiltration in vivo which is a 
positive result. It is important to consider that higher porosity and larger pores not 
necessarily a measure for better interconnectivity between pores which is also 
significant for nutrient distribution. Consequently it may be that the aligned fibres 
allow for a porosity distribution with better interconnectivity between pores and this 
may account for better cellular filtration. 
Another reason why it was vital for there to be adequate infiltration into the scaffold 
was due to the fact that this could potentially affect the nature of remodelling which 
occurs. This process begins with the adherent macrophages, present during the 
inflammation,  secreting growth and angiogenic factors that have roles in the 
regulation of fibroblast proliferation and angiogenesis (Martin and Leibovich 2005). 
In in vitro circumstances it has been shown that human macrophages can be react 
to biopolymers by stimulating fibroblast activity. Also it has been shown that high 
fibroblast stimulation correlates to the in vivo fibrotic response (Miller and Anderson 
1989). In effect, biomaterial adherent macrophages can produce stimulating factors 
that can cause fibrosis and this, in turn, can result in the development of a fibrous 
capsule that is known to develop around an implanted material. This fibrous capsule 
can have a harmful effect on the implant and can interfere with its function 
(Anderson, Rodriguez et al. 2008).  
The fibrous capsule is formed of a dense collagen matrix and possesses very low 
numbers of cells (Anderson 2011). Its primary purpose is to isolate the material from 
the internal environment which is often not desirable. In the case of degradable 
materials this is undoubtedly a poor outcome. However this is not the only outcome.  
The nature of the foreign-body reaction around a biomaterial may be controlled by a 
number of factors.  The surface properties of the biomaterial, the shape of the 
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implant, and the surface-to-volume of the implant can all impact on the reaction. 
High-surface-to-volume implants such as electrospun scaffolds (in addition to 
fabrics, porous materials, particulate, or microspheres) are found to have higher 
ratios of macrophages and foreign-body giant cells when implanted as opposed to  
bulk and smooth-surface implants, which tend to have fibrosis as a significant 
feature of their implantation (Anderson 2011).  
The formation of a fibrous capsule was not found in any of the PLGA-SIS scaffolds. 
What was found was a large number of FBGC’s and monocytes (macrophage 
precursors) as described in the literature as present with high-surface-to-volume 
implants.  While there was actually was a high level of granulation tissue formed 
around the scaffolds this was actually quite diffuse in structure, was reasonably well 
cellularised and of high vascularity. In conclusion, while the foreign body reaction 
can be considered an undesirable result it can actually occur without formation of a 
fibrous capsule as was the case with the PLGA-SIS scaffolds used here.  As a 
result it could be speculated that the inflammatory process would undergo resolution 
leading to the restoration of normal tissue structure. 
The final feature of the scaffold was its use as a means of drug delivery. A number 
of things emerged from the addition of VEGF to the hybrid scaffolds.  The first stage 
of VEGF incorporation was carried out in vitro. The VEGF assay showed that there 
was undoubtedly retention of the VEGF within all the three 3 scaffolds tested 
(Figure 4.20a). The data also showed that the concentration was largely identical for 
all three and that there was little difference over the three time points. The graph in 
Figure 4.20b was the result of the calculations of the actual quantities of VEGF 
present in the solution. The levels were found to be between 60 - 110 ng of VEGF, 
which was generally considered quite low given the initial quantity added was 500 
ng per sample. Care should be taken when considering these figures as absolute as 
it is likely that some of the VEGF might have denatured, and a certain amount is 
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likely to remain associated with the scaffold. What can be taken here, given the 
drastic reduction, is that the direct loading method employed here was quite 
inefficient.  
Upon testing it was also clear that the VEGF was mostly released in the initial burst 
release by day 1. In a study also using VEGF adsorption, it was found that there 
was an initial burst release after 1 day, as observed here though it was additionally 
observed that there was a small and sustained release over the course of days 2-5 
(Singh, Wu et al. 2012). This represents a shorter term than analysed here (days 7 
and 14) as opposed to daily, however a small increase was observed by day 7 and 
a slower release could potentially account for this.  In another study there was also 
a burst release at day one followed by a slow decrease to virtually nothing by day 7 
(Lode, Wolf-Brandstetter et al. 2007). This trend may also be present here however 
the time-points were chosen to reflect the proposed in vivo work and not carried out 
on a daily basis as mentioned previously. 
To demonstrate the scaffold as a suitable delivery method for VEGF a CAM assay 
was also performed. It is well established that VEGF can affect the CAM (Wilting, 
Christ et al. 1992; Wilting, Christ et al. 1993; Verma, Gu et al. 2011). The principle 
conclusion of the CAM assay was that it demonstrated the effectiveness of 
incorporating VEGF into a scaffold of this nature. The results of the CAM assay 
show there was a fair degree of variability however and this can probably be due to 
the method of loading. The average length of the complexes was statistically higher 
for the VEGF samples versus the control which was not the case for the non-VEGF 
samples. It was also statistically demonstrated that when the data from all the VEGF 
samples were compared to the combined non-VEGF samples that there was a 
statistical difference between the two sets in terms of the mean number of junctions. 
In conclusion it was demonstrated that in an in vivo model the scaffolds and the 
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VEGF can have a direct effect by increasing angiogenesis, a result also confirmed 
in the literature.  
The actual implantation in vivo results included specific analysis to assess any 
effects of the VEGF in the scaffolds. There were two basic results from the analysis. 
Firstly that the incorporation of the VEGF resulted in a statistically significant 
increases in the blood vessel density in the surrounding granulation tissue when 
samples with and without VEGF were compared (with a single exception but which 
still had a higher mean value). In effect, the newly formed connective tissue which 
formed around the encapsulated scaffolds had, as a result of the initial burst release 
of VEGF from the scaffold, had an increase in the number of blood vessels after a 4 
week period. All the VEGF samples were statistically higher than the commercial 
control. This is a result which has been observed previously, including increased 
microvessel density with VEGF added to a PLGA sub dermal implant for bone 
tissue applications (Lindhorst, Tavassol et al. 2010). 
The second result was first observed through visual analysis and it was that while 
the numbers of blood vessels were higher in the samples with VEGF the increase 
appeared to be in the number of smaller diameter vessels with the numbers of 
larger vessels remaining similar. The decision was then taken to also analyse the 
vessel diameters as well counting the numbers. While the trend here was not as 
clear, the samples with VEGF showed a general trend of have lower mean values. 
This observation is in line with the literature where the action of VEGF is described 
as causing the formation of new vascular buds (Anderson, Ponce et al. 2004). 
It is also important to state that VEGF is an angiogenic factor that has only been 
used with limited success. There is a large body of work that shows that VEGF, 
when used in isolation can induce vessels which are immature and leaky, giving rise 
to local oedema and inefficient tissue perfusion (Alfranca 2009). This has been 
207 
 
found to be mitigated though the use of heparin, which natural binds to the molecule 
(Ferrara 2004). Heparin-binding VEGF isoforms produce a branching network with 
vessels which do not have the problems listed previously (Vempati, Popel et al. 
2014). Consequently this represents a limitation of this work, however the VEGF 
was also an important method by which quantifiable data could be obtained post in 
vivo implantation to demonstrate that the scaffolds had the potential for drug 
delivery.  
 
4.4.2 Conclusion 
The main points of the conclusion of this chapter will be discussed in more detail in 
the next chapter and tie into the conclusions of the thesis as a whole.  
Within the scope of this chapter alone it can be concluded that the PLGA-SIS 
scaffolds were found to have good mechanical properties and also found to be 
highly porous in structure. The fibres could also be produced with consistently 
alignment and the adhesion between the two layers was also maintained throughout 
the work in this chapter.  These factors point to the potential of this scaffold in terms 
of its physical properties. 
In terms of biocompatibility the hybrid scaffolds were again found not to possess 
any major limitations in a tissue engineering capacity. When tested in vivo, a foreign 
body reaction was elicited though this did not progress to fibrous capsule formation 
which is a highly desirable result.  While the SIS on its own performed very well in 
vivo it was also concluded that if the immune reaction to the PLGA fibres was 
reduced then this would improve the performance of the scaffold by limiting the 
potentially harmful effects of the foreign body reaction.  
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The final area of concern was the alignment of the PLGA fibres. Here it was 
concluded that the highly aligned samples (5000 rpm) are likely to present the best 
possible solution due to the in vivo performance with the highest cellular infiltration, 
the circumferential mechanical advantage and finally due to the potential for smooth 
muscle cell alignment.  
It was also concluded that the addition of VEGF resulted in an increase in the 
numbers of blood vessels in the granulation tissue surrounding the scaffolds and 
therefore had the potential for use to improve vascularity in and around the scaffold. 
It was also shown that VEGF incorporation was possible through the use of the 
adsorption. While it might not present the ideal method for drug delivery due to its 
low rate of retention it could be used if an initial burst release is required.  
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5.1 - Conclusions 
One of the first aims outlined in this work was to produce a base SIS scaffold which 
is structurally and biologically suitable for spin coating with polymer fibres. The ideal 
method for the decellularisation of intact tubular SIS was concluded to be using 
sodium deoxycholate under perfusion (with the elimination of DNase from the 
protocol). The preference for perfusion decellularisation over agitation for tubular 
organs was also expressed by Sjoqvist et al. when the methods were compared for 
the rat oesophageal decellularisation (Sjoqvist, Jungebluth et al. 2014). After 
analysis, and further adjustments to the procedure, it was conclude that this type of 
SIS fulfilled the required criteria and could be consistently produced.  
A further aim of this work was for the SIS produced to be suitable for 
electrospinning. Work carried out in Chapter 3 it was concluded that electrospinning 
a polymer layer onto tubular SIS (with two different polymers) was possible and that 
attachment, once refinement of the SIS processing was carried, was suitable 
between the two layers so they could be treated as a single structure.  
The aim of the Chapter 4 was to evaluate the effectiveness of the combined hybrid 
scaffold and to test its potential for drug delivery. It was concluded that the PLGA-
SIS scaffolds were found to have good mechanical properties and were highly 
porous in structure. Here it was also concluded that the scaffolds showed suitable 
biocompatibility. The SIS on its own (the control group) had no foreign body reaction 
and therefore the foreign body reaction found on the hybrid scaffolds was largely 
due to the presence of the PLGA.  A further conclusion was that the highly aligned 
samples (5000 rpm) are likely to present the best possible solution due to the in vivo 
performance. The final conclusion was that the addition of VEGF showed an 
increase in the number of blood vessels and so could improve the function of the 
scaffold.  
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With all that taken together a few further observations can be made. Firstly that the 
basic approach of a combined ECM and biopolymer appears to be a potential 
approach to oesophageal tissue engineering. Secondly, while these scaffolds, and 
indeed other similar approaches, appear to have potential actually using such 
systems successfully in a patient presents a large array of further problems. 
Considering all the literature and news of clinical outcomes for similar organ 
replacement procedures it appears that there will have to be an increase in 
complexity and knowledge prior the successful clinical application of such systems. 
Nevertheless, hybrid systems combining the properties of two or more different 
materials in addition to a variety cell types remains a positive direction for the 
development of tissue engineered tubular organs.    
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5.2 - Future Work 
As mentioned previously In studies where a section of oesophagus was replaced 
common complications included stricture, dilation and the lack of significant muscle 
growth  (Doede, Bondartschuk et al. 2009). One method which has always been 
part of a theoretical end game of this work was the culture of smooth muscle tissue 
cells onto the scaffold prior to implantation. Circumferential smooth muscle would 
very rapidly be exposed to mechanical forces which would aid in their development 
and the formation of a more functional tissue engineered structure.  
Minimising the foreign body reaction is also important as it was this that presented 
as the greatest potential limitation of the scaffolds. Cell adhesion should be an area 
for improvement there are a large number of ways to improve the biocompatibility of 
the PLGA fibres such as the incorporation of fibronectin into the PLGA fibres 
(Hersel, Dahmen et al. 2003). Work here has shown that the incorporation of these 
types of biomaterials can improve the immune reaction to, and therefore the in vivo 
performance of, certain polymers. This is significant particularly for an initial 
culturing scenario as it is in this microenvironment that the introduced cells, in 
addition to the native cells, are expected to thrive. 
One future potential improvement could be the use of additional layers. While the 
electrospinning might prevent further additions to the electrospun layer, providing 
the initial SIS-PLGA layer is produced and intact (to prevent leakages), additional 
layers could be added by cutting and suturing additional layers of the combined 
SIS-PLGA over the base layer. This could provide additional mechanical strength 
while also allowing for different layers to be cultured separately and with different 
cell types.  
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Alternative polymers are also a potential area for improvement. While the properties 
of PLGA are very good there is the potential for a polymer with better elastic 
properties. This not easy to find and the literature does not offer any clear examples 
which might easily replace the PLGA here. Polymer blends, particularly using 
biopolymers such as elastin, might offer some potential avenues.  
In addition to this the incorporation of VEGF could be improved by it being present 
in the fibres themselves. At 4 weeks the fibres were present and intact and 
therefore being resorbed at a slow rate (which was intended); this represents the 
ideal circumstances for a sustained low-level release of growth factors which might 
improve the overall in vivo performance of the scaffold. That said, a small dose of 
adsorption-introduced VEGF as the initial burst release has been shown to have an 
appreciable effect and therefore could also be included. Nanoparticle encapsulation 
of VEGF has been successfully carried out and with some variations to the 
electrospinning process these could be incorporated into the nanofibres. There is 
also the potential for the VEGF to be added to water soluble polymers and then 
coaxially electrospun along with the PLGA fibres. 
As mention previously VEGF has been found to function better with heparin and 
therefore incorporating this into future work in this area would be ideal. This can be 
achieved through the use of heparin binding to the SIS. This would also have the 
effect of increasing the retention of the VEGF in addition to increasing its active 
lifespan in vivo (Vempati, Popel et al. 2014). In recent work tubular SIS was created 
for arterial tissue engineering and then heparin was bound the surface. To this 
VEGF was added which was then immobilised by the heparin.  This cell-free 
scaffold was then successfully implanted into the arterial vascular system of an 
ovine model and developed functioning endothelial and medial blood vessel layers. 
(Koobatian, Row et al. 2016).  
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One of the most important directions for future work is for the scaffold to be test in 
vivo as a short-segment oesophageal replacement in an animal model. Previous 
work has shown that dogs represent a better analogue to pigs in terms of their 
orientation and relative length.  
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Appendix A 
A-1 Proximal vs. Distal Small Intestine Submucosa 
                                            (a)                                                                                    (b) 
  
                                          (c) 
 
Figure A1 Comparison data from mechanical testing of the proximal (jejunum) and distal (ileum) showing (a) Elastic 
modulus values (MPa) (n = 8) (b) Yield stress values (MPa) (n = 8) (c) Failure strain values (%) (n = 8). Error bars 
shown are the standard error. 
 
Mechanical testing (Figure A1) was carried out using fresh porcine small intestine 
submucosa with a view to ascertain whether using small intestine submucosa from 
different regions might make a difference to the mechanical performance of SIS. In 
these tests there appeared to be no differences in the values from the two types of 
SIS. Consequently the decision was taken to use tissue primarily from the jejunum 
which is the longest section of the small intestine and from which it is easier to 
harvest the SIS. 
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A-2 Improved washing regime 
The samples were placed in the containers and then the containers were completely 
filled with deionised water. Care was taken to ensure that no air bubbles were 
present. The input channels of all the containers were then placed in a large 5 litre 
flask filled with deionised water and the pump then allowed to run. The deionised 
water was then allowed to overflow from each container creating a one-way flow. 
The 5 litre flask was then topped up with fresh deionised water as required, and the 
entire arrangement was run for 6 h.  
A-3 Earlier Perfusion Rig 
 
Figure A2 Early perfusion rig. The design was updated to allow for a fully sealed environment, 
Early perfusion was carried out using an open-top vessel arrangement (Figure A2). 
Upon decellularisation these would be covered with plastic wrapping material, 
however the seal was never complete.  
A-4 ISO Standards 
 ISO 10993-5:2009(en) Biological evaluation of medical devices — Part 5: Tests for 
in vitro cytotoxicity. https://www.iso.org/obp/ui/#iso:std:iso:10993:-5:ed-3:v1:en 
 ISO 10993-12:2007(en) Biological evaluation of medical devices — Part 12: Sample 
preparation and reference materials https://www.iso.org/obp/ui/#iso:std:iso:10993:-
12:ed-3:v1:en 
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Appendix B 
B-1 Changing Syringe Type 
The syringes in initial use were conventional syringes with rubber bungs. With the 
use of dichloromethane as a solvent the result was that the rubber was being 
dissolved by the solvent causing decolouration of the polymer. As future research 
would involve in vivo and in vitro work preventing any contaminant from entering the 
polymer became relevant. A rubberless syringe was adopted for future use. In 
addition to this polymer was also made in small 10 cm3 batch so that to would not 
be reused so that potentially contaminants would not accumulate. This method also 
improved the process as a whole, as repeated use of a polymer solution caused 
solvent loss. Solvent loss caused the concentration to change, affecting the 
viscosity, needle tip drying and subsequent clogging, in addition to other factors.  
B-2 Salt Leaching  
                                                             (a)                                                   (b) 
   
 Figure B1 PCL fibres (20%) with salt crystals (a) NaCl befor wash (b) NaCl after wash  
 
No difference and no improvement obeserved. It was likely that the large salt 
crystals separated from the polymer upon emergence or remained in the syring. 
While this might be improved through the use of smaller crystals, on appearance the 
scaffolds appeared to have a resonable amount of porsity. 
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Collection 
Surface 
SIS 
type 
Dia-
meter 
(cm) 
Arrange-
ment 
Polymer 
Concentra
tion (% -
w/v) 
Solvent 
Flow 
Rate 
(ml h-
1) 
Needle Size 
Height 
(cm) 
Voltage 
(kV) 
Time 
(m/cm) 
Mandrel 
Speed 
(rpm) 
Additional 1 Additional 2 Comment Reference 
Foil n/a n/a 1 PCL 10 DCM 60 
21 Gauge 
(0.514mm) 
4 20     30 2 9 
  
No clear fibres, pooling of the 
polymer  
Foil n/a n/a 1 PCL 20 DCM 60 
21 Gauge 
(0.514mm) 
4 20     30 2 9 
  
No clear fibres, pooling of the 
polymer  
Foil n/a n/a 1 PCL 30 DCM 60 
21 Gauge 
(0.514mm) 
4 20     30 2 9 
  
No clear fibres, pooling of the 
polymer  
Foil n/a n/a 1 PCL 10 DCM 60 
21 Gauge 
(0.514mm) 
7 20     30 2 9 
  
Very few fibres, still heavy pooling 
 
Foil n/a n/a 1 PCL 20 DCM 60 
21 Gauge 
(0.514mm) 
7 20     30 2 9 
  
Very few fibres, still heavy pooling 
 
Foil n/a n/a 1 PCL 30 DCM 60 
21 Gauge 
(0.514mm) 
7 20     30 2 9 
  
Very few fibres, still heavy pooling 
 
Foil n/a n/a 1 PCL 10 DCM 15 
18 Gauge 
(0.838mm) 
15 20 2 540 
  
Some fibres present 
 
Foil n/a n/a 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 2 540 
  
Some fibres present 
 
B-3 Electrospinning Parameters and Variations 
Table B1 Key variations of electrospun fibres produced for Chapters 3 & 4. This list is not exhaustive and predominately only includes samples producing using a mandrel. Each variation, in 
addition to others, were produced using flat collectors such as foil or glass slides placed over a flat plate electrode. 
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Foil n/a n/a 1 PCL 30 DCM 15 
18 Gauge 
(0.838mm) 
15 20 2 540 
  
Very poor fibres 
 
Foil n/a n/a 1 PCL 15 DCM 15 
18 Gauge 
(0.838mm) 
15 20 2 540 
  
Improvement over 30%  PCL, yet 
no better than 20%  
SIS 
SDS
/TX 
1.9 1 PCL 10 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 540 
  
Fibres present, irregular and 
inadequately dried 
Chapter 
3.3.1 
SIS 
SDS
/TX 
1.9 1 PCL 15 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 540 
  
Fibres present, irregular and 
inadequately dried 
Chapter 
3.3.1 
SIS 
SDS
/TX 
1.9 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 540 
  
Improved Fibres 
Chapter 
3.3.1 
SIS 
SDS
/TX 
1.9 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 1260 
  
No improved alignment over 540 
rpm 
Chapter 
3.3.1 
SIS 
SDS
/TX 
1.9 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 1440 
  
No improved alignment over 540 
rpm 
Chapter 
3.3.1 
SIS 
SDS
/TX 
1.9 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 1620 
  
No improved alignment over 540 
rpm 
Chapter 
3.3.1 
SIS 
SDS
/TX 
1.9 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 1800 
  
Some improved alignment over 540 
rpm 
Chapter 
3.3.1 
SIS 
SDS
/TX 
1.9 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 540 attachment 
  
Chapter 
3.3.1 
SIS 
SDS
/TX 
1.9 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 540 starting wet 
  
Chapter 
3.3.1 
SIS 
SDS
/TX 
1.9 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 540 
constant 
wet   
Chapter 
3.3.1 
SIS 
SDS
/TX 
1.9 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 540 acetone 
  
Chapter 
3.3.1 
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SIS 
SDS
/TX 
1.9 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 540 NaCl No Wash No salt crystals detected  
Appendix 
B-2 
SIS 
SDS
/TX 
1.9 1 PCL 20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 5 540 NaCl Washed No salt crystals detected 
Appendix 
B-2 
Foil n/a n/a 1 
PLGA (D-
& L-) 
10 DCM 15 
18 Gauge 
(0.838mm) 
15 20 2 540 
  
Suitable for fibres (but not followed 
due to changes in the polymer)  
Foil n/a n/a 1 
PLGA (D-
& L-) 
15 DCM 15 
18 Gauge 
(0.838mm) 
15 20 2 540 
  
Suitable for fibres (but not followed 
due to changes in the polymer)  
Foil n/a n/a 1 
PLGA (D-
& L-) 
20 DCM 15 
18 Gauge 
(0.838mm) 
15 20 2 540 
  
Suitable for fibres (but not followed 
due to changes in the polymer)  
Foil n/a n/a 1 
PLGA (D-
& L-) 
25 DCM 15 
18 Gauge 
(0.838mm) 
15 20 2 540 
  
Suitable for fibres (but not followed 
due to changes in the polymer)  
Foil n/a n/a 1 
PLGA 
(High 
Viscosity) 
10 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 2 540 
  
The viscosity was creating some 
clogging problems with the needle. 
Lower concentrations evaporated 
too quickly. 
 
Foil n/a n/a 1 
PLGA 
(High 
Viscosity) 
15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 2 540 
  
The viscosity was creating some 
clogging problems with the needle. 
Lower concentrations evaporated 
too quickly. 
 
Foil n/a n/a 1 PLGA 10 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 2 540 
  
Globules of polymer along with very 
fine fibres 
Appendix 
B-4 
Foil n/a n/a 1 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 2 540 
  
Positive result for the polymer 
Appendix 
B-4 
Foil n/a n/a 1 PLGA 20 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 2 540 
  
Clogging present/Good Fibres 
Appendix 
B-4 
SIS 
SDS
/TX 
1.9 1 PLGA 10 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 540 
   
 
SIS 
SDS
/TX 
1.9 1 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 540 
  
Remained the best option  
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SIS 
SDS
/TX 
1.9 1 PLGA 20 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 540 
   
 
SIS 
SDS
/TX 
1.9 1 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 540 attachment 
  
Chapter 
3.3.2  
SIS 
SDS
/TX 
1.9 1 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 540 starting wet 
  
Chapter 
3.3.2 
SIS 
SDS
/TX 
1.9 1 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 1440 
   
Chapter 
3.3.2 
SIS 
SDS
/TX 
2.54 2 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 10 
   
Chapter 
3.3.2 
SIS 
SDS
/TX 
2.54 2 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 1000 
   
Chapter 
3.3.2 
SIS 
SDS
/TX 
2.54 2 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 2000 
   
Chapter 
3.3.2 
SIS 
SDS
/TX 
2.54 2 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 3000 
   
Chapter 
3.3.2 
SIS 
SDS
/TX 
2.54 2 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 10 starting wet 
  
Chapter 
3.3.2 
SIS 
SDS
/TX 
2.54 2 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 3000 starting wet 
  
Chapter 
3.3.2 
SIS 
SDS
/TX 
2.54 2 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 10 
 
Initial Spin for 
1m at 7ml h-1 
Additional layer created an 
incomplete covering  
SIS 
SDS
/TX 
2.54 2 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 10 
 
Initial Spin for 
2m at 7ml h-1  
Chapter 
3.3.2 
SIS 
SDS
/TX 
2.54 2 PLGA 15 DCM 1 
18 Gauge 
(0.838mm) 
15 10    15 5 3000 
 
Initial Spin for 
2m at 7ml h-1  
Chapter 
3.3.2 
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Foil n/a n/a 2 PLGA 15 
DCM:DMF 
(9:1) 
1 
18 Gauge 
(0.838mm) 
15 10    15 2 10 
  
Little reduction of clogging 
 
Foil n/a n/a 2 PLGA 15 
DCM:DMF 
(8:2) 
1 
18 Gauge 
(0.838mm) 
15 10    15 2 10 
  
Significant reduction to clogging 
 
Foil n/a n/a 2 PLGA 15 
DCM:DMF 
(7:3) 
1 
18 Gauge 
(0.838mm) 
15 10    15 2 10 
  
Similar to 8:2 
 
SIS SD 2.54 2 PLGA 15 
DCM:DMF 
(8:2) 
1 
18 Gauge 
(0.838mm) 
15 10    15 15 10 
 
Initial Spin for 
2m at 7ml h-1  
Chapter 
4 
SIS SD 2.54 2 PLGA 15 
DCM:DMF 
(8:2) 
1 
18 Gauge 
(0.838mm) 
15 10    15 15 1000 
 
Initial Spin for 
2m at 7ml h-1  
Chapter 
4 
SIS SD 2.54 2 PLGA 15 
DCM:DMF 
(8:2) 
1 
18 Gauge 
(0.838mm) 
15 10    15 15 2000 
 
Initial Spin for 
2m at 7ml h-1  
Chapter 
4 
SIS SD 2.54 2 PLGA 15 
DCM:DMF 
(8:2) 
1 
18 Gauge 
(0.838mm) 
15 10    15 15 3000 
 
Initial Spin for 
2m at 7ml h-1  
Chapter 
4 
SIS SD 2.54 2 PLGA 15 
DCM:DMF 
(8:2) 
1 
18 Gauge 
(0.838mm) 
15 10    15 15 4000 
 
Initial Spin for 
2m at 7ml h-1  
Chapter 
4 
SIS SD 2.54 2 PLGA 15 
DCM:DMF 
(8:2) 
1 
18 Gauge 
(0.838mm) 
15 10    15 15 5000 
 
Initial Spin for 
2m at 7ml h-1  
Chapter 
4 
SIS SD 2.54 2 PLGA 15 
DCM:DMF 
(8:2) 
1 
18 Gauge 
(0.838mm) 
15 10    15 
7.5 / 
7.5 
10 / 
3000 
[mixed] 
Initial Spin for 
2m at 7ml h-1 
No advantage observed with 
mechanical testing 
 
SIS SD 2.54 2 PLGA 15 
DCM:DMF 
(8:2) 
1 
18 Gauge 
(0.838mm) 
15 14    15 15 10 
improved 
SIS wash 
Initial Spin for 
2m at 7ml h-1  
Chapter 
4 
SIS SD 2.54 2 PLGA 15 
DCM:DMF 
(8:2) 
1 
18 Gauge 
(0.838mm) 
15 14    15 15 3000 
improved 
SIS wash 
Initial Spin for 
2m at 7ml h-1  
Chapter4 
SIS SD 2.54 2 PLGA 15 
DCM:DMF 
(8:2) 
1 
18 Gauge 
(0.838mm) 
15 14    15 15 5000 
improved 
SIS wash 
Initial Spin for 
2m at 7ml h-1  
Chapter4 
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B-4  PLGA Electrospinning 
                                                        (a)                                                                  (b) 
    
                                                        (c)                                                                (d) 
    
                                                         (e)                                                                 (f) 
    
Figure B2 Results flat electrospinning onto foil with different concentrations of polymer; (a) (b) 10% PLGA (c) (d) 
15% PLGA (e) (f) 20% PLGA 
 
Preliminary work with varying PLGA concentration using electrospinning to flat 
surface (aluminium foil). Here it was found that with the 10% PLGA soultion the 
electrospinning largely failed. For both the 15% and  20% PLGA there was clear 
electrospun fibres produced, however, with the 20% PLGA solution clogging 
became an issue. Consequently 15% PLGA became the solution adopted for future 
work.  
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Appendix C 
C-1 Histological Images 
 (a) Commercial - 2 Weeks 
    
 
(b) Commercial - 4 Weeks 
    
 
 
 
(c) SIS  Control - 2 Weeks 
    
 
(d) SIS Control - 4 Weeks 
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(e) 10rpm - 2 Weeks 
    
 
(f) 10rpm - 4 Weeks 
    
 
 
 
 
(g) 3000rpm - 2 Weeks 
    
 
(h) 3000rpm - 4 Weeks 
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(i) 5000rpm - 2 Weeks 
    
 
(j) 5000rpm - 4 Weeks 
    
 
 
 
 
(k) 10rpm + VEGF - 2 Weeks 
    
 
(l) 10rpm + VEGF - 4 Weeks 
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(m) 3000rpm + VEGF - 2 Weeks 
   
 
(n) 3000rpm + VEGF - 4 Weeks 
    
 
 
 
(o) 5000rpm + VEGF - 2 Weeks 
    
 
(p) 5000rpm+ VEGF - 4 Weeks 
    
 
Figure C1 Low resolution histological images (H&E) from the samples groups. The samples type are (a) 
Commercial - 2 Weeks (b) Commercial - 4 Weeks (c) SIS  Control - 2 Weeks (d) SIS Control - 4 Weeks (e) 10rpm - 
2 Weeks (f) 10rpm - 4 Weeks (g) 3000rpm - 2 Weeks (h) 3000rpm - 4 Weeks (i) 5000rpm - 2 Weeks (j) 5000rpm - 4 
Weeks  (k) 10rpm + VEGF - 2 Weeks (l) 10rpm + VEGF - 4 Weeks (m) 3000rpm + VEGF - 2 Weeks (n) 3000rpm + 
VEGF - 4 Weeks (o) 5000rpm + VEGF - 2 Weeks (p) 5000rpm + VEGF - 4 Weeks 
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C-2 Mercury Intrusion Porometry  
(a) 10 rpm 
 
(b) 10 rpm 
 
(c) 10 rpm 
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(e) 3000 rpm 
 
(f) 3000 rpm 
 
(g) 3000 rpm 
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(h) 5000 rpm 
 
(i) 5000 rpm 
 
(j) 5000 rpm 
 
Figure C2 Full size mercury intrusion porometry data charts (a)(b)(c) 10 rpm (e)(f)(g) 3000 rpm (h)(i)(j) 5000 rpm 
 
245 
 
C-3 In Vivo Certificates 
 
Certification of IACUC Approval 
 
Principle investigator 
Name Dept Status Phone Lab animal training number 
Hae-Won Kim NBM Associate professor +82-10-4156-7336 DKU-13-028 
 
Protocol information 
Proposal No 14-030 
Project title Korean 조직재생공학을 위한 소재-세포-인자 융합연구를 위해 자체 개발한 생체 적합성 
고분자의 생적합성 평가 
English Evaluation of Biocompatibility of Developed Biopolymer in Rat for Tissue 
Regeneration Engineering Interdisciplinary Research: Construction of Targeting 
Materials-Cells-Biofactors 
Period After approval ~ Oct 30 2015 (12 months) 
Animal species 
and Number 
SD Rat, ♂ 32 
Classification Grade D 
 
Approval result 
Revised date Sep. 16. 2014 
Approval date Sep. 16. 2014 
Approval number DKU 14-030 
Decision status Approve as is 
This protocol has been approved by the Dankook university IACUC.  
September 16 2014 
Chairperson of Dankook University IACUC 
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